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ABSTRACT 
 
The genetic sequence of human mitochondrial DNA (mtDNA) is of particular interest to 
forensic investigations involving human identification, as well as population genetics. 
The current mtDNA database is lacking sufficient representatives of African 
mitochondrial DNA sequences compared to European and Asian sequences. The present 
study was concerned with the analysis of mtDNA in the Egyptian population. FTA 
cards were used for blood sample collection, storage, and shipment and DNA 
extraction. An optimised laboratory protocol for rapid PCR amplification of the 
mitochondrial hypervariable regions was developed. A database of 261 mitochondrial 
hypervariable region I (HVI) sequences and 78 hypervariable region II (HVII) 
sequences was established from 261 adult Egyptians. A total of 113 polymorphic sites 
were reported in the HVI region (nt16024-16365) which identified a total of 187 
different haplotypes, of which 151 were unique to single individuals. The most 
commonly observed HVI haplotype was identical to the Cambridge Reference Sequence 
(CRS). Analysis of 78 HVII sequences (nt73-340) revealed a total of 42 polymorphic 
sites that identified 62 different haplotypes, of which 51 were unique to single 
individuals. Sites that showed the highest variability in the HVI and HVII regions 
agreed with the previously reported mutational hotspots. Combination of the HVI and 
HVII data resulted in identification of 207 different mitochondrial haplotypes, of which 
183 (~88%) were unique to single individuals. Such a large number of unique 
mitochondrial haplotypes indicates a high diversity of mtDNA in the Egyptian 
population, which has a direct impact on forensic applications, since the significance of 
a match between an evidence sample and a reference sample depends on the population 
frequency of a profile. The random match probabilities in the HVI and HVII datasets 
were 2.34% and 3.22%, respectively. Combination of the two datasets reduced the 
random match probability to 1.28%. The genetic diversities in the HVI and HVII 
sequences were estimated to be 0.9804 and 0.9803, respectively, whereas, the genetic 
diversity in the combined dataset was 0.9911. A new strategy was developed to 
facilitate Restriction Fragment Length Polymorphism (RFLP) analysis of the whole 
mitochondrial genome for the purpose of haplogroup assignment. All the Egyptian 
individuals were assigned to well known mitochondrial haplogroups and the frequency 
distribution of different lineages was estimated. A mixed maternal ancestry of the 
Egyptian population was reported via detection of a mixture of mitochondrial DNA 
lineages with varying racial backgrounds. The most frequently reported mitochondrial 
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lineages were haplogroup T (13.8%) followed by haplogroups L3 (12.6%), H (12.3%), 
U (~10%) and M (8.4%). The genetic relationship between Egypt and its neighbours 
was revealed, and it was found that present day Egyptians were the closest African 
population to the Middle East and Europe, with an overall 62.5% European, 25% 
African, and 12.5% Asian mitochondrial lineages. The data presented here will enrich 
the limited Egyptian mitochondrial DNA reference data currently available for forensic 
applications. 
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1. GENERAL INTRODUCTION 
 
Biological Issues 
 
1.1 DNA and human identification 
 
The use of DNA in human identification and forensic investigation has increased 
dramatically since DNA fingerprinting was first demonstrated by Sir Alec Jeffreys in 
1984. The many uses of DNA based identification include paternity testing. The human 
genome incorporates 3 billion base pairs in its structure that encode only for 20,000- 
25,000 genes corresponding to roughly 5% of the genome. Thus, the majority of the 
human genome is non-coding. These regions are of particular interest to DNA identity 
testing as they are more liable to mutate and change without causing any physical or 
physiological consequences. Therefore, they provide useful markers for human 
identification. 
 
These markers have contributed enormously to the fields of medical and forensic 
science including the forensic investigative work and identity testing. The human 
genome is full of repeated DNA sequences and these repeated loci are classified 
according to the length of the core repeat unit and the number of repeats into: Variable 
Number Tandem Repeats (VNTRs) which are also known as minisatellites, and Short 
Tandem Repeats (STRs) or microsatellites. Unlike VNTRs, which number a few 
thousand in our genome, STRs are present at > 100 000 regions that cover most of our 
genome. The lengths of the core unit repeat range from 2-6 bp in microsatellites to 10-
100 bp in minisatellites (Habano et al. 1999; Butler 2005a).  
 
STRs are more convenient to forensic applications compared to VNTRs due to the fact 
that they are scattered all through the human genome with allele size ranging between 
100-400 bp compared to 400-1000 bp of VNTRs. Hence, this relatively small size of 
STRs is more convenient to the forensic applications where degraded DNA is common. 
Moreover, the number of the repeat units of STR markers can be highly variable among 
individuals and thus makes them more effective for human identification purposes 
(Edwards et al. 1991). 
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Currently, there are many commercial kits available for multiplex PCR amplification of 
STR loci that are routinely and extensively used in DNA profiling. However, all these 
kits are of limited value when dealing with highly degraded forensic samples. That in 
turn explains the increasing interest in Single Nucleotide Polymorphism (SNP) typing in 
the forensic arena (Sobrino et al. 2005; Dixon et al. 2006). 
 
Several potential applications of SNPs exist for human identity testing that could further 
aid criminal investigations. These are mainly targeting three areas;  
 
 Estimation of the ethnic origin of samples retrieved at the crime scene 
Frudakis et al. have screened 211 SNPs in the human pigmentation and xenobiotic 
metabolism genes and they have found remarkable differences in the frequencies of 56 
SNPs (mostly in pigmentation genes) between groups of unrelated individuals 
descending from different ancestral background (Frudakis et al. 2003a). 
 
 Prediction of the physical traits of the perpetrators 
In the last 10 years, the attention of researchers has been drawn to the possibility of 
anticipation of the human phenotypic characteristics through identification of certain 
genetic variants. For example, an SNP typing assay has been developed by the Forensic 
Science Service, that involved a set of mutations in the human melanocortin 1 receptor 
gene which is associated with the red hair phenotype (Grimes et al. 2001; Frudakis et al. 
2003b). 
 
 Recovery of much more information from degraded DNA samples 
Being easily recoverable from degraded samples compared to STR markers, SNPs have 
been very successful in victims‟ identification in many circumstances particularly in 
mass disasters in which body parts have been highly degraded. As experienced in 
Tsunami earthquake in Thailand, 2004, where DNA samples were badly damaged and it 
was not possible to obtain fully informative STR profiling, meanwhile the use of 
mitochondrial SNPs gave the opportunity to carry out further analysis that helped in the 
identification of the human remains (Deng et al. 2005). Furthermore, identification of 
victims of the World Trade Centre attacks in New York, 2001, was more successful 
after supplementation of STR profiling results with mitochondrial SNPs data (Holland 
et al. 2003). 
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1.2 Mitochondrial genome 
 
1.2.1 Mitochondria 
      
Mitochondria are double-membraned subcellular organelles that are present in high 
copy number (several hundreds to several thousands) in the mammalian cell. 
Mitochondria are the powerhouse of the cell in which many crucial metabolic processes 
occur such as oxidative phosphorylation (Holland and Parsons 1999).   
  
They have their own unique genome (mtDNA), which is distinct from the nuclear DNA. 
Each mitochondrion has more than 2 copies of the mtDNA; thus there are on average 
thousands of copies of mtDNA in each somatic cell compared to the two copies of the 
nuclear genome (Kobilinsky et al. 2004). 
 
1.2.2 Structure and gene content of the mitochondrial DNA 
 
The mitochondrial genome is a double-stranded, antiparallel, double helical circular 
DNA molecule, approximately 16,569 bp in length encoding 37 densely packed genes. 
Twenty-two of these genes encode tRNAs, two encode 12S and 16S rRNAs, and 13 
encode enzymes involved in the processes of oxidative phosphorylation and ATP 
production (Holland and Parsons 1999). 
 
The two strands of the mtDNA are the light (L-strand) and the heavy (H-strand) strands 
due to a selective distribution of the nucleotides with more guanine and thymine (the 
highest molecular weights) on the latter. There is asymmetric distribution of genes 
within the mitochondrial genome since the heavy strand carries most of the genetic 
information. Twelve of the  polypeptides, the two ribosomal RNAs, in addition to 14 
tRNAs are encoded from the heavy strand while L strand transcribes the remaining 
eight tRNAs and only one enzyme corresponding to ND6 subunit of complex I (NADH-
dehydrogenase-ubiquinone reductase) (Figure 1.1) (Fernandez-Silva et al. 2003). 
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Figure 1.1: A map of the human mitochondrial genome. The subunits of NADH 
dehydrogenase (ND1–ND6 and ND4L) are shown in blue; subunits of cytochrome c oxidase 
(COI–COIII) are shown in red; cytochrome b is shown in green; and the subunits of the ATP 
synthase (ATPase 6 and 8) are shown in yellow. The two ribosomal RNAs (rRNAs; 12S and 
16S) are shown in purple. The black lines represent the 22 tRNAs. Reproduced from Taylor and 
Turnbull  (2005).  
 
There is a specific region consisting approximately of 1122 bp which does not code for 
any gene products and hence named „non-coding‟ region. Whereas, all the remaining 
part of the DNA molecule is known as the coding region in which the genes are tightly 
arranged with no introns in between.  The non-coding region, despite not transcribing 
any gene products, it contains the origin of replication of the heavy strand as well as 
promoters for the transcription initiation and therefore, it is mostly referred to as the 
control region or CR (Shadel and Clayton 1997; Fish et al. 2004).  
 
The CR is also known as the displacement loop or D-loop based on the mode of 
replication. In the displacement model, replication of mtDNA starts within the CR at the 
origin of replication of the heavy strand (Figure 1.2) (Brown et al. 2005).  
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Figure 1.2: Displacement (asymmetric) replication versus strand-coupled (symmetric) 
model of mtDNA replication. The model of asymmetric replication (shown on the left) 
illustrates how the circular genome starts replication of one strand (H-strand) with expansion 
and displacement of the D-loop. This expansion proceeds till the origin of replication of the other 
strand (L-strand) gets exposed with subsequent replication. This asymmetry of strand synthesis 
results in the production of one segregated daughter molecule with an incompletely synthesized 
L-strand, hence called a gapped circle (GpC). On the contrary, the strand-coupled replication 
model (shown on the right) illustrates a synchronous replication of the double strands 
bidirectionally leading to completely synthesized double stranded molecules (Brown et al. 
2005). 
 
1.2.3 Cambridge Reference Sequence (CRS) 
 
The primary sequence of the mitochondrial genome was first determined in 1981 and 
was known as the Anderson Reference Sequence (Anderson et al. 1981). This sequence 
was primarily derived from an individual of European descent. However, in 1999 
following the improvement in DNA sequencing technology, several minor errors have 
been identified and corrected to derive the Cambridge Reference Sequence (CRS) 
(Andrews et al. 1999). 
 
The base numbering system of the Cambridge Reference Sequence (CRS) starts in the 
middle of the control region (CR). The CR starts at the nucleotide position 16024 to 
16569 and then continues from position 1 to 576 (Figure 1.3). Despite of the 
corrections that have been done for the minor errors in the Anderson Reference 
Displacement 
replication 
Symmetric 
replication 
 GpC 
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Sequence, the historical nucleotide numbering system was maintained to avoid any 
possible confusion.  
 
This control region involves two distinct segments that exhibit a very high level of 
variability among individuals and so named hypervariable regions. The hypervariable 
region one (HVI) extends from base position 16024 to 16365, whereas the second 
hypervariable region (HVII) extends from position 73 to 340 (Figure 1.3) (Butler 
2005b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: A schematic representation of the mitochondrial human genome. The control 
region (CR) is opened to show the extension of the hypervariable regions (HVI and HVII) with 
lengths of 342 and 268 bases respectively. 
 
1.2.4 Mitochondrial inheritance and recombination  
 
The most widely accepted model for mitochondrial inheritance is that it is transmitted 
strictly through the maternal line. Conception occurs by introducing the sperm‟s nucleus 
into the ovum to constitute the nuclear genetic material of the zygote. Therefore, the 
cytoplasm and all other cellular components including the mitochondria will be derived 
from the maternal side solely (Giles et al. 1980; Gyllensten et al. 1985; Primorac and 
Schanfield 2000).  
342 bases 268 bases
HVI HVII
Human
Mitochondrial DNA
16569 bp
Control 
Region
Control Region
~1122bp
Nucleotide position                   16024             16365   16569 1  73            340                  576              
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Despite the widespread agreement to the simple clonal mode of mitochondrial 
inheritance, many studies have been conducted over the last 25 years that support the 
concept of paternal participation as well as recombination probabilities. 
 
1.2.4.1    Paternal inheritance of mtDNA 
 
A current debate exists about a different pattern of mitochondrial inheritance which 
involves paternal transmission through a phenomenon termed “paternal leakage” that is 
thought to occur during fertilization. Although, until recently, paternal leakage was 
thought to be impossible, there are some studies that support this phenomenon (Ankel-
Simons and Cummins 1996; Kvist et al. 2003). Through analysis of mitochondrial DNA 
in sheep, Zhao et al. (2004) have provided direct evidence of paternal inheritance. They 
suggested presence of both parents‟ mtDNA at an early stage of development after 
which only one type of mtDNA survived to later development. The most striking 
evidence of paternal leakage in human was reported by Schwartz and Vissing (2002), 
while investigating a case with mitochondrial myopathy caused by a 2-bp mitochondrial 
deletion. During this investigation which involved analysis of the mitochondrial DNA 
of the patient‟s parents and his sister, a paternal mitochondrial haplotype was detected 
in the patient‟s quadriceps muscle in a ratio of 10: 1 paternal to maternal type. 
Nonetheless, this was the only case that showed evidence of paternal inheritance of the 
mtDNA in human since 2002. In addition, the paternal mtDNA was only found in a 
specific muscle tissue and not in blood which is commonly used for mitochondrial DNA 
analysis. A finding which might explain the occurrence of paternal mtDNA 
transmission in that case on the basis of certain selection forces, and thus the 
phenomenon of paternal leakage can not be generally accepted as a crucial route of 
mitochondrial inheritance. Therefore, it was not expected for this phenomenon to have 
an actual impact on the current study which involved analysis of mtDNA in human 
blood samples.  
 
In contrast, there are many other researchers who disagree with the phenomenon of 
paternal leakage and have documented various evidences that support their opinions. 
First, it was found that even if paternal leakage occurred, the parental mitochondria 
would be diluted by the enormous number of the maternal ones especially after passing 
through the mitochondrial genetic bottleneck (Chen et al. 1995a; Wolff and Gemmell 
2008). Second, there is a proposed mechanism of ubiquitination of sperm mitochondria 
outer membrane which makes them recognizable, therefore, they will be targeted and 
Chapter 1: General Introduction 
 8 
destroyed selectively through a process of proteolytic digestion by the newly formed 
embryo cellular machinery (Thompson et al. 2003; Sutovsky et al. 2004; Butler 2005b). 
Moreover, the sequestration of mtDNA molecules within the inner mitochondrial 
membrane hinders against heterologous recombination (Elson et al. 2001).   
 
1.2.4.2    Recombination characteristics of mtDNA 
  
The other feature of the mitochondrial inheritance that is still under discussion is the 
mitochondrial recombination. There is growing evidence which supports the likelihood 
of mtDNA recombination at both intermolecular as well as intramolecular levels.  
 
MtDNA recombination has been well documented in yeast and plants (Gray 1989) as 
well as in invertebrates (Ladoukakis and Zouros 2001). There are studies that have 
demonstrated evidences of mtDNA recombination in fish (Ciborowski et al. 2007) and 
in lizard (Ujvari et al. 2007). Extracts of mitochondria from human cells were shown to 
harbour enzymes that catalyze the homologous recombination of DNA plasmids 
(Thyagarajan et al. 1996). Different recombinant molecules were reported within human 
cytoplasmic hybrid clones suggesting that recombination events involve different 
mtDNA regions (D'Aurelio et al. 2004).  
 
Despite the evidence that supports the possibility of mtDNA recombination, there are 
still barriers to recombination to occur. First, there was an early evidence against the 
free exchange of mtDNA molecules within a cell (Enriquez et al. 2000; Jacobs et al. 
2000). However, more recently, mitochondrial fusion and fission have been identified 
and analysed in model organisms, such as yeasts, worms and flies (Hoppins et al. 2007; 
Westermann 2008, 2009). Second, it is not very well known how long the paternal 
mitochondria will need to survive to enable fusion/recombination (Howell 1997). 
Lastly, the limited number of the recombinant DNA molecules (if recombination does 
occur) within the zygote, will then have to undergo clonal expansion to allow passage 
through the mitochondrial genetic bottleneck and transmission to subsequent 
generations (Elson et al. 2001), see also heteroplasmy. 
  
Following all these discussions, the answer to the question whether mitochondrial DNA 
recombines sufficiently to influence human evolution and disease etiology is still 
equivocal. Overall, the currently available population genetic data suggests that 
recombination is not occurring at detectable levels (White et al. 2008). 
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1.2.5 Heteroplasmy within the mitochondrial genome   
 
The general rule for an individual is to have a single mtDNA genotype (homoplasmy). 
However, occasionally, an individual may carry two sequences that differ in one or two 
nucleotide positions. This is referred to as heteroplasmy. 
 
Heteroplasmy arises because of the high mutation rate of mitochondrial DNA compared 
to the nuclear genome (Ingman 2001; Kivisild et al. 2006) which is attributed to the 
mutagenic properties of Reactive Oxygen Species (ROS) (the harmful by-products of 
oxidative phosphorylation), an error-prone polymerase and deficient DNA repair 
mechanisms (Clayton 1991; Bogenhagen 1999). This high mutation rate is more prone 
to produce a state of heteroplasmy when it is coupled with deficiency in the protective 
mechanisms that are known to effectively clear any genetic diversity from the 
mitochondrial DNA population, e.g. mitochondrial germline bottleneck, gene transfer, 
selection against deleterious mutations and vegetative segregation (Martin and 
Herrmann 1998; Rispe and Moran 2000; Rand 2001). Moreover, heteroplasmy may be a 
result of the recently presumed paternal leakage phenomenon as revealed in the reported 
human case with mitochondrial myopathy in which two different mitochondrial 
haplotypes were identified in the patient‟s muscle with a ratio of 10:1 paternal to 
maternal, whereas only the maternal mtDNA haplotype was detected in the patient‟s 
blood (Schwartz and Vissing 2002). 
 
Heteroplasmy is now accepted as a widespread phenomenon but still much less 
common than homoplasmy. Although mitochondrial heteroplasmy can complicate the 
interpretation of phylogenetic networks of population data, heteroplasmy may provide a 
useful tool for defining haplotypes (if heteroplasmy remains stable) (White et al. 2008). 
Heteroplasmy may further aid in resolving the relationships among individuals at the 
population level as was experienced in the identification of the remains of Russia‟s last 
Tsar, Nicholas II. By analysis of mtDNA from the presumed skeleton of the Tsar, 
heteroplasmy was detected at the nucleotide position 16169 (C/T – 1:1.6) and his 
identification was confirmed by analysis of his brother‟s mitochondrial DNA that was 
heteroplasmic at the same nucleotide position, thus providing a powerful evidence 
supporting the identification of Tsar Nicholas II (Gill et al. 1994; Ivanov et al. 1996). A 
more recent analysis has demonstrated rapid segregation of the two mitochondrial 
haplotypes (16169C/ 16169T) in two maternal lines derived from Tsar‟s mother 
(Rogaev et al. 2009). 
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Heteroplasmy can be one of two types; 
 
 Site heteroplasmy (which is also known as sequence heteroplasmy or point 
heteroplasmy) occurs when two different nucleotides are detected at a single nucleotide 
position (Figure 1.4) (Carracedo et al. 1998; Carracedo et al. 2000; Butler 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: Mitochondrial HVI sequence between positions 16204 and 16220. The 
electropherogram at the top (a) shows sequence heteroplasmy at position 16210 possessing 
both G and A nucleotides with clearly defined peaks well above the background noise 
compared to (b) the same region on a different sample containing only an A peak at position 
16210.   
 
 Length heteroplasmy results from the slippage of the DNA polymerase during 
replication of a repetitive sequence resulting in either deleted or inserted bases. If this 
error is not repaired, the individual will posses two distinct populations of mitochondrial 
DNA with one genome slightly larger than the other. The poly C stretch in HVII found 
between nucleotide positions 303 to 315 is an example of this  phenomenon (Kobilinsky 
et al. 2004). It was reported that length heteroplasmy is much more prevalent than point 
heteroplasmy (Carracedo et al. 2000). 
 
  16210 
R  (a) 
 
(b) 
  A/G 
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Heteroplasmy can be detected in an individual in several forms (Stewart et al. 2001); 
 Individuals may have more than one mtDNA haplotype in a single tissue. 
 Individuals may exhibit one mtDNA haplotype in one tissue and other 
haplotype in another tissue. 
 Individuals may be heteroplasmic in one tissue and homoplasmic in another 
tissue.         
 
The rate of heteroplasmy differs between different tissues of the body, among which the 
brain was suggested to be the most common site of heteroplasmy (Lightowlers et al. 
1997). Whereas, a higher frequency of heteroplasmy was observed in muscle compared 
to blood, heart and brain (Calloway et al. 2000). 
 
Comparison of HVII length heteroplasmy between mothers and children identified 
variation in length heteroplasmic level between generations. Variability between  
individuals was greater  in hair samples compared to blood, buccal cells and nails (Asari 
et al. 2007; Asari et al. 2008). 
 
In contrast, HVI length heteroplasmy seems to be more stable in various tissues within 
individuals (Malik et al. 2002a; Lutz-Bonengel et al. 2004) and among different 
individuals within the same lineage (Cavelier et al. 2000; Malik et al. 2002b) despite 
showing wide variation between unrelated individuals (Lee et al. 2004). 
 
Several studies have identified a higher frequency of heteroplasmy in hair shafts 
compared to other tissues (Tully et al. 2004; Paneto et al. 2007). Moreover, it has been 
shown that not only does the rate of heteroplasmy differ between different tissue types 
within an individual, but it also varies between extracts from different segments of a 
single hair (Salas et al. 2001; Tully et al. 2004). This is a consequence of the stochastic 
segregation of mitochondrial DNA types following the bottleneck in the female germ 
line (Figure 1.5) (Kirches et al. 2001). 
 
 
 
 
 
 
Chapter 1: General Introduction 
 12 
 
 
 
 
 
 
 
 
Figure 1.5: Heteroplasmy and mitochondrial segregation. During cell division, mitochondria 
are randomly distributed into daughter cells.  Their mitochondrial genotype will then evolve into 
a normal or a mutant form depending on the percentages of wild type and mutant mtDNA 
involvement. Reproduced from (www1). 
 
1.3 Modern human populations 
Evidence of mitochondrial recombination and paternal leakage is not strong enough to 
play a fundamental role in mitochondrial inheritance. Therefore, mitochondrial 
inheritance down the maternal line should still be considered as the primary route of 
mitochondrial inheritance, and mtDNA is expected to pass unchanged from generation 
to generation along the maternal line apart from spontaneous mutations. Thus, all 
modern human populations could be tracked back along the maternal lineages to a 
common ancestor. 
Cell Division 
Random Segregation 
 
 
 
 
 
 
 Mitochondria with wild type mtDNA 
 Mitochondria with mutant mtDNA 
 Normal phenotype 
 Disease phenotype 
Maternal inheritance of mitochondrial DNA: 
 heteroplasmy and segregation 
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1.3.1 Population genetic variation 
 
Differences between mtDNA sequences are attributed to mutations. which are known to 
pass on under certain circumstances: firstly, the mutation has to occur in a female; 
specifically in the germ line cells that give rise to oocytes, then the mature egg carrying 
the mutated mtDNA must be fertilized by an X-bearing sperm to give rise to a female 
embryo that will develop later into a female adult, who can then pass it on to her 
children (Ingman 2001).   
 
1.3.2 Mitochondrial Eve 
 
Mitochondrial Eve represents the woman whose mtDNA exists in all the humans living 
now on Earth and she is estimated to have lived 100,000 to 200,000 years ago. 
However, that does not mean that she was the only woman on earth at that time, but she 
was the only woman who contributed her mtDNA to modern human (Figure 1.6) (Cann 
et al. 1987).   
 
 
Figure 1.6: Phylogenetic tree representing mitochondrial DNA sequence relationships 
among modern humans. The evolutionary tree has its roots in Africa and its branches are 
short enough to hypothesize that all humans have a fairly recent common ancestor “ 
mitochondrial eve” (Cann et al. 1987).   
 
1.3.3 Pattern of modern human migration  
 
According to Cann et al. (1987), humans who lived on earth before the emergence of 
mitochondrial eve were completely replaced by her descendants by migrating out of 
Africa somewhere between 100,000 and 200,000 years ago. 
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Several phylogenetic studies have been conducted on mitochondrial DNA sequences 
that support the “Out-of-Africa” scenario for the evolution of modern human 
populations. These studies have shown that the deepest-rooting branches of the 
mitochondrial DNA tree are located in sub-Saharan Africa. Moreover, they have 
demonstrated that the highest mtDNA diversity in the world is found within Africa 
(Figure 1.7) (Torroni et al. 2006; Salas et al. 2007). 
Figure 1.7: Tracing modern human evolution through mitochondrial DNA mutations. 
Mitochondrial DNA map representing different routes of modern human migrations out of Africa 
based on previous phylogenetic studies. Times of early human expansion across the world 
were shown in boxes. Data were obtained from the mitochondrial DNA migrations map-1 
produced by Family Tree DNA at (www2). 
 
However there is a persistent debate about the “Out-of-Africa” replacement theory and 
the other opposing theory is the multidirectional hypothesis. Wolpoff et al. (2000), have 
suggested that human populations in both Africa and Eurasia have contributed to the 
evolution of modern human (Figure 1.8).   
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Figure 1.8: Out-of-Africa versus the multidirectional hypothesis. The diagram represents 
the current theories of modern human evolution. The first hypothesis  (model A) suggests that 
there was a second wave of migration out of Africa that has occurred 100,000 years ago, in 
which the modern humans of African origin have invaded the world and have completely 
replaced archaic human populations. Model B is a compromised version of hypothesis A that 
emphasizes the African origin of the modern human populations with possibility of minor local 
contributions. Models A and B support the out of Africa theory. Model C represents the 
multidirectional theory in a way that allows continuous mixing between continental populations. 
Lastly, model D represents the multidirectional theory with completely independent multiple 
origins. Reproduced from Jin and Su (2000).  
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1.4 Mitochondrial DNA haplogroups  
 
1.4.1 Definition of mitochondrial DNA haplogroups    
   
Mitochondrial mutations accumulate sequentially leading to constitution of independent 
lineages. Relationships among different lineages can be estimated by phylogenetic 
networks (Bandelt et al. 1995; Maca-Meyer et al. 2001) in which mutations are 
classified in hierarchal levels.. The haplotype is defined as a specific DNA sequence 
observed in a population sample (Budowle et al. 2003) and thus describes the entire 
combination of substitutions retrieved from the complete sequence in any given sample 
and therefore indicates the tips of the phylogeny (Behar et al. 2008b).  
 
Closely related haplotypes are clustered as clades, which represent closely related 
maternal lineages. A cluster of clades that share common mutations is referred to as a 
haplogroup. A haplogroup is defined as a set of haplotypes that share basal mutations, 
indicating  a common ancestry (Budowle et al. 2003). Thus, mitochondrial haplogroups 
are identified by certain clusters of mtDNA mutations, both in coding and non-coding 
regions, relative to the CRS. Figure 1.9 illustrates this hierarchy.  
 
Currently, there are over six thousand complete mitochondrial DNA sequences 
available in the mitochondrial database (www3). These sequences can be integrated into 
the construction of a phylogenetic tree of global human mtDNA. Continuous updating 
of the global phylogenetic tree is always required in order to include newly identified 
mitochondrial lineages (Van Oven and Kayser 2009). Fortunately, this continuous 
refinement of the mitochondrial phylogeny does not change the high level structure of 
the earlier phylogenies (Logan 2009). 
 
The major haplogroups are specific to geographical locations and/or ethnic groupings  
(Richards et al. 2000; Maca-Meyer et al. 2001). Therefore, mapping of mitochondrial 
DNA haplogroups clarifies modern human migration and colonisation around the world. 
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Figure 1.9: Simplified diagram of the mitochondrial phylogeny showing the hierarchal 
levels of mitochondrial mutations with subsequent classification of mitochondrial DNA 
into haplogroups, clades and haplotypes. Diamond shapes with different colours represent 
mutations in the mitochondrial DNA relative to the CRS. A haplogroup (represented by a violet 
patterned sphere) is present at the top of the phylogeny, it is derived from the most recent 
common ancestor or alternatively from one of the other major haplogroups by having a certain 
set of basal mutations (A) and it gives rise to various clades (represented by stripped brown 
spheres). Each clade is differentiated from one another by having a different set of additional 
mutations (B) and it gives rise to various haplotypes (represented by brown solid small spheres 
at the tips of the phylogeny) which represent closely related maternal lineages. Each haplotype 
has a specific DNA sequence with one more set of mutations (C). The haplotype is identified by 
the entire combination of mutations (A+B+C) within the whole mitochondrial genome relative to 
the CRS. (*) indicates a back mutation at a certain nucleotide position and (**) indicates 
homoplasy (parallel mutation events).  
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1.4.2 Nomenclature of the mitochondrial DNA haplogroups 
 
A universal, agreed nomenclature has been defined for mitochondrial DNA haplogroups 
(Torroni et al. 1994; Torroni et al. 1996; Wallace et al. 1999; Finnila et al. 2001b; 
Herrnstadt et al. 2002). This nomenclature system is based on the use of both letters and 
numbers (Figure 1.10). However, the given letters and numbers do not reflect the 
chronological order of emergence of these haplogroups within the human evolution 
instead, they reflect the order of their discovery. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10: A simplified phylogenetic tree of the mitochondrial DNA haplogroups. 
Different mitochondrial lineages were represented by different letters. The L haplogroups 
represent the most deep rooting branches of the tree originating from the most recent common 
matrilineal ancestor (MRCA) and are African specific. All the other mitochondrial lineages are 
derived from the two major macrohaplogroups M and N which are subclades of haplogroup L3. 
Reproduced from Van Oven and Kayser (2009).   
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1.4.3 Distribution of the mitochondrial DNA haplogroups around the world 
 
1.4.3.1     African specific mitochondrial haplogroups 
 
There are three major haplogroups (L1, L2 and L3) that represent the most ancient and 
diverse mtDNA haplogroups, and these are largely restricted to the sub-Saharan African 
lineages, apart from the L3 haplogroup which is also present in non-Africans, and is 
considered as the progenitor of the two Eurasian macrohaplogroups (M and N). 
Dispersal of haplogroup L3 lineages out of Africa has been estimated  to have occurred 
60,000 – 80,000 years ago (Watson et al. 1997; Salas et al. 2007). The proposed 
radiation ages for the two macrohaplogroups M and N are 30,000 to 57,600 years ago 
and 43,000 to 53,000 years ago, respectively (Maca-Meyer et al. 2001).  
 
The Levantine Corridor and the Horn of Africa are thought to be the two main routes for 
early human migrations out of Africa. Through analysis of mtDNA from ten African 
and Middle Eastern populations, Rowold et al. (2007) identified the Levantine Corridor 
as the more likely route. In contrast, other archaeological and genetic evidence supports 
a single route of human dispersal out of Africa through the Horn of Africa into South 
Asia and Australia, followed by a second wave of migration into Europe (Mellars 2006; 
Kumar et al. 2009). 
     
1.4.3.2     Asian specific mitochondrial haplogroups 
 
Mitochondrial lineages in Asia appear to be a mixture of subclades from both 
macrohaplogroups M and N. These subclades clearly show a geographic localization, 
with macrohaplogroup M and its subclades concentrated in the Southern area and South 
West Asia, contributing to the great majority of the Indian and Mongoloid lineages. 
Macrohaplogroup N and its subclades are localised in Northern Asia with only a few 
representatives in South Asia (Tanaka et al. 2004; Thangaraj et al. 2006).  
 
Both M and N derived lineages are found among Eastern Asian populations, resulting 
from separate waves of modern human dispersal from Northern and Southern Asia (Yao 
et al. 2002; Allard et al. 2004; Tanaka et al. 2004; Asari et al. 2007; Li et al. 2007; Asari 
et al. 2008).  
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Analysis of  Chinese, Korean, Japanese and Thai populations have shown 
heterogeneous structures harbouring both M derived lineages (D4 and D4a subclades) 
and N derived lineages (haplogroups A and R, and subclades F1a and B4a). The most 
commonly observed Chinese haplogroup was B4a followed by haplogroups A, F1a, and 
D4, whereas haplogroups A, D4 and D4a were the most common haplogroups among 
Korean and Japanese populations. In Thai populations, mitochondrial haplogroups B4a, 
F1a, and R have the highest frequencies Figure 1.12 (Allard et al. 2004).   
 
Haplogroup M which originated in South-Western Asia has given rise to the subclade 
M1 which appears to re-migrated into Africa following the northern coastal route about 
40,000 – 45,000 years ago (Olivieri et al. 2006). However, a younger coalescence age 
for the whole M1 subclade of 20,000 – 30,000 years ago was estimated by others 
(Gonzalez et al. 2007). 
 
1.4.3.3     European Caucasian mitochondrial haplogroups 
 
There are 9 major Western European haplogroups ; H, I, J, K, T, U, V, W, and X 
derived from the macrohaplogroup N (Figure 1.13) (Maca-Meyer et al. 2001; Budowle 
et al. 2003; Torroni et al. 2006). 
 
According to the Scientific Working Group on DNA Analysis Methods (SWGDAM) 
European Caucasian data, haplogroup H was the most commonly observed mtDNA 
haplogroup (45.7%), followed by haplogroups U (15.6%), T (10.5%), K (10.5%), and J 
(10%) (Macaulay et al. 1999; Finnila et al. 2001b; Achilli et al. 2004). 
 
1.4.3.4    Native American mitochondrial haplogroups 
  
The American continent is known to be the last land to be colonised by humans, 
however, estimates of the timing of this colonization vary from 11,000 to 40,000 years 
ago.  Until recently, the maternal ancestry of Native Americans was traced back to one 
of four major mitochondrial haplogroups (A2, B2, C1 and D1). These haplogroups 
originated in Asia from the two macrohaplogroups N and M (Figures 1.11 and 1.13) 
and then migrated to the Americas via Beringia. Nevertheless, later studies have 
identified five other minor mitochondrial lineages (subclades) as Native American 
haplogroups. These lineages are X2a, D2a, D3, D4h3 and C4c (Tamm et al. 2007; 
Achilli et al. 2008).  
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All the major African haplogroups (L1, L2, and L3) have been detected in the 
SWGDAM African-American dataset, primarily the L2a cluster (18.9%), but 
haplogroups L1c, L1b, L3e2 and L3b are also common (Table 1.1). Overall, the 
African mitochondrial lineages constitute approximately 90% of the mtDNA in Afro-
descendents Americans. Several European Caucasian and East Asian haplogroups are 
also present, with the most common of these being haplogroup H (2.8%) (Allard et al. 
2005). 
 
Table 1.1: Frequency of the African mitochondrial lineages in the Afro-descendents 
Americans. According to the SWGDAM African-American dataset. 
 
Haplogroup L2a L1c L1b L3e2 L3b L2c L3d L3e1 L2b L3f 
Frequency (%) 18.9 11.0 9.1 9.0 8.1 6.2 6.0 4.9 4.7 4.6 
 
 
1.4.4 Definitive markers for the identification of mitochondrial DNA 
haplogroups  
 
Analysis of either the whole mitochondrial genome or the hypervariable regions has 
been considered as the main focus of mitochondrial population studies. Examination of 
distinct populations has improved both the quantity and the quality of the mtDNA 
database, enabling the use of mtDNA in forensic identification, medical genetics and 
studies of human evolution. 
 
In order to facilitate and standardise the process of haplogroup assignment of 
mitochondrial DNA sequences, specific markers for each haplogroup were identified. 
These markers are variations in the whole mitochondrial genome relative to the CRS. 
These variations represent mutations occurring in the mtDNA throughout the human 
evolution and are shared by closely related mitochondrial lineages. These mutations are 
known as SNPs. Phylogenetic networks of the mitochondrial DNA sequences were 
constructed with specification of the diagnostic SNPs for each haplogroup (Figures 
1.11-1.13). 
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Phylogenetic tree of the major African mitochondrial haplogroups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11: Human mitochondrial DNA phylogeny - major African mitochondrial 
haplogroups. Along the links of the tree are the mutations that are known to be shared 
between different haplotypes within the same haplogroups. Nucleotide positions are relative to 
the CRS (Gene Bank accession NC_012920). Mutations are transitions unless an exact base 
change is specified. Insertions are indicated by a dot followed by the number and type of 
inserted nucleotide(s). Mutations in the control region are shown in blue and mutations in the 
coding region are shown in black (Palanichamy et al. 2004; Bandelt et al. 2006; Torroni et al. 
2006; Behar et al. 2008b; Malyarchuk et al. 2008). 
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Phylogeny of M and N derived Asian mitochondrial lineages 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12: Human mitochondrial DNA phylogeny - M and N derived mitochondrial 
lineages reported in Asian populations. Along the links of the tree are the mutations that are 
known to be shared between different haplotypes within the same haplogroups. Nucleotide 
positions are relative to the CRS (Gene Bank accession NC_012920). Mutations are transitions 
unless an exact base change is specified. d indicates a deletion. Control region mutations are 
shown in blue and coding region mutations are shown in black. D4 and D4a (highlighted in 
yellow) are the most commonly observed M derived lineages among east Asian populations 
whereas A, B4a and F1a (highlighted in red) are the most commonly observed N derived 
lineages among east Asian populations (Palanichamy et al. 2004; Tanaka et al. 2004; Bandelt 
et al. 2006; Kong et al. 2006; Metspalu et al. 2006; Olivieri et al. 2006; Thangaraj et al. 2006; 
Derenko et al. 2007; Gonzalez et al. 2007; Achilli et al. 2008; Kumar et al. 2008).  
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Phylogenetic tree of the major European mitochondrial DNA haplogroups 
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Figure 1.13: Human mitochondrial DNA phylogeny - major European mitochondrial 
haplogroups. Along the links of the tree are the mutations that are known to be shared 
between different haplotypes within the same haplogroups. Nucleotide positions are relative to 
the CRS (Gene Bank accession NC_012920) which represents a descendant of H2a2 
subclade. Mutations are transitions unless an exact base change is specified. Control region 
mutations are shown in blue and coding region mutations are shown in black. The most 
commonly observed European haplogroups are highlighted in turquoise with the frequency of 
each shown between brackets. (Macaulay et al. 1999; Finnila et al. 2001b; Reidla et al. 2003; 
Achilli et al. 2004; Loogvali et al. 2004; Shen et al. 2004; Achilli et al. 2005; Behar et al. 2006; 
Carelli et al. 2006; Gonzalez et al. 2006; Kivisild et al. 2006; Torroni et al. 2006; Abu-Amero et 
al. 2007; Roostalu et al. 2007; Tamm et al. 2007; Behar et al. 2008a; Brandstaetter et al. 2008; 
Alvarez-Iglesias et al. 2009; Logan 2009). 
 
1.5 Impact of mitochondrial DNA on the forensic domain 
 
1.5.1       Medico legal peculiarities of the mitochondrial genetic system 
 
Mitochondrial DNA has multiple unique characteristic features that drive its direct 
impact on different forensic applications: 
 
 MtDNA is a small genome, present in high copy number per somatic cell (up to 
several thousands of copies) compared to the two copies of the nuclear genome, in 
addition to the fact that they are encapsulated in a double-walled organelle, mtDNA is 
highly recoverable from severely degraded forensic samples, whereas nuclear DNA is 
not (Bandelt et al. 2006). Moreover, the circular nature of the mitochondrial genome 
provides a protective mechanism against the breakdown by exonucleases and hence 
increases its survival potential (Butler 2005b). 
 
 Mitochondrial DNA is inherited down the maternal line according to the most 
widely accepted model of inheritance, and hence mtDNA passes unchanged from 
mother to daughters and sons, from generation to generation apart from spontaneous 
mutations. Thus maternal relatives can provide clues for solving missing persons and 
mass disaster investigations even in the absence of the direct mother (Giles et al. 1980; 
Lightowlers et al. 1997; Primorac and Schanfield 2000). 
 
 MtDNA is characterised by rapid evolutionary rate with 5-10 times higher 
mutation rate compared to the nuclear genome. This high mutation rate is more evident 
in the hypervariable regions (Howell et al. 2007). There are local differences in the 
mutation rate among different nucleotide positions within the control region. There are 
certain nucleotide positions which are particularly highly mutating, showing high level 
of nucleotide variability and so referred to as “hot spots” (e.g. positions 146, 150, 152, 
195, 16189, 16311, 16362, 16519) while others are known to be more stable (e.g. 
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positions 477, 493, 16108, 16219) (Van Oven and Kayser 2009). This differential rate 
of mutation might be explained by the presence of certain sequence background of some 
sites in the control region which in turn leads to a higher mutation rate at these sites than 
at others (Howell et al. 2003) or alternatively, these sites might be evolving under 
positive selection conditions (Howell et al. 2007).  
 
Fortunately, this high rate of nucleotide variability and polymorphisms do not have 
major consequences on the human health since these regions do not code for essential 
substances. On the other aspect, these nucleotide polymorphisms provide a valuable tool 
for human identification and differentiation between different maternal lineages as well 
as tracing of modern human migration and colonisation around the world  (Kogelnik et 
al. 1998; Ingman and Gyllensten 2001). 
 
1.5.2 Mitochondrial DNA as a useful tool in human identification (case studies) 
 
1.5.2.1    Identification of historical cases by mitochondrial DNA analysis 
 
A royal maternity kinship cleared by ancient DNA analysis 
 
There have been doubts among historians whether the woman entombed at Roskilde 
Cathedral (during the Scandinavian Viking era) was indeed Estrid, the mother of the last 
Danish Viking King, Sven Estridsen or not. Analysis of the mitochondrial DNA from 
dental pulps of the two royals was able to assign the king‟s sequence to haplogroup H, 
whereas the mitochondrial sequence of the woman‟s sample was assigned to subclade 
H5a and differed from the king‟s sequence at two nucleotide positions in HVI. 
Therefore, it was highly unlikely that the entombed woman was the mother of the king 
(Dissing et al. 2007).  
 
Identification of the remains of the Romanov Nicholas II royal family 
 
The controversy surrounding the fate of the last Russian Emperor, Nicholas II and his 
family after the Russian Civil War in 1918 was solved partly by mtDNA analysis. In 
early 1990s, a first grave was found in the Ural region of Russia which contained the 
remains of the Romanov Imperial family. Mitochondrial DNA analysis of both skeletal 
remains and an archival blood sample (~ 117 years old) of Nicholas II has confirmed his 
identity after using his brother‟s mtDNA as a reference sample. Following analysis of 
the mtDNA from the other skeletal remains with the aid of maternal reference samples 
(collected from descendants of the same maternal lineage as the Emperor‟s wife), 
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identity of the last Russian Emperor‟s wife Empress Alexandra and three of their 
children was verified (Gill et al. 1994; Ivanov et al. 1996). The fate of the two youngest 
children of the Romanov family was unknown till 2007 when a second grave was 
discovered in the same Ural region containing bone fragments of two burned skeletons. 
Following DNA extraction from the severely damaged bone fragments, mtDNA 
analysis was successfully used to verify the kinship relationship between these remains 
and those exhumed from the first grave, confirming the identity of the two skeletons as 
being the two youngest children of the Romanov family (Rogaev et al. 2009).    
 
There are several other historical cases in which mtDNA analysis has been successfully 
applied and has greatly enabled verification of the human identity; (Table 1.2). 
 
Table 1.2: Historical cases identified by mitochondrial DNA analysis. Herein listed some 
cases in which mtDNA analyses have been used to verify the identity of the putative body 
remains.  
 
Genetic identification of  Reference 
7500-year-old Neolithic skeletons of the first European farmers Haak et al. (2005) 
A 5000-year-old mummified human body found in the Tyrolean 
Alps 
Handt et al. (1994) 
The Early Christian writer evangelist Luke Vernesi et al. (2001) 
Francesco Petrarch (1304-1374), the Italian poet and scholar  Caramelli et al. (2007)  
The famous astronomer Nicolaus Copernicus (1473-1543) Bogdanowicz et al. (2009) 
Louis XVII (1785-1795),  son of Louis XVI, King of France and 
Marie-Antoinette 
Jehaes et al. (2001) 
The American outlaw Jesse James (1847-1882) Stone et al. (2001) 
The prominent Nazi official Martin Bormann (1900-1945?) Anslinger et al. (2001) 
  
 
1.5.2.2   Genetic identification of human skeletal remains from mass graves 
 
During repatriation and identification of Finnish World War II soldiers, 167 (out of 181) 
bone samples were successfully sequenced for mitochondrial hypervariable regions and 
were found to belong to a minimum of 104 individuals. Identity of 79 individuals (76%) 
was confirmed by comparing their mitochondrial DNA sequences against the 
corresponding family reference sequences. The majority of the reference samples were 
obtained from direct maternal relatives, meanwhile more distant relatives were helpful 
in certain cases. There was an extreme case, where a positive match for a soldier was 
found to the grandson of his great-grandmother‟s sister (Palo 2007). 
Chapter 1: General Introduction 
 28 
During the identification of the human remains after the (1991-1995) Serbian 
aggression on Croatia and Bosnia and Herzegovina (BH), DNA analysis was requested 
for identification of cases in which the standard forensic methods failed. However, in 
certain cases, the quantity and /or the quality of the nuclear DNA was not satisfactory 
and so, the mtDNA analysis was performed (Andelinovic et al. 2005). 
 
In the Armed Forces DNA identification Laboratory (AFDIL), United States, it was 
possible to amplify a 410bp segment of the mtDNA control region from extremely 
degraded DNA samples, which were extracted from 125 years old skeletal remains of 
U.S. Civil War soldiers (Fisher et al. 1993). A success rate of 83.6% was reported for 
obtaining a mitochondrial DNA profile either partial or complete from 116 unidentified 
skeletal remains submitted to the Mitotyping Technologies laboratory, State College, 
between February 1999 and May 2005 (Nelson and Melton 2007). Amongst all skeletal 
remains, femurs and teeth were the most successful samples in providing either full or 
partial profiles.   
 
In Germany, mitochondrial hypervariable regions analysis has been successfully applied 
at the Institute of Legal Medicine for the identification of victims of crime cases or 
missing persons whose bodies remained undiscovered for many years (up to 9 years) 
where STR typing was unsuccessful (Bender et al. 2000). 
 
1.5.2.3    Utility of mitochondrial DNA analysis in mass disasters 
 
DNA identification of Tsunami victims in Thailand 
 
After the 2004 Ocean earthquake Tsunami at Southeast Asia that killed nearly 5,400 
people in Southern Thailand including a large number of foreign tourists and local 
residents. There have been extensive efforts conducted by the forensic scientists aiming 
to reveal the identity of these victims. Unfortunately, serious decomposition of bodies 
caused failure in recovery of enough DNA for nuclear marker typing, however, forensic 
scientists succeeded in obtaining fully informative results for mitochondrial markers 
(HVI and HVII) from 258 tooth samples with a success rate of 51% (258/ 507) (Deng et 
al. 2005).  
 
Chapter 1: General Introduction 
 29 
DNA identification of the World Trade Centre (WTC) disaster victims  
 
The World Trade centre attacks in New York, in September, 2001 which resulted in 
more than 2,700 human losses of varied racial and ethnic background, represented a 
great challenge for DNA identification efforts which were confronted with a massive 
number (several thousands) of skeletal remains. These remains were subjected to severe 
DNA deteriorating conditions including the explosion itself, intense fire and heat, and 
the subsequent water exposure by the fire extinguishers. These adverse environmental 
conditions did not facilitate the human identification using the standard STR profiling 
techniques. In an effort to develop a high quality, high throughput DNA analysis 
procedure, supplementation of the STR profiling results with the mitochondrial DNA 
data has improved the success rate of victims‟ identification (Holland et al. 2003).   
 
The use of mitochondrial DNA typing in the identification of air crash victims 
 
Mitochondrial DNA analysis has played an important role in the identification of 
victims after several aircraft accidents, particularly when complete STR typing profiles 
were not available. In the experience of the air plane crash in the Philippines, in 1998, 
which killed all 104 passengers and crew, the success rate of victims‟ identification after 
using the STR typing was low (50%), due to extreme degradation of the DNA extracted 
from the victims‟ remains. However, the use of mtDNA typing combined with the STR 
profiling raised the success rate up to 95% (Goodwin et al. 1999). In another air 
accident, two victims were crushed into small pieces, and the investigators were 
provided with 33 fragmentary tissue samples recovered from under the sea and 
suspected to belong to the victims. Identification of the victims was enabled by applying 
ABO genotyping, STR profiling and mtDNA analysis altogether (Mukaida et al. 2000). 
In the efforts conducted for the identification of 10 individuals died after an aircraft 
accident in the Madeira Island north cost, in 2003, autosomal STR typing of nine 
biological samples resulted in five different profiles. However, the STR profiles 
obtained from three of these fragments were incomplete and so the accurate 
identification of those individuals was completed via analysis of Y- chromosome STRs 
and mitochondrial hypervariable regions (Anjos et al. 2004).    
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1.5.2.4    A case of exchanged body remains solved by mtDNA analysis 
 
In a case of homicide involving five Portuguese citizens whose identification was 
suspected to have been exchanged, mitochondrial hypervariable regions analysis 
confirmed the exchange of body remains. MtDNA sequence of each body always 
matched the alleged mother. Moreover, a kinship relation was suggested by detecting 
similar mitochondrial substitutions in two bodies and one of the presumptive mothers 
(Table 1.3) (Cruz et al. 2004). 
 
Table 1.3: HVI and HVII mtDNA Sequences of the five individuals and four alleged 
mothers compared to the Cambridge Reference Sequence (CRS). A letter in each position 
indicates a nucleotide substitution relative to the CRS and the absence means that the 
sequence at that nucleotide position is identical to the reference sequence. A nucleotide 
position followed by a dot and a number indicates inserted nucleotide which is not present in 
CRS. Each pair of matched sequences is highlighted in the same colour. Kinship relation was 
evident between samples from body 2, body 5 and mother 3 by having the same HVI and HVII 
sequences  (Cruz et al. 2004). 
 
 
1.5.2.5    Identification of burned human remains using mtDNA analysis 
 
In a case of homicide in Italy, in which burned body remains were found in a wood, the 
putative mother was the only relative available. STR typing analysis was performed and 
provided an incompatibility at VWA locus, meanwhile, analysis of the mitochondrial 
hypervariable regions revealed a perfect match between the sequences obtained from 
the burned remains and the putative mother in both HVI and HVII regions which raised 
Nucleotide position
HVI
Sample origin 16069 16126 16129 16148 16168 16172 16187 16188 16189 16193 16223 16224 16230 16264 16270 16278 16293 16311 16320
CRS C T G C C T C C T C C T A C C C A T C
Body 1 . . A T T C T G C . T . G . . T G C T
Body 2 . . . . . . . . . . . C . . . . . C .
Body 3 . C . . . . T . C . T . . T T T G C .
Body 4 T C . . . . . . . T . . . . . T . . .
Body 5 . . . . . . . . . . . C . . . . . C .
Mother 1 . . A T T C T G C . T . G . . T G C T
Mother 2 . C . . . . T . C . T . . T T T G C .
Mother 3 . . . . . . . . . . . C . . . . . C .
Mother 4 T C . . . . . . . T . . . . . T . . .
HVII
73 93 95 114 150 152 182 185 189 195 198 136 247 263 295 309.1 315.1 316
CRS A A A C C T C G A T C T G A C -- -- G
Body 1 . G C . . . . . G . . C A G . C C .
Body 2 G . . T . . . . . . . . . G . C C A
Body 3 G . . . . C T T . C T . A G . . C .
Body 4 G . . . T . . . . . . . . G T . C .
Body 5 G . . T . . . . . . . . . G . C C A
Mother 1 . G C . . . . . G . . C A G . C C .
Mother 2 G . . . . C T T . C T . A G . . C .
Mother 3 G . . T . . . . . . . . . G . C C A
Mother 4 G . . . T . . . . . . . . G T . C .
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the likelihood of the maternal relationship between the victim remains and the putative 
mother (Cerri et al. 2004).   
 
In a relatively similar case of homicide in Japan, a skeletonised female body, which was 
found in a forest, was identified a year and eight months later using both DNA analysis 
and dental characteristics in a Chest X-ray photograph. The image of the Chest X-ray 
included frontal parts of the upper and lower jaws which enabled a comparison between 
the dental characteristics of the candidate and the photographs and the dental X-ray 
images that were taken when the unknown body was found. The comparison of the 
dental characteristics revealed a similarity in the patterns of fillings, in addition to the 
characteristic protrusion of the left upper central incisor. DNA analysis involved both 
mitochondrial haplotype analysis and ABO genotyping. Mitochondrial haplotype 
obtained from the body remains (teeth) showed an exact match with the haplotype 
obtained from the putative mother and her daughter, and thus, supported the mutual 
blood relationship (Minaguchi et al. 2005). 
 
1.5.2.6    A rape case solved by mtDNA mixture analysis 
 
Using the differential lysis-based DNA extraction and cloning techniques, it was 
possible to obtain the mitochondrial hypervariable regions HVI and HVII from the male 
fraction of the DNA extracted from the vaginal swab in a case of rape. Following 
sequencing of clones, the suspect‟s haplotype was detected despite being in a very low 
ratio compared to the female fraction (Hatsch et al. 2007). However, detection of the 
suspect‟s haplotype is not a sufficient evidence to prove his direct involvement in the 
rape accident particularly that the male mtDNA in this case was only detected at a very 
low ratio compared to the female one. Thus it is absolutely difficult to exclude the 
presence of a third mtDNA type at a non-detectable level using this differential-lysis 
protocol that might belong to the actual rape perpetrator.      
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1.6 The association of mitochondrial DNA haplogroups with the 
health status 
 
A current area of interest for many researchers is the role of mitochondrial haplogroup 
specific sequence variations in the pathogenesis of complex diseases and 
neurodegenerative disorders (Torroni and Wallace 1994). On top of the list of disorders 
that have been extensively investigated is Leber Hereditary Optic Neuropathy (LHON). 
Analysis of the mitochondrial DNA in LHON European patients has reported increased 
risk of disease expression of the LHON mutation (11778/ND4) in presence of either a 
J1c or J2b mtDNA. And so, these mitochondrial subclades may enhance the effect of 
the LHON mutation on some functional parameters of the respiratory-chain complexes I 
and III (Carelli et al. 2006). In LHON patients of Asian origin, there was a significant 
increase in the risk of hearing loss in patients carrying mitochondria haplogroup 
M7b1
‟
2, whereas haplogroup M8a has been shown to provide a protective effect (Bilal 
et al. 2008).  
 
LHON is not the only disorder in which mitochondrial haplogroup J may be involved. 
In a study of 1833 American HIV-1 patients of European origin, a provisional 
association of haplogroups J and U5a with accelerated progression to AIDS and death 
was reported (Hendrickson et al. 2008). Haplogroup J may also be associated with optic 
neuritis (Reynier et al. 1999). Higher frequencies of haplogroups J, L and T were 
reported among 52 Iranian Multiple Sclerosis (MS) patients. It was also noted in the 
same study that a high proportion of haplogroup H was associated with optic nerve 
involvement, whereas , haplogroup A was associated with a younger age of onset 
(Ghabaee et al. 2009). 
 
Mitochondrial DNA has always been considered to play a role in several disorders that 
include stroke as a component of the symptoms. It was suggested that mitochondrial 
haplogroup H1 has a protective effect against ischemic stroke (Rosa et al. 2008), 
whereas, R0a, HV, and U haplogroups were proposed as potential factors for increasing 
risk of stroke. Mitochondrial haplogroup U has also been implicated in increasing the 
risk of many other serious conditions, like occipital stroke in patients with migraine 
(Majamaa et al. 1998), Alzheimer‟s disease in men (Van der Walt et al. 2004), and 
severe Knee Osteoarthritis (Rego-Perez et al. 2008). Despite the apparent protective 
effect against ischemic stroke, haplogroup H was proposed to interfere with the 
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therapeutic effect of high doses of riboflavin in migraine patients (Di Lorenzo et al. 
2009).  
 
Haplogroup T has gained a particular attention in the last few years among the 
expanding list of association studies. It has been suggested to be more prevalent among 
patients with Coronary artery disease and type 2 Diabetes. The association between 
mitochondrial haplogroup T and type 2 Diabetes was more pronounced among patients 
with diabetic retinopathy (Kofler et al. 2009). In addition, haplogroup T2 mutational 
motif was linked to Age-Related Macular Degeneration (AMD) (SanGiovanni et al. 
2009). Several studies have suggested implication of the mitochondrial DNA in male 
infertility (Folgero et al. 1993; Kao et al. 1995; Zeviani and Antozzi 1997; Moore and 
Reijo-Pera 2000; Shamsi et al. 2008; Venkatesh et al. 2009). There was a proposed 
association between mitochondrial haplogroup T and reduced sperm motility 
(asthenozoospermia) (Ruiz-Pesini et al. 2000). 
 
Longevity in the Japanese population has been investigated with regards to the possible 
involvement of mitochondrial DNA. An association between haplogroup D4a and 
longevity in Japan was reported (Bilal et al. 2008). The African mitochondrial DNA 
lineages have been underrepresented in the growing series of association studies, 
nonetheless, an association was reported between African ancestry and increased risk of 
asthma (Vergara et al. 2009).  
 
Despite the big number of association studies that have been carried out during the last 
few years, aiming to unravel the role of mtDNA sequence variation in various disorders, 
they all (apart from LHON) have to be considered provisional. This is due to presence 
of several limitations in these studies, including small number of samples, restriction to 
certain population groups, non availability of replicated studies (Carelli et al. 2006). 
Many of these studies require to be validated by examining different populations to rule 
out the possible associations due to diet, life style or environmental factors (Bilal et al. 
2008).  
 
Normal mitochondrial function requires both mtDNA and nuclear DNA encoded 
factors, and so nuclear DNA markers should not be overlooked when considering 
associations (Suissa et al. 2009). 
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1.7 Amelogenin  
 
The amelogenin gene belongs to a family of extracellular matrix protein, involved in 
enamel mineralization. It is encoded by two single-copy genes located on the short arm 
of both the X- chromosome (AMELX, on Xp22.1-Xp22.3) and the Y- chromosome 
(AMELY, on Yp11.2) (Nakahori et al. 1991). The two amelogenin homologues differ in 
size and sequence, and hence amelogenin is commonly used as a genetic marker for sex 
determination in forensic casework, archaeological specimens, preimplantation and 
prenatal diagnoses (Kashyap et al. 2006; Cadenas et al. 2007).  
 
The commonly used DNA-based gender test targets a conserved region of the 
amelogenin gene in intron 1 which includes a 6 bp deletion on the X- homologue. 
Therefore, PCR amplification of this region produces two different amplicons in male 
samples that differ in size by 6 bp and can be easily distinguished by gel 
electrophoresis. In female samples PCR amplification of the same region results only in 
one product (Nakahori et al. 1991; Sullivan et al. 1993). 
 
The amelogenin gene is included as a component of several commercial multiplexing 
kits that are commonly used for DNA profiling such as PowerPlex
®
16 Bio and 
PowerPlex
®
 ES manufactured by Promega and AmpF/STR
® 
Identifiler
TM
, AmpF/STR
®
 
Profiler Plus
TM
 ID and AmpF/STR
®
 SEfiler
TM
 manufactured by Applied Biosystems. 
Amplification failure can cause misidentification of a male sample as a female, with 
possibly severe consequences in criminal investigations and prenatal diagnosis of X-
linked recessive disorders (Shadrach et al. 2004; Kashyap et al. 2006; Mitchell et al. 
2006).     
 
The male specific part of the Y-chromosome is well known to possess massive 
palindromes and inverted repeats, and hence has long been described as a candidate for 
high degree of structural polymorphisms and genomic rearrangements. These variations 
include heterochromatin and euochromatin length variations, pericenteric inversion and 
neutral translocations with autosomes (Skaletsky et al. 2003; Jobling et al. 2007; Yong 
et al. 2007).   
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In the last ten years, a few cases of amelogenin drop-out were reported in certain 
populations causing misinterpretation of sex testing. Failure of amelogenin typing could 
be a result of either mutations in the primer binding sites or a deletion of the AMELY 
locus on the Y-chromosome (Kashyap et al. 2006). While establishing a national DNA 
database in Australia, amelogenin Y-homologue drop-out was reported (Roffey et al. 
2000). Similarly, a rare mutation in the primer binding region in intron 1 on the X-
homologue (AMELX) was reported in a Caucasian male (Shadrach et al. 2004). 
However, the extreme rarity of such events, postulate that these alterations are resulting 
from individual mutations rather than polymorphisms.  
 
Failure to amplify AMELY can be due to an interstitial deletion of a relatively large 
segment involving the pericentromic region of the short arm of the Y-chromosome. 
These deletions have arisen through non-allelic homologous recombination (NAHR) 
between the proximal major repeat array of TSPY gene and the distal copy of TSPY 
immediately downstream of IR3 inverted repeat (Figure 1.14) (Santos et al. 1998; 
Lattanzi et al. 2005; Jobling et al. 2007; Yong et al. 2007). 
 
Y
p
1
1
.3
2
Y
p
1
1
.3
1
Y
p
1
1
.2
Y
p
1
1
.1
Y
q
1
1
.1
Y
q
1
1
.2
1
Y
q
1
1
.2
2
1
Y
q
1
1
.2
3
Y
q
1
2
Y
q
1
1
.2
2
2
Y
q
1
1
.2
2
3
IR3 IR3
Inverted Repeat
TSPY array
TSPY B TSPY A
A
M
E
L
Y
A
B
6
 M
b
1
1
 M
b
Euchromatic positive G-band
Euchromatic ngative G-band
Pericentromeric heterochromatin
Heterochromatin
Deleted region 
Breakpoint region
Intact region
Y
p
1
1
.3
2
Y
p
1
1
.3
1
Y
p
1
1
.2
Y
p
1
1
.1
Y
q
1
1
.1
Y
q
1
1
.2
1
Y
q
1
1
.2
2
1
Y
q
1
1
.2
3
Y
q
1
2
Y
q
1
1
.2
2
2
Y
q
1
1
.2
2
3
A
M
E
L
Y
6
 M
b
1
1
 M
b
 
 
Figure 1.14: Schematic representation of the human Y-chromosome. A is an ideogram of 
the Y-chromosome with the cytogenetic designations for the bands. The blue box outlines the 
deleted region. B illustrates the deleted region of Yp11.2 on the short arm of the Y-
chromosome. The breakpoints reside within the TSPY array proximally and inverted repeat IR3 
distally. AMELY locus is included in the deleted region. Reproduced from Yong et al. (2007). 
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Several studies have been carried out using Y-STRs, STS (Sequence-tagged site 
mapping) and TSPY copy estimation in order to analyse and characterise as accurate as 
possible the exact length of the deleted regions on the Y-chromosome short arm. A 
deletion of about 2.5 Mb on the pericentromic region of the short arm was reported in 
two Italian case studies (Lattanzi et al. 2005). Similarly, an approximately 2.56-Mb 
deletion in the Yp11.2 was reported in a Japanese case study (Kumagai et al. 2008). A 
2.3-Mb deletion was reported in 5 Kathmandu (Nepal) phenotypically normal males 
(Cadenas et al. 2007). A longer deletion was also reported in Singapore and Malaysia 
populations with approximate length of 3-3.7 Mb (Yong et al. 2007). Interestingly, a 
Japanese case report has shown three separate deleted regions in the Yp11.2 with 
estimated lengths of 2.51 Mb, 25 Kb and 834 bases (Takayama et al. 2009).  
 
The reported frequencies of AMELY drop-out (Table 1.4) clearly illustrates an 
association with people originating from the Indian subcontinent (Yong et al. 2007). 
Nevertheless, the variation in the characteristics of the reported deletions (length and 
pattern) suggests an independent occurrence of deletions through independent 
evolutionary events among different ethnic groups (Mitchell et al. 2006; Kumagai et al. 
2008). 
 
The highest frequencies of the AMELY drop-out were reported among the haplogroup 
J2 Y-chromosome lineages. Nonetheless, fewer AMELY null cases were also reported 
in the Y-chromosome haplogroups F* and D*. Therefore, these findings suggest that the 
deletion events, despite showing relatively similar patterns, have occurred 
independently at least three times throughout the human evolution and arguing against a 
common ancestry (Kashyap et al. 2006; Cadenas et al. 2007; Chang et al. 2007; Yong et 
al. 2007).  
 
The reported variation in the frequency of AMELY deletion among different Y-
chromosome haplogroups (with the highest frequency among J2 lineages) was 
suggested to be due to the difference in the age of the deletion event, and hence the 
older age of the deletion event correlates to the higher frequency (Yong et al. 2007).   
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Table 1.4: Summary of percentages of the AMELY drop-out reported cases in different 
populations’ studies. The data did not include reported cases of AMELY drop-out resulting 
from point mutations in the primer binding sites. Reproduced from Yong et al. (2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) 
(Santos et al. 1998), 
(b) 
(Thangaraj et al. 2002), 
(c) 
(Kashyap et al. 2006) 
(d) 
(Cadenas et al. 2007)
 (e)
 
(Parkin et al. 2007),
 (f)
 (Steinlechner et al. 2002), 
(g) 
(Lattanzi et al. 2005), 
(h)  
(Bosch et al. 2002), 
(i)
 
(Michael and Brauner 2004), 
(j) 
(Mitchell et al. 2006) 
(k) 
(Steemers et al. 2006), 
(l) 
(Yong et al. 2007),
 (m) 
(Takayama et al. 2009). 
 
Owing to the extreme importance of accurate gender determination in many crucial 
situations as in rape cases, mass disasters and others, it is of utmost necessity to include 
other sexing markers for gender determination particularly in certain regional 
populations (Yong et al. 2007).   
 
 
 
 
 
 
 
 
 
Country Population 
No. of studied 
individuals 
(Ref)
 
Frequency 
(%) 
Sri Lanka Sri Lankan 24
(a)
 8.3 
India Indian 270
(b)
 1.9 
India (whole) Indian (caste and tribes) 4,257
(c)
 0.23 
Nepal Nepalese 77
(d)
 6.5 
 Nepalese 769
(e)
 1.2 
Austria Austrian 28,182
(f)
 0.018 
Italy Italian 13,000
(g)
 0.008 
Spain Spanish 768
(h)
 0.13 
Israel  96
(i)
 1.0 
Australia Mixed 109,000
(j)
 0.02 
Malaysia Indian  315
(k, l)
 3.2 
 Malay 334
(k, l)
 0.6 
 Chinese 331
(k, l)
 0 
Singapore Indian 175
(l)
 1.76 
 Malay 182
(l)
 0.6 
 Chinese 210
(l)
 0 
Japan  500
(m)
 0.2 
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Technical issues 
 
1.8 MtDNA sample sources 
 
Mitochondrial DNA is well known to be very resistant to extreme environmental 
conditions, and as a consequence, it has an utmost importance in many forensic 
applications, particularly in such circumstances where the nuclear DNA is limited or 
degraded (Bender et al. 2000; Cruz et al. 2004). Dealing with degraded DNA samples, 
as in cases of mass disasters, is always considered as a challenge due to the absolute 
difficulty in obtaining useful information via typing nuclear markers, however it is not 
always the case for mtDNA markers (Palo 2007; Marjanović 2007 ). 
 
Due to its presence in high copy number per somatic cell, mitochondrial DNA is easily 
recoverable from any kind of biological samples like blood, saliva, and semen. 
Specimens such as skin, hairs (as little as 1-2 cm of a single shaft) and bones are always 
good sources for mtDNA (Graffy and Foran 2005; Palo 2007; Marjanović 2007 ).     
 
MtDNA has also been extracted from teeth and used for forensic DNA identification 
purposes, this is particularly important as nuclear DNA is usually degraded in teeth 
specimens (Sampietro et al. 2006; Tsutsumi et al. 2006). 
 
Interestingly, fingerprints have been shown to provide a convenient source of mtDNA. 
Thus, mtDNA markers retrieved from fingerprints can be used for forensic 
identification purposes. This is particularly important where the prints are smeared or 
partial in a way that hinder the potential for identification using the traditional 
fingerprint analysis (Andreasson et al. 2006). 
 
1.9 Different methods of DNA extraction  
There are three main techniques for DNA extraction that can be used in forensic DNA 
laboratories:- 
 
1.9.1 Organic Extraction (Phenol-chloroform extraction). 
 
It involves serial addition of several chemicals to break open the cell walls and to break 
down the proteins to be followed by separation of DNA from proteins. It is the most 
effective method used to obtain high molecular weight DNA, which is essential for 
Restriction Fragment Length Polymorphism (RFLP) analysis. It has been in use for the 
longest period of time. However, this method of extraction is time consuming and 
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involves the use of multiple hazardous chemicals. In addition, it necessitates transfer of 
samples between different tubes that increases the liability of contamination (Butler 
2001).  
 
1.9.2 Chelex Extraction 
 
It has become a popular alternative method of DNA extraction among forensic 
scientists. It entails the use of a chelating-resin suspension that can be added directly to 
the samples, followed by two steps of heating at different temperatures. Then 
centrifugation is performed followed by direct application of the supernatant into the 
PCR reaction. Chelex acts by binding to the polyvalent metal ions (such as magnesium 
ions (Mg
2+
)) required as co factors for nucleases to work. Thus, removing Mg
2+ 
ions 
inactivates nucleases, and hence protects the DNA molecules. This method of extraction 
is simple and more rapid than the organic extraction one. In addition, it involves fewer 
steps, and thus reduces the potential for contamination compared to the organic method. 
However, it involves denaturation of the DNA, and thus produces single-stranded DNA 
which is only useful for PCR-based analysis (Kain and Lanar 1991; Walsh 1991; Sweet 
et al. 1996; Butler 2001). 
 
1.9.3 FTA 
TM
 Cards 
 
FTA (Flinders Technology Associates) Cards (Whatman) is a relatively novel method 
designed to simplify the collection, shipment, archiving and purification of nucleic acids 
from a wide variety of biological sources. 
  
1.9.3.1    Definition of FTA cards 
 
They are absorbent cellulose-based cards, impregnated with a patented chemical 
formula that lyses cell membranes and denatures proteins upon contact. DNA is 
physically entrapped, immobilized within the matrix and stabilized for storage at room 
temperature over a period of several years (Fujita and Kubo 2006).  
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1.9.3.2    Characteristics of FTA cards  
 
FTA cards are considered advantageous over the standard methods of DNA collection 
and purification in many aspects; 
 
 FTA cards are considered unique in their ability to store DNA samples at room 
temperature and hence no need for a precious freezer space with no risk of 
freeze-thaw degradation of samples. Additionally, they do not require special 
storage conditions apart from keeping the cards away from light and humidity. 
 
 They have the ability to protect DNA from nucleases, oxidation, and UV 
damage as well as microbial and fungal attacks. Thus, FTA cards play an 
important niche in preserving the quality of DNA samples, which in turn enable 
long term storage of samples over several years without the threat of DNA 
degradation (He et al. 2007).  
 
 Infectious pathogens (viruses, bacteria, etc.) in samples applied to FTA cards are 
rendered inactive upon contact. Which subsequently guard against the risk of 
infections‟ transmission (Moscoso et al. 2004; Muthukrishnan et al. 2008). 
 
 FTA cards can be loaded with minimal volumes of DNA-containing samples 
which is particularly important when dealing with precious limited volume 
forensic samples. 
 
 The easy and simple way of applying FTA cards render them more suitable for 
self-collection and field sample collection than any other methods 
(Muthukrishnan et al. 2008). Additionally, FTA technology facilitates collection 
of samples from geographically isolated populations and gets them transported 
by mail for accurate molecular diagnosis (Guio et al. 2006) 
 
 Use of FTA cards simply involves direct application of a sample spot on the 
card that is left to dry and then a small disc (1.2mm or 2-mm) is punched out of 
that card and subjected to serial wash processes using different solutions aiming 
to purify DNA from inhibitors. The PCR reaction mix is then added directly to 
the clean dried punch. Therefore, no hassle of contacting multiple hazardous 
chemicals (Smith and Burgoyne 2004).  
 
Chapter 1: General Introduction 
 41 
 Processing of FTA cards does not necessitate transfer of samples between 
different tubes that in turn reduces the potential of contamination. 
 
 Purifying the DNA from FTA cards does not involve its denaturation and hence 
it produces double-stranded DNA that can undergo various analyses.   
 
1.9.3.3    Different applications of FTA cards 
 
FTA cards have seen the light in the last few years and have been involved in many 
areas of research. That could be attributed to their enormous potential for storing a wide 
range of biological samples including blood (Mai et al. 2004; Sultan et al. 2009; Untoro 
et al. 2009), saliva (Beckett et al. 2008; Park et al. 2008; Johanson et al. 2009), sputum 
(Guio et al. 2006), semen (Fujita and Kubo 2006), faecal material (Jaravata et al. 2006; 
Nechvatal et al. 2008), nasal swab (Mai et al. 2004), plant material (Tsukaya 2004; 
Ndunguru et al. 2005; Owor et al. 2007), bacterial suspension (Moscoso et al. 2004; 
Rajendram et al. 2006), viral suspension (Brassard et al. 2009), yeast (Borman et al. 
2006), cell culture (Muthukrishnan et al. 2008), Bone marrow and skin smears 
(Jamjoom and Sultan 2009), solid tissue impression (Moscoso et al. 2007) as well as 
tumour cell suspension (Galaal et al. 2007) and many other kinds of biological samples 
(Adams et al. 2006; Moscoso et al. 2006; Perozo et al. 2006; Purvis et al. 2006; 
Sudhakaran et al. 2009). 
 
FTA cards have recently gained increasing popularity in the domain of forensic 
investigations and herein mentioned few examples of studies where FTA cards have 
played a pivotal role:  
 
 FTA cards were used for collection of blood samples from 638 individuals 
(representing the three ethnic groups of the Malaysian population) that have been 
analysed to determine the allele frequencies of the 15 STR loci in the 
AmpFISTR Identification kit (Seah et al. 2003). Similarly, the allele frequency 
of CODIS 13 was determined through analysis of 402 blood samples (from 
western and eastern Indonesia) collected on FTA cards (Untoro et al. 2009).   
 
 Following the use of buccal cells collected from long term Betel quid chewers, 
FTA cards have shown promising results for STR markers typing with success 
rate of 89 % as compared to 7 % using the standard organic extraction 
procedures (Salvador and De Ungria 2003). 
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 Several studies have recommended FTA cards as a convenient method for DNA 
storage and purification to be used for WGA (Whole Genome Amplification), 
SNP typing and PCR-based genotyping (Lema et al. 2006; Beckett et al. 2008; 
Tomas et al. 2008).  
 
 Using FTA technology, Fujita and Kubo (2006) were able to develop a method 
for extraction of sperm DNA from mixed body fluids containing semen. 
 
 Based on non-invasive characteristics, Beckett et al. (2008) have suggested FTA 
cards as a convenient tool for collection of buccal samples from paediatric 
populations for molecular epidemiologic studies. 
 
Apart from the forensic applications, FTA cards were adopted for the detection of viral 
infections as follow:  
 
 Porcine reproductive and respiratory syndrome virus was detected in pig whole 
blood on FTA cards (Kobayashi et al. 2003). 
 Foot and mouth disease virus was retrieved from tongue epithelial cells from 
infected animals applied on FTA cards (Muthukrishnan et al. 2008). 
 Owor et al (2007) were able to clone complete Maize streak virus genome using 
FTA cards for DNA purification from leaf samples of infected maize plant. 
 Infectious bursal disease virus in poulty was detected in bursal samples applied 
on FTA cards (Moscoso et al. 2006; Purvis et al. 2006). 
 
Not only viruses but also bacteria and parasites were detected by analysis of various 
samples on FTA cards. Listed below are examples of these: 
 
 Mycobacterium tuberculosis was detected by PCR analysis of sputum specimens 
on FTA cards as a tool for molecular testing of TB (Guio et al. 2006). 
 Bovine manure on FTA cards was successfully used for detection of 
Mycobacterium avium (Jaravata et al. 2006).  
 Trypanosoma brucei were identified in blood samples collected from human, 
sheep and mouse on FTA cards (Becker et al. 2004; Gonzales et al. 2006; 
Morrison et al. 2007).  
 Using FTA technology, Jamjoom and Sultan (2009) were able to diagnose 
leishmaniasis in bone marrow samples and skin smears.  
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 Blood samples on FTA cards were successfully used for diagnosis of Maralria 
(Sultan et al. 2009).  
 
1.10 RFLP Technology 
 
1.10.1 Definition of RFLP 
 
RFLP (Restriction Fragment Length Polymorphism) was one of the first techniques to 
be widely used in the forensic DNA analysis as well as medical genetics. In the early 
1980s, the RFLP technique was adapted by Sir Alec Jeffreys for the purpose of DNA 
profiling through isolation of minisatellites (VNTRs). And hence it has been established 
as a standard DNA identification protocol that enables differentiation between samples 
of different sources (Jeffreys and May 2003).  
 
It is based on the use of a set of restriction endonucleases that cleave the double-
stranded DNA at specific sequence patterns which are known as cut sites or recognition 
sites. Thereafter, RFLP analysis results in digestion of the double-stranded DNA into 
fragments of varying lengths which are separated according to their molecular weights 
using gel electrophoresis. The analysis is then completed by performing Southern 
blotting and hybridization of the fragments to radioactive labelled DNA complementary 
probes to be visualized by X-ray exposure (Botstein et al. 1980; Rudin and Inman 
2002b). Based upon the presence or absence of these recognition sites resulting from the 
base substitution events, variations in the fragment lengths may generate and hence may 
help in the differentiation between DNA samples derived from different sources 
(Habano et al. 1999). 
 
1.10.2 Characteristics of RFLP technology  
 
RFLP analysis is characterised by a high power of discrimination (~1 in 1 billion using 
6 loci) due both to the hypervariability of each locus and the ability to look at many 
loci. In addition, it has the capability of handling sample mixtures using single-locus 
probes. Nevertheless, it has many drawbacks compared to the other available techniques 
including the time factor since it is a long tedious process. In addition, RFLP analysis 
requires a relatively large volume of high quality (high molecular weight) double-
stranded DNA to start with, which is not always available in forensic investigations that 
are occasionally confronted by degraded DNA. Therefore, RFLP is not the most 
preferred technique by the forensic DNA laboratories nowadays, and subsequently it has 
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almost been usurped by the more recent more efficient PCR-based DNA analysis 
techniques (Rudin and Inman 2002a).   
 
1.10.3 Applications of RFLP analysis  
 
RFLP has played an important role in forensic as well as medical genetics. DNA 
profiling using RFLP analysis was the main tool for DNA-based human identification 
system that has been successfully used to aid forensic investigations in both criminal 
cases and disputed paternity. Furthermore, RFLP markers have been used for 
construction of the first-generation genetic linkage maps of human chromosomes and 
performing the genetic linkage analysis by determination of genetic loci responsible for 
genetic diseases such as cystic fibrosis, multiple endocrine neoplasia type I, familial 
polyposis coli and familial breast cancer (Botstein et al. 1980; Habano et al. 1999).  
 
However, the more recent PCR-based analyses have almost replaced the traditional 
RFLP typing system. PCR-RFLP analysis, which removes the need for southern 
blotting and hybridization, has become a very popular technique in many laboratories 
and is currently adapted for several purposes such as screening of the human genome 
for mutations associated with resistance to viral infections (Krings et al. 1999), species 
identification of different animals and micro-organisms (Malathi et al. 2009; Simon et 
al. 2010), prediction of the treatment outcome of certain diseases (Kazibwe et al. 2009). 
 
Several polymorphic sites in the coding and non-coding regions of the human 
mitochondrial DNA were screened for using PCR-RFLP technique for the purpose of 
haplotype analysis and haplogroup assignment among various populations as a tool for 
studying human history and population dynamics (Andelinovic et al. 2005; Park et al. 
2008; Vidrova et al. 2008).   
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1.11 Aims and objectives of the project 
The presented project was mainly concerned with mitochondrial molecular analysis of 
the Egyptian population. 
The primary aims included: 
1. Evaluation of the currently available techniques, namely FTA cards, for 
mitochondrial DNA testing and assessment of their efficiency for collection, 
storage and transportation of the DNA containing samples which would further 
aid the development of forensic investigations. 
2. Assessment of the nucleotide diversity and heterogeneity among the Egyptian 
population via analysis of the mitochondrial hypervariable regions (HVI and 
HVII) sequence genotypes. That would lead to enrichment of the mtDNA 
database, which by the time that project was launched was lacking sufficient 
information about the molecular structure of this population group.      
3. Assignment of the Egyptian mitochondrial haplotypes to known haplogroups. 
The frequency of different haplogroups was to be concluded and correlated with 
the published data, particularly of those haplogroups that were thought to show 
certain geographic localisation. 
4. Screening of the coding region of the mtDNA among the Egyptian samples for 
sets of mutations that were thought to be definitive markers for mitochondrial 
DNA haplogroups. For that, a novel strategy for PCR-RFLP analysis of the 
mtDNA was to be developed.  
5. The data obtained via hypervariable regions analysis was to be correlated with 
that obtained by PCR-RFLP strategy. Efficiency of both analyses was to be 
evaluated for more accurate assignment of the mitochondrial DNA to known 
haplogroups.   
 
It was hoped that this investigation would yield important insights into the molecular 
diversity of the Egyptian population that would further enhance our understanding of 
the original structure of this population group. Furthermore, it was anticipated that this 
study would enrich the mtDNA database that would further aid the development of the 
global mitochondrial phylogenetic network. 
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In addition, this project was concerned with Y-chromosome analysis through screening 
of 131 Egyptian males for amelogenin Y gene deletion, which was previously reported 
at very low frequencies in certain populations as a component of a large interstitial 
deletion on the short arm of the Y-chromosome (Yp11.2).  
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2. MATERIALS AND METHODS 
 
2.1 Use of FTA cards for collection and processing of blood samples  
 
2.1.1 Collection and storage of samples 
 
 Whole blood samples were collected from 261 adult Egyptians (131 males and 
130 females) with consent. Ethical permission for this study was granted by 
Ethics Committee, University of Alexandria, Egypt (Appendix I)
a
. 
  
 Samples were mainly collected from those individuals belonging to a lower 
economic class in the community who used to receive free medical care at the 
main university hospital. This population group was mainly chosen due to the 
fact that they have less potential for travelling abroad with minimal chances of 
admixture and thus should be a good representative model of the residential 
Egyptian population.  
 
 A simple questionnaire was applied where all the participants confirmed being 
born to Egyptian mothers. 
 
 Based on our previous medical knowledge, samples were collected by 
venipuncture and each individual sample was split into two; a small volume 
(~150-200µl) was applied as fresh blood directly to an FTA (Flinders 
Technology Associates) micro-card (WB120310, Whatman) (Figure 2.1) using 
a micropipette and left to dry at room temperature and the remaining volume of 
the sample (5-ml) was placed in a vacuum blood collection tube containing 
EDTA and stored at -20
o
C for one year before application to an FTA micro-card.       
                                                                                         
 FTA cards were stored and transported from Egypt to the UK at room 
temperature. 
 
 
 
 
 
 
                                                 
a
 The letter of approval provided by the Ethics Committee has included the provisional title of the project 
which was later on modified to the current title. 
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Figure 2.1: Whatman FTA kit. A is a whole blood sample on FTA micro-card 
(Cat.No.WB120310), B is a Harris Uni-Core Micro-Punch with 1.2 mm steel tip (Cat. No. 
WB1000028), C is a cutting mat, and D is the FTA Purification Reagent.  
 
 
2.1.2 Processing of blood samples on FTA cards for DNA purification 
 
Processing of blood stained FTA micro-cards involved three main steps:- 
 
1- A small disc was manually punched out of the card, using a Harris Uni-Core 
Micro-Punch fitted with 1.2 mm steel tip, and placed in a sterile 500µl PCR 
microcentrifuge tube. To avoid cross contamination between samples, discs 
from non-stained areas were punched out of the cards in between different 
samples. 
 
2- The discs were then washed in the PCR tube according to the manufacturer‟s 
instructions (Whatman) in order to remove any non-DNA material that might 
inhibit the PCR reaction. Variations on the recommended washing protocol were 
performed to maximise the removal of inhibitors in the blood samples (Table 
2.1). The waste wash was discarded after each washing time. Washes were 
continued until the discs were blank and then discs were transferred to fresh 
sterile 500µl PCR tubes.  
 
3- Discs were then allowed to dry either at room temperature for 1 hour or at 56oC 
for 10 minutes, according to Whatman‟s recommendations. Finally, the dried 
discs were transferred to fresh sterile 500µl PCR tubes to which the PCR master 
mix was then added.   
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Whenever processing of blood samples on FTA cards was performed, a non-stained disc 
was included and taken through the whole process of washing and drying in a separate 
sterile eppendorf tube, to be used as a negative control in the subsequent analysis.    
 
Table 2.1: Summary of different methods used for washing blood stained discs. 
  
(a) 
WB120204, Whatman. 
(b) 
10mM Tris, 0.1mM EDTA, pH 8.0. 
(c)  
Sodium
 
Carbonate, Fisher Scientific. 
(d)
 Sodium Dodecyl Sulfate, Sigma-Aldrich. 
 
 
Preliminary experiments were performed using both 2-mm and 1.2-mm discs. However 
comparative results revealed no significant difference between both of them, therefore 
1.2-mm disc was considered as the optimum disc size to be used all through the current 
study. 
 
Method 
First Wash Intermediate Wash Final wash 
Reagent 
(volume) 
Duration 
(min) 
Number 
of times 
Reagent 
(volume) 
Duration 
(min) 
Number 
of times 
Reagent 
(volume) 
Duration 
(min) 
Number 
of times 
1 
FTA 
Purification 
Reagent
(a)
 
(200µl) 
5 3 / / / 
TE
-1
 
Buffer
(b)
 
(200 µl)
 
 
5 2 
2 " 10 4 / / / " 10 4 
3 " " " 
0.3 M 
Na2CO3
(c)
 
(200µl)  
5 1 " " " 
4 " " " 
5% SDS
(d)
 
(500µl)  
" " " " " 
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2.2 Analysis of the mitochondrial hypervariable regions (HVI and 
HVII) 
 
2.2.1 Polymerase Chain Reaction (PCR)  
 
Following processing of the blood samples on FTA micro-cards, dried discs were then 
subjected to PCR amplification of mitochondrial hypervariable regions (HVI and HVII) 
either in separate reactions or simultaneously. The experiment was repeated in an 
identical manner for all the Egyptian blood samples (n=261).  
 
2.2.1.1    Design of primers  
 
Two sets of primer pairs have been used to amplify mitochondrial hypervariable regions 
HVI and HVII between nucleotide positions 16024-16365 and 73-340 respectively 
(Table 2.2):  
 
 A set of short primers (~20mer) previously designed by Gabriel et al. (2003) was 
used in conjunction with the conventional thermal cyclic conditions. 
 A second set of Long (~30mer) oligonucleotides was designed and synthesized 
during the current study to be used with fast PCR conditions.   
 
Table 2.2: Details of the primers for PCR amplification of the mitochondrial hypervariable 
regions (HVI and HVII). Sequences, length, nucleotide position, GC content and melting 
temperature of primers were mentioned. Sequences of short primers were obtained from 
Gabriel et al. (2003). Sequences of long primers were designed based on the CRS of the 
human mitochondrial genome (accession number NC_012920). 
 
 
Name 
Primer sequence  
(5′ to 3′) 
Length 
(bases) 
Nucleotide 
position 
(a)
 
GC 
content 
(%) 
Tm 
(
o
C) 
Short primers      
HVI F Short CTCCACCATTAGCACCCAA 19 15975-15993 52.6 63.9 
HVI R Short ATTTCACGGAGGATGGTG 18 16418-16401 50.0 61.5 
HVII F Short CACCCTATTAACCACTCACG 20 15-34 50.0 60.0 
HVII R Short CTGTTAAAAGTGCATACCGC 20 429-410 45.0 60.2 
Long primers      
HVI F Long AAGTCTTTAACTCCACCATTAGCACCCAAAGC 32 15965-15996 43.8 72.9 
HVI R Long GGATATTGATTTCACGGAGGATGGTGGTC 29 16426-16398 48.3 73.6 
HVII F Long GGTCTATCACCCTATTAACCACTCACGGGAG 31 8-38 51.6 72.9 
HVII R Long GGGTGACTGTTAAAAGTGCATACCGCCAAAAG 32 435-404 46.9 73.7 
 
(a) 
Nucleotide positions
 
according to the Cambridge Reference Sequence. 
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Combinations of primers were used (Table 2.3) in order to develop an appropriate 
protocol for the analysis of mitochondrial hypervariable regions that would be 
consistently applied for all the Egyptian blood samples: 
 
 HVI F and HVI R primers were used for PCR amplification of hypervariable 
region I. 
 HVII F and HVII R primers were used for amplification of hypervariable region 
II. 
 All four primers; HVI F, HVI R, HVII F, HVII R, were used together for 
multiplex amplification of the two hypervariable regions simultaneously in the 
same reaction as two separate fragments. 
 HVI F and HVII R primers were used for amplification of both regions together 
as one fragment. 
 
Table 2.3: Combinations of primers used for PCR amplification of the mitochondrial 
hypervariable regions. The expected PCR product size of each combination is indicated. 
 
 
Primers Amplification of 
PCR product 
size (bp) 
HVI F and HVI R (Short) HVI 444  
HVII F and HVII R (Short) HVII 415 
HVI F and HVI R (Long) HVI 462  
HVII F and HVII R (Long) HVII 428  
HVI F, HVI R, HVII F and HVII R (Short) Multiplex of HVI and HVII 444 and 415 
HVI F, HVI R, HVII F, HVII R (Long)       "               "              "   462 and 428 
HVI F and HVII R (Short) HVI and HVII as one fragment 1024 
HVI F and HVII R (Long)       "              "              "   1039 
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2.2.1.2   Constituents of PCR master mix   
 
The reaction mixtures were prepared in sterile nuclease-free 500µl PCR tubes and 
contained the following constituents for each reaction volume of 50µl per sample: 
 
-  5x GoTaq colourless Flexi buffer (Promega)                                10.0µl           
-  MgCl2 (25mM; Promega)                                            5.0µl 
-  DeoxyNTP mixture (10mM; Promega)                        2.0µl  
-  Forward primer x (100pmol/µl)                                          0.5µl  
-  Reverse primer y (100pmol/µl)                                           0.5µl 
-  GoTaq DNA polymerase (5u/µl; Promega)                        0.25µl 
-  Nuclease free water to final volume of 50µl                      31.75µl 
 
GoTaq Flexi buffer and MgCl2 solution were vortexed briefly following complete 
thawing. The listed components were added to a sterile thin-walled 500µl eppendorf 
tube contained the processed dried disc. 
 
Positive and negative controls were also included. The positive control was 1.0μl of 
human placental DNA (10ng/µl; Sigma) and the negative control was a processed dried 
blank disc. All the other constituents of the PCR master mix were unchanged except for 
the nuclease free water which was readjusted in the positive control reaction. 
 
Following the results of preliminary experiments, the constituents of the PCR master 
mix included a modification to reduce the effects of inhibitor(s) in blood that was 
achieved by adding acetylated Bovine Serum Albumin (BSA) (Promega). 
 
Modified constituents for a 50µl reaction mix were as follows: 
 
-  5x GoTaq colourless Flexi buffer (Promega)                                    10.0µl  
-  MgCl2 (25mM; Promega)                                                                    5.0µl 
-  DeoxyNTP mixture (10mM; Promega)                                                2.0µl 
-  Bovine Serum Albumin (BSA) (10 mg/ml; Promega)                         2.0µl  
-  Forward primer x (100pmol/µl)                                                           0.5µl  
-  Reverse primer y (100pmol/µl)                                                            0.5µl 
-  GoTaq DNA polymerase (5u/µl; Promega)                                       0.25µl 
-  Nuclease free water to final volume of 50µl                                    29.75µl 
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2.2.1.3   PCR Thermal Cyclic Conditions 
 
All PCR reactions were performed in a thermocycler (TECHNE GENUIS). 
Conventional cyclic conditions were used when short primers (~20mer) have been 
included in the PCR reaction mix as follows:  
 
Initial Denaturation                  94
o
C                5 min                  1 cycle 
Denaturation                             92
o
C              45 sec 
Annealing                                 59
o
C              1 min                  30 cycles 
Extension                                  72
o
C              1 min 
Final Extension                         72
o
C             10 min                  1 cycle 
Soak                                            4
o
C                Hold                   1 cycle 
    
Optimised PCR thermal cyclic conditions were as follows;   
  
Initial Denaturation                  98
o
C               30 sec                1 cycle 
Denaturation                             92
o
C               5 sec                                        
Annealing/ Extension               72
o
C               30 sec              
Final Extension                         72
o
C               1 min                1 cycle 
Soak                                            4
o
C                Hold                 1 cycle 
 
A high initial denaturation temperature at 98
o
C has been used to ensure full denaturation 
of the initial genomic template in a short period of time (30 sec) as recommended by 
Sullivan et al. (2006) at Bio-Rad laboratories. Despite being specific recommendations 
for the hot-start polymerases, this modification was applicable to GoTaq DNA 
polymerase as well without any reduction in the efficiency of amplification.  
 
2.2.1.4   Gel electrophoresis of the PCR products 
 
PCR products were analysed by agarose gel electrophoresis. Small volumes (5-10µl) of 
the PCR products were separated using 2% (w/v) agarose (Bioline) gels containing 1x 
SYBR Safe DNA gel stain (stock of 10,000x in DMSO, Invitrogen) in 1x TAE buffer 
(40mM Tris-base, 20mM glacial acetic acid, and 5mM EDTA; pH 8). PCR products 
were mixed with 6x loading dye (0.25% (w/v) bromophenol blue (Sigma-Aldrich), 40% 
(w/v) sucrose (Fisher Scientific), 4ml (v/v) TE buffer and 10.8ml of 0.1% (v/v) DEPC-
treated water). A 100bp DNA ladder (Promega) (5µl ladder + 1µl loading dye) was used 
as a molecular marker to monitor the migration of samples and determine the size of 
 
 30 cycles 
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different PCR products. Gels were run at 80-100V for 45 min to 1 hour. The bands were 
then visualised using a UV transilluminator within the Syngene gel documentation 
system.  
 
2.2.1.5   Purification of the PCR products  
 
PCR products were purified to remove excess nucleotides and primers using Wizard
®
 
SV Gel and PCR Clean-Up Purification System (Promega) according to the 
manufacturer’s instructions. [This system was based on the selective adsorption of DNA 
to Silica-gel membranes present at the bottom of the SV Minicolumn under controlled 
ionic conditions using Membrane Binding Solution, whilst all impurities were washed 
out using micro-centrifugation and the Membrane Wash Solution.] DNA was eluted in 
50µl of nuclease-free water. Purified samples (3µl) were checked by agarose gel 
electrophoresis.  
 
2.2.1.6   Ethanol precipitation  
 
For those samples that have shown poor DNA yield after purification of the PCR 
products as evidenced by faint bands on the second gel, Ethanol precipitation was 
considered in order to increase the DNA concentration. For this, 2.5 vol. of 100% (v/v) 
ethanol and 1/10 vol. of 3M sodium acetate (Sigma-Aldrich) (pH 5.2) were added to 
each sample, after which the samples were vortexed and incubated at −20oC for 2 hours. 
The tubes were then centrifuged at 13,000rpm at 4
o
C for 20 min. The supernatant was 
discarded and 150µl of 75% (v/v) ethanol was added. The tubes were briefly vortexed 
and centrifuged at 13000rpm at 4
o
C for a further 5min. The supernatant was removed 
and the pellets were air-dried. Pellets were resuspended in 10µl nuclease-free water. 
 
2.2.2 Sequencing of the mitochondrial hypervariable regions (HVI and HVII) 
 
Sequencing reactions were performed and analysed at the Functional Genomics and 
Proteomics Laboratories at University of Birmingham. Samples were prepared for 
sequencing by adding 5µl of the purified PCR products and 4µl of the sequencing 
primer (at a final concentration of 0.8pmol/µl). Both forward and reverse short primers 
(Table 2.2) have been used in two separate sequencing reactions for each sample.  
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2.2.3 Data analysis  
 
2.2.3.1    Mitochondrial haplotype analysis  
 
Nucleotide diversity and heterogeneity among the Egyptian population was assessed via 
analysis of the sequencing results of HVI and HVII regions of the mitochondrial 
genome. The obtained nucleotide sequences were aligned against the Cambridge 
Reference Sequence (CRS) (accession number NC_012920) using CLUSTALW 
analysis tool of Biology Workbench at (www5). Instances of point heteroplasmy were 
evaluated on the proportion of minor versus major component. Variations from the CRS 
represented mutations, nucleotide positions of these mutations were determined and 
subsequently mitochondrial haplotypes were concluded and correlated to the published 
databases.  
 
2.2.3.2    Mitochondrial haplogroup assignment 
 
Assignment of the Egyptian mitochondrial hypervariable region haplotypes to the well 
established mitochondrial haplogroups was performed via correlation of the reported 
haplotypes to the published databases as well as the electronic databases including the 
global human mitochondrial DNA phylogenetic tree (www6). This global phylogenetic 
tree is regularly updated to maintain high resolution of the phylogenetic network of the 
mitochondrial DNA (Van Oven and Kayser 2009).     
 
Following analysis of a considerable representative number of complete Egyptian HVI 
and HVII sequences between nucleotide positions 16024-16365 and 73-340 
respectively, and depending on the usefulness of each hypervariable region solely in 
haplogroup assignment, a modification was considered which included analysis of HVI 
(between nucleotide position 16024-16365) together with nucleotide position 73 in 
HVII.   
 
2.2.3.3    Statistical analysis 
 
The overall number of nucleotide variations in the mitochondrial HVI region was 
determined and those occurring at a high frequency were identified. The total number of 
different haplotypes was determined, the frequency of each haplotype was estimated 
and the most commonly observed haplotypes were identified. The probability of 
randomly selecting two unrelated individuals with the same mitochondrial haplotype 
(random match probability, RMP) was calculated using the equation p=∑x2, where x is 
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the frequency of each mtDNA haplotype (Stoneking et al. 1991). Genetic diversity of 
the mtDNA hypervariable regions in the studied population group was calculated using 
the algorithm h= n(1−∑x2 )/(n−1), where n is the sample size and x is the frequency of 
each mtDNA haplotype (Nei and Tajima 1981).  
 
2.3 PCR-RFLP screening of the whole mitochondrial genome among 
the Egyptian population 
 
To further aid in the mtDNA analysis and haplogroup assignment of the Egyptian 
population, the mitochondrial genome was screened for 26 RFLP (Restriction Fragment 
Length Polymorphism) markers that were described as haplogroup specific. For this, 
mitochondrial genome was amplified by PCR as nine non-overlapping fragments, which 
were subsequently digested using restriction endonucleases. Amplification of the whole 
mitochondrial genome (~16Kb) as one PCR product was considered at the beginning of 
that part of the study, however, it was shown to be inconvenient due to the extreme 
difficulty in the analysis of digestion patterns produced by different restriction enzymes 
particularly AluI (64 cut sites) and DdeI (72 cut sites) endonucleases using the standard 
gel electrophoresis techniques. On the other hand, amplification of 26 regions of the 
mitochondrial genome in the entire Egyptian population sample (n=261) to screen for 
the determined 26 RFLP markers was expected to be tedious and time consuming. 
Therefore, a decision was made to minimize the number of PCR amplicons as much as 
possible that would be further used in the FRLP analysis. Hence, the nine fragments 
protocol was designed to include the total number of RFLP markers. Those fragments 
were subsequently digested using different endonucleases where the digestion patterns 
could be easily analysed using the standard gel electrophoresis techniques.     
  
2.3.1 Design of primers for PCR amplification of the nine targeted regions of the 
mitochondrial genome  
 
In order to achieve the target of the mitochondrial genome amplification, nine pairs of 
primers (Table 2.4) were designed to amplify nine non-overlapping fragments (Figure 
2.2). Sequences of primers were based on the Cambridge Reference Sequence (CRS) of 
the human mitochondrial genome (accession number NC_012920). 
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Figure 2.2: Schematic representation of the nine targeted regions of the whole 
mitochondrial genome. The nine targeted regions are represented by the yellow boxes with 
the length of each fragment inside. Fragments are designated by letters from A-I. The 
nucleotide positions of the different fragments are shown in red. The nine fragments altogether 
constituted 11645bp of the whole mitochondrial genome (16569bp). Each fragment was 
designed to have one or more of the RFLP definitive markers of the different mitochondrial DNA 
haplogroups.   
 
 Design of multiplex PCR amplification of the mitochondrial genome  
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Table 2.4: Primers pairs used for PCR amplification of nine targeted regions of the mitochondrial genome.  All primers were based on the Cambridge 
Reference Sequence of the human mitochondrial genome (accession number NC_012920).  
   
 
(a)
 Nucleotide positions
 
according to the Cambridge Reference Sequence. 
 
Primer name 
Primer sequence 
(5′ to 3′) 
Primer position
(a)
 
Length 
(bases) 
GC content 
(%) 
Tm (
o
C) 
PCR product 
(Size) 
Mt A F 
Mt A R 
TTATTTTCCCCTCCCACTCC 
AATCACTGCTGTTTCCCGTG 
451-470 
827-808 
20 
20 
50 
50 
63.8 
65.0 
Fragment A 
(377bp) 
Mt B F 
Mt B R 
CCGTCACCCTCCTCAAGTAT 
GGCAGGTCAATTTCACTGGT 
1489-1508 
2690-2671 
20 
20 
55 
50 
62.9 
63.9 
Fragment B 
(1202bp) 
Mt C F 
Mt C R 
ATGGCCAACCTCCTACTCCT 
TGGTTATGGTTCATTGTCCG 
3314-3333 
4732-4713 
20 
20 
55 
45 
63.7 
63.2 
Fragment C 
(1419bp) 
Mt D F 
Mt D R 
ACTAGCCCCCATCTCAATCA 
AGCGAAGGCTTCTCAAATCA 
4875-4894 
7335-7316 
20 
20 
50 
45 
63.4 
63.9 
Fragment D 
(2461bp) 
Mt E F 
Mt E R 
TGAAGCCCCCATTCGTATAA 
ATAGGCATGTGATTGGTGGG 
8024-8043 
9231-9212 
20 
20 
45 
50 
64.0 
64.5 
Fragment E 
(1208bp) 
Mt F F 
Mt F R 
CGCCTGATACTGGCATTTTG 
CAAGGTGGGGATAAGTGTGG 
9921-9940 
11150-11131 
20 
20 
50 
55 
65.3 
64.1 
Fragment F 
(1230bp) 
Mt G F 
Mt G R 
CACCTATCCCCCATTCTCCT 
GCGAGGGCTGTGAGTTTTAG 
12077-12096 
13812-13793 
20 
20 
55 
55 
63.9 
63.8 
Fragment G 
(1736bp) 
Mt H F 
Mt H R 
CCAATAGGATCCTCCCGAAT 
AGGAGTGAGCCGAAGTTTCA 
14253-14272 
14857-14838 
20 
20 
50 
50 
63.8 
63.9 
Fragment H 
(605bp) 
Mt I F 
Mt I R 
ATTGCAGCCCTAGCAGCACT 
ATGAGGCAGGAATCAAAG 
15312-15331 
149-132 
20 
18 
55 
44.4 
66.1 
57.7 
Fragment I 
(1407bp) 
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2.3.2 Multiplex PCR amplification of the nine fragments of the mitochondrial 
DNA 
 
Amplification of 11645bp of the mitochondrial genome was performed in a two- stage 
PCR; the first stage was a multiplex amplification of all the nine non-overlapping 
fragments for 10 cycles using all nine pairs of primers, followed by the second-stage 
PCR in which the PCR product of the first reaction was used as a template. The second-
stage PCR involved amplification of each fragment solely using the specific pair of 
primers (25 cycles). This protocol of two-stages PCR was designed aiming to reduce the 
initial volume of the DNA template that would be required for performing the nine 
separate PCR reactions, which would have a major impact on the forensic investigations 
where the amount of a sample may be an issue. 
 
2.3.2.1   PCR using Phusion High-Fidelity DNA polymerase  
 
The reaction mixtures for the multiplex amplification (first-stage PCR) were prepared in 
500µl sterile nuclease-free PCR tubes (Eppendorf) as follows: 
 
-  5x Phusion HF buffer (Finnzymes)                                    10.0µl  
-  MgCl2 (25mM; Promega)                                                    2.0µl 
-  DeoxyNTP mixture (10mM; Promega)                               2.0µl 
-  Bovine Serum Albumin (BSA) (10 mg/ml; Promega)        2.0µl  
-  Nine forward primers (Mt A-I F) (100pmol/µl) 9.0µl (1.0µl of each primer) 
-  Nine reverse primers (Mt A-I R) (100pmol/µl)                  9.0µl (1.0µl of each primer) 
-  Phusion High-Fidelity DNA polymerase  
    (2u/µl; Finnzymes)                                                             0.5µl 
-  Nuclease free water to final volume of 50µl                                     
 
The listed components were then added to a sterile thin-walled 500µl eppendorf tube 
contained the processed dried disc (as previously described in section 2.1.2), ensuring 
that all solutions were kept on ice and keeping the reactions capped as often as possible.  
A negative control was run throughout the whole experiment using a processed non-
stained disc replacing the sample disc. 
 
Phusion DNA polymerase is a magnesium dependent enzyme and Phusion buffer 
contains MgCl2 at a concentration of 7.5mM giving a final concentration of 1.5mM in 
the 50µl reaction. However, 1.5mM MgCl2 was not the optimum concentration for 
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Phusion polymerase to work efficiently with these primers. Therefore, 2.0µl of 25mM 
MgCl2 stock was added to the reaction which together with Phusion buffer produced the 
overall final concentration of Mg
2+
 at 2.5mM.  
 
Following the first-stage PCR for 10 cycles, the reaction mixtures for the second-stage 
PCR were prepared for each target region of the mitochondrial DNA separately in a 
sterile thin-walled 500µl PCR tube as follows: 
 
-  5x Phusion HF buffer (Finnzymes)                                                10.0µl  
-  MgCl2 (25mM; Promega)                                                                 2.0µl 
-  DeoxyNTP mixture (10mM; Promega)                                            2.0µl 
-  Bovine Serum Albumin (BSA) (10 mg/ml; Promega)                     2.0µl  
-  Forward primer x (100pmol/µl)                         1.0µl  
-  Reverse primer y (100pmol/µl)                                              1.0µl  
-  Multiplex (first-stage) PCR product (as template)                            2.0µl   
-  Phusion High-Fidelity DNA polymerase (2u/µl; Finnzymes)          0.5µl 
-  Nuclease free water to final volume of 50µl                                     
 
Negative control was run by replacing the multiplex PCR product as the template with 
nuclease-free water. All reactions were placed in a thermocycler (TECHNE GENIUS) 
for 25 cycles.  
 
2.3.2.2 PCR conditions for amplification of 11Kb of the human mitochondrial 
genome 
 
The thermal cyclic conditions for the multiplex first-stage PCR were as follows: 
 
Initial Denaturation (1 cycle)                                      at 98
o
C, for 30 sec  
10 cycles of 
Denaturation                                                                at 98
o
C, for 10 sec 
Annealing                                                                    at 64
o
C, for 20 sec                   
Extension                                                                     at 72
o
C, for 1 min 10 sec 
1 cycle of 
Final Extension                                                           at 72
o
C, for 3 min   
The thermal cyclic conditions that were used for second-stage PCR amplification of the 
nine targeted regions of the mitochondrial genome were summarised in Table 2.5. 
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Table 2.5: PCR conditions used for the second-stage PCR amplification of the nine 
targeted regions of the mitochondrial genome. The duration of extension in each cycle was 
directly related to the expected size of the PCR product. 
 
Name of 
PCR 
product 
Size of 
PCR 
product 
Initial 
denaturation 
(1 cycle) 
25 cycles of Final 
extension 
(1 cycle) Denaturation Annealing Extension 
A 377bp 
98
o
C  
for 30 sec 
98
o
C  
for 10 sec 
64
o
C  
for 10 sec 
72
o
C  
for 15 sec 
72
o
C 
 for 3 min 
B 
C 
E 
F 
G 
I 
1202bp 
1419bp 
1208bp 
1230bp 
1736bp 
1407bp 
" " 
64
o
C 
for 20 sec 
72
o
C 
for  1 min 
and 10 sec 
72
o
C 
for 5 min 
D 2461bp " " " 
72
o
C 
 for  1 min 
 and 30 sec 
" 
H 605bp " " " 
72
o
C  
for 40 sec 
" 
   
2.3.2.3   Gel electrophoresis of PCR fragments 
 
Small volumes (5µl) of all PCR products were separated using 1% and 2% (w/v) 
agarose (Bioline) gels containing 1x SYBR Safe DNA gel stain (Invitrogen) (in 1x TAE 
buffer), along with 1kb and 100bp DNA ladders (Promega), respectively. 
Electrophoresis was performed at 100V for 45 min. DNA fragments were visualised 
with an ultraviolet (UV) transilluminator and gel documentation system (Syngene). 
 
2.3.3 Restriction digestion of the PCR products (RFLP analysis) 
 
2.3.3.1   Constituents and conditions of the various restriction digestion reactions   
 
All products of the second-stage PCR were digested using restriction endonucleases for 
detection of the RFLP markers that were specific for the different mitochondrial DNA 
haplogroups (Bailliet et al. 1994; Macaulay et al. 1999; Alves-Silva et al. 2000; Finnila 
et al. 2001b; Tolk et al. 2001). A set of 15 endonucleases (Promega and Biolabs) were 
used. Restriction digestions were prepared in 500µl sterile PCR tubes as follows: 
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Restriction digestion: 
Second-stage PCR product                                                             14.0µl 
Restriction enzyme 10x Buffer (Table 2.6)                                         2.0µl 
Acetylated BSA (10 µg/µl; Promega)                                                  0.2µl 
Nuclease-free water                                                                    3.4µl 
Restriction enzyme (10u/µl)                                                                 0.4µl 
Final volume                                                                                     20.0µl 
 
The restriction enzyme was the last component to be added to the digestion reaction and 
then all the constituents were mixed by gentle pipetting up and down. Reactions were 
incubated at 37
o
C for 2 hours except for TaqI restriction enzyme where the incubation 
was performed at 65
o
C for 2 hours according to the optimum assay temperature given 
by Promega.  
Digestion products were separated in agarose gels ranging from 1% − 3.5% containing 
SYBR Safe stain (in 1x TAE buffer), along with 1 Kb DNA ladder (Promega) or  hyper 
ladder IV (Bioline) for 45min at 100V. DNA fragments were visualised using UV 
transilluminator and gel documentation system (Syngene). 
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Table 2.6: Restriction enzymes and the corresponding buffers used in the RFLP analysis 
of the mitochondrial genome. 
 
Restriction enzyme* Buffer 
AccI 10x Buffer G (500mM Tris-HCl (pH 8.2) and 50mM MgCl2) 
AluI 
10x Buffer B (60mM Tris-HCl (pH 7.5), 500mM NaCl, 60mM MgCl2 and 
10mM DTT) 
AvaII 
10x Buffer C (100mM Tris-HCl (pH 7.9), 500mM NaCl,100mM MgCl2 
and 10mM DTT) 
BamHI 
10x Buffer E (60mM Tris-HCl (pH 7.5), 1M NaCl, 60mM MgCl2 and 
10mM DTT) 
DdeI 
10x Buffer D (60mM Tris-HCl (pH 7.9), 1.5M NaCl,60mM MgCl2 and 
10mM DTT) 
EcoRI 
10x Buffer H (900mM Tris-HCl (pH 7.5), 500mM NaCl and 100mM 
MgCl2) 
HaeII 10x Buffer B 
HaeIII 10x Buffer C 
HincII 10x Buffer B 
HinfI 10x Buffer B 
HpaI 
10x Buffer J (100mM Tris-HCl (pH 7.5), 500mM KCl, 70mM MgCl2 and 
10mM DTT) 
MboI 10x Buffer C 
MseI 
1x NEBuffer 4 (50mM potassium acetate (pH7.9), 20mM Tris-acetate, 
10mM magnesium acetate and 1mM DTT) 
NlaIII 1x NEBuffer 4 
TaqI 10x Buffer E 
 
* All restriction enzymes were purchased from Promega apart from MseI and NlaIII that were 
purchased from Biolabs and they all were in the concentration of 10u/µl. 
2.3.3.2    HaeIII restriction digestion of fragment A of the mitochondrial genome 
(nt451-827)  
 
The PCR product containing fragment A (377bp) which extended between 
mitochondrial nucleotide positions 451 and 827 was digested with HaeIII endonuclease. 
The Cambridge Reference Sequence of the mitochondrial DNA (accession number 
NC_012920) lacks the recognition sequence for HaeIII restriction enzyme 
(5′…GG▼CC…3′) between those two nucleotide positions. Whereas, mitochondrial 
DNA belonging to the native American mitochondrial DNA haplogroup A has an 
A663G mutation (Bailliet et al. 1994) which produces a novel HaeIII cut site at that 
position along fragment A (Figure 2.3). 
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Figure 2.3: HaeIII digestion of mitochondrial fragment (A) nt451−827. (a) represents the 
Cambridge Reference Sequence of the mitochondrial DNA amplified using Mt A forward primer 
(blue arrow) and Mt A reverse primer (brown arrow) which lacks HaeIII recognition site and (b) 
mitochondrial sequence belonging to haplogroup A which has an A663G mutation shown in red 
(Bailliet et al. 1994) producing a HaeIII cut site and the digestion products are two fragments of 
sizes 214 and 163 bp. Sequences of (a) and (b) were obtained from NCBI database (accession 
number NC_012920) and MITOMAP database at (www7) respectively. 
 
2.3.3.3 DdeI and MboI restriction digestions of fragment B of the mitochondrial 
genome (nt1489-2690) 
 
Products of the PCR amplification of fragment B of the mitochondrial genome (1202bp) 
(nucleotide position 1489 − 2690) were digested with DdeI and MboI endonucleases in 
separate reactions. These restriction digestions aimed to identify two sets of 
mitochondrial DNA haplogroups via detection of certain RFLP markers.  
 
The CRS of the mitochondrial genome between nucleotide positions 1489 and 2690 has 
six DdeI recognition sites (5′…C▼TNA_G…3′) according to Andrews et al.(1999) 
including one site at nucleotide position 1715 (Figure 2.4.a). The recognition sequence 
at that position is lost following a G1719A substitution which occurs in the 
mitochondrial DNA sequences belonging to haplogroups N and I and subclade X2 
(Palanichamy et al. 2004; Kivisild et al. 2006; Tamm et al. 2007; Achilli et al. 2008), 
and hence loss of that cut site is diagnostic of these lineages (Figure 2.4.b). 
 
 
 
a.
b.
451 827
AGCC
GGCC
663
HaeIII digestion of fragment A
663
+HaeIII
Mt A F
Mt A R
214 bp 163 bp
377 bp
▼
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The same region of the mitochondrial DNA (nt1489-2690) in the CRS lacks a 
recognition sequence for MboI restriction enzyme (5′…▼GATC…3′); (Figure 2.4.c). 
However, the African mitochondrial subclades L1b and L3e were described to have a 
T2352C mutation (Rando et al. 1998; Herrnstadt et al. 2002; Behar et al. 2008b; 
Malyarchuk et al. 2008) that produces an MboI cut site at position 2349 which is 
considered as a definitive marker for these two African lineages (Figure 2.4.d).    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Restriction digestion of the fragment B of the mitochondrial genome (nt1489 
−2690. Fragment B was amplified using Mt B forward primer (blue arrow) and Mt B reverse 
primer (brown arrow) and it involved 1202bp of the mitochondrial genome. Numbers above the 
fragment represented the nucleotide positions and numbers below were the expected lengths of 
the restriction digestion products. Longitudinal red bars represented the restriction cut sites. A 
plus sign (+) indicates a new cut site and a minus sign (−) indicates loss of a cut site. The top 
half of the figure shows the results of DdeI digestion of fragment B and the bottom one shows 
the products of MboI digestion of the same fragment. (a) and (c) represent the digestion results 
of the Cambridge Reference sequence of the mtDNA (accession number NC_012920), the 
length of each segment was mentioned below its corresponding bar. (a) shows the expected 
pattern of DdeI digestion of CRS with seven fragments of varying sizes ranging from 28bp up to 
MboI digestion
DdeI digestion
+MboI
Mt B R
1638 1668 1715 1896 1924 2037
149bp        30bp      48bp           180bp            28bp    113bp                 653bp
1489
Mt B F
2690
1202bp
a.
b.
1638 1668 1896 1924 2037
149bp        30bp                      228b                 28bp        113bp                 653bp
c.
1202bp
d.
GATT
GATC
2352
▲
860bp 341bp
2349
RFLP analysis of the fragment B
−DdeI
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653bp. (b) represents mitochondrial DNA sequence belonging to hapolgroups N, I or X2 in 
which the DdeI cut site at position 1715 was lost resulting in merging the two segments of sizes 
48 and 180bp into one segment of 228bp. (c) shows the absence of MboI recognition sequence 
along this region of the CRS. (d) represents an example of mitochondrial DNA sequence 
belonging to subclades L1b or L3e in which T2352C mutation occurred resulting in an MboI cut 
site gain at position 2349. 
 
2.3.3.4    HpaI and NlaIII restriction digestions of fragment C of the mitochondrial 
genome (nt3314-4732) 
 
PCR products containing fragment C (1419bp) (nucleotide position 3314 − 4732) were 
analysed with HpaI and NlaIII endonucleases separately. HpaI restriction digestion was 
carried out to screen for an African specific marker characterised by a C3594T mutation 
(Chen et al. 1995b; Salas et al. 2002) which produces an HpaI recognition sequence 
(5′…GTT▼AAC…3′) (Figure 2.5). This cut site gain is a diagnostic marker of the 
major African mitochondrial haplogroups L0, L1, L2, L5 and L6. 
 
For NlaIII restriction digestion, the CRS of the mitochondrial DNA includes two 
internal cut sites (5′…CATG▼…3′) between nucleotide positions 3314 and 4732 
according to the NCBI database (Figure 2.5.c). Mitochondrial DNA belonging to 
haplogroup JT (a descendant of the macro-haplogroup R, which originated in Southwest 
Euroasia) has a T4216C mutation (Torroni et al. 1996; Macaulay et al. 1999; Finnila et 
al. 2001a; Pike 2006; Logan 2009) which results in an additional recognition sequence 
for NlaIII endonuclease (Figure 2.5.d).  
   
Additionally, NlaIII digestion of the fragment C of the mitochondrial genome helped in 
the identification of the mitochondrial haplogroup V (a sister to haplogroup H, 
originated from the haplogroup HV0a), in which an G4580A mutation (Torroni et al. 
2001; Achilli et al. 2004; Palanichamy et al. 2004; Torroni et al. 2006) causes loss of 
NlaIII recognition sequence (Figure 2.5.e). 
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Figure 2.5: Restriction digestion analysis of the fragment C of the mitochondrial genome 
(nt3314 and 4472). Fragment C was the product of the PCR amplification of mtDNA using Mt C 
forward primer (blue arrow) and Mt C reverse primer (brown arrow) and it represented 1419bp 
of the mitochondrial genome. Numbers shown above the horizontal bars represent the 
nucleotide positions and numbers below are the expected lengths of the restriction digestion 
products. Longitudinal red bars represent the restriction cut sites. A plus sign (+) indicates a 
new cut site and a minus sign (−) indicates loss of a cut site. (a) and (b) show the expected 
results of HpaI digestion and (c), (d) and (e) show NlaIII digestion products. (a) represents the 
sequence of fragment C as in the CRS which lacks HpaI recognition sequence, and (b) 
represents an example of mitochondrial DNA sequence belonging to one of the major African 
mitochondrial haplogroups (L0, L1, L2, L5 or L6) which has a C3594T mutation producing a 
HpaI cut site which is considered a specific marker to the African lineages. (c) illustrates the 
sequence of the fragment C as in the CRS, having two NlaIII recognition sites. (d) represents an 
example of the mitochondrial haplogroup JT having an additional NlaIII cut site at nucleotide 
position 4216 resulting from T4216C mutation. This mutation is a diagnostic marker of the 
mitochondrial haplogroup JT and its descendants. (e) illustrates mitochondrial DNA sequence 
belonging to haplogroup V with the G4580A mutation causing loss of NIaIII recognition site at 
4577.   
Mt C R
3314
Mt C F
4732
1419bp
a.
b.
c.
d.
RFLP analysis of the fragment C
1419bp
GTCAAC
3594
GTTAAC
▲
+HpaI278bp 1140bp
e.
45773839
529bp 738bp 152bp
529bp 373bp 152bp
3839 4577
365bp
TATG
CATG
4216
4216
▲
+NlaIII
CATG
▲
CATG
▲
4577
529bp 890bp
TATG
4216
CATA
−NlaIII
NlaIII digestion
HpaI digestion
CATG
▲
3839
CATG
▲
3839
CATG
▲
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2.3.3.5   AluI restriction digestion of the fragment D of the mitochondrial genome 
(nt4875-7335) 
 
The fragment D was produced by PCR amplification of the mitochondrial genome using 
Mt D forward and Mt D reverse primers (Table 2.4). It included 2461bp extending 
between the mitochondrial nucleotide positions 4875 and 7335. The fragment D was 
digested with AluI restriction enzyme to further aid in the assignment of the mtDNA 
samples to well established mitochondrial haplogroups. 
 
The CRS of the mtDNA belongs to the mitochondrial haplogroup H (the most common 
European mitochondrial haplogroup; 40-45% (Macaulay et al. 1999; Finnila et al. 
2001b; Achilli et al. 2004)). According to Andrews et al. (1999), the nucleotide 
sequence between positions 4875 and 7335 contains fifteen AluI recognition sites 
(5′…AG▼CT…3′). However, the CRS lacks an AluI recognition sequence at position 
7025 due to the presence of a cytosine base at nt7028 which is a specific marker to 
mitochondrial haplogroup H (Figures 2.6.a and b) (Loogvali et al. 2004; Roostalu et al. 
2007).  
 
Mitochondrial haplogroup D (a descendant of the macro-haplogroup M, originating in 
central Asia) is characterised by the C5178A mutation (Tanaka et al. 2004; Kong et al. 
2006; Metspalu et al. 2006; Derenko et al. 2007; Achilli et al. 2008) leading to loss of 
AluI recognition sequence at that position (Figure 2.6.c) which is considered as a 
definitive marker for mitochondrial haplogroup D.   
 
For better separation of the products of AluI restriction digestion, DNA fragments were 
separated on an 8% neutral polyacrylamide gel in 1xTBE buffer (89mM Tris-base, 
89mM boric acid, 2mM EDTA; pH 8.3), along with hyper ladder IV (Bioline) as a 
molecular marker. Samples were mixed with 6x loading dye (0.25% (w/v) bromophenol 
blue (Sigma-Aldrich), 40% (w/v) sucrose (Fisher Scientific), 4ml (v/v) TE buffer and 
10.8ml of 0.1% (v/v) DEPC-treated water) and electrophoresis was performed at 40V 
for 90min to 2 hours. After which, the gel was stained in 1xTBE buffer containing 30% 
(v/v) SYBR Safe DNA gel stain (Invitrogen) for 15 min. DNA fragments were 
visualised using ultraviolet transilluminator and gel documentation system (Syngene). 
Preparation of the polyacrylamide gel will be discussed in section 2.6.2.1. 
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Figure 2.6: AluI restriction digestion of the fragment D of the mitochondrial genome 
(nt4875 − 7335). Blue and brown horizontal arrows represent forward and reverse primers 
respectively. Numbers shown above the horizontal bars represents the nucleotide positions and 
numbers below are the expected lengths of the restriction digestion products. Longitudinal red 
bars represent the restriction cut sites. A plus sign (+) indicates a new cut site and a minus sign 
(−) indicates loss of a cut site. (a) represents the Cambridge Reference Sequence between the 
nucleotide positions 4875 and 7335 showing lack of AluI recognition site at nucleotide position 
7025 due to the presence of a cytosine base at 7028. (b) represents mitochondrial DNA 
between nucleotide positions 6728 and 7335 not belonging to haplogroup H having an AluI 
recognition site at position 7025 due to presence of a thymine base at nucleotide position 7028. 
(c) illustrates an example of mitochondrial DNA belonging to haplogroup D between nucleotide 
positions 4875 and 5823 with its characteristic C5178A mutation leading to loss of the AluI 
recognition site at that position producing a 594bp fragment instead of the two fragments of 
186bp and 408bp in the CRS. 
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2.3.3.6 RFLP analysis of the fragment E of the mitochondrial genome (nt8024-
9231) 
 
Mitochondrial DNA fragment E (1208bp) (nucleotide position 8024 − 9231) (Table 
2.4) was analysed by restriction digestion with four restriction enzymes individually; 
AvaII, HaeIII, MboI and HaeII. Collectively, these restriction analyses provide a highly 
specific set of RFLP markers that greatly enhance the mitochondrial haplogroup 
assignment. 
 
AvaII digestion was used to differentiate the mitochondrial haplogroups (N1b, N1e, I 
and W) from all the other lineages including haplogroup H to which the CRS belongs. 
These four mitochondrial lineages represent direct descendants (non-R derived) of the 
macro-haplogroup N and they are characterised by a G8251A mutation (Palanichamy et 
al. 2004; Behar et al. 2006; Kivisild et al. 2006; Derenko et al. 2007). This mutation 
produces an AvaII cut site (5′…G▼G (A/T) C…3′) which is not present in the CRS 
(Figure 2.7.a and b). Therefore, it is considered as a characteristic marker for this set of 
closely related mitochondrial haplogroups. 
 
Following the AvaII restriction digestion of the fragment E, HaeIII digestion was 
performed to confirm the assignment of the previously mentioned four mitochondrial 
haplogroups since the G8251A mutation causes loss of HaeIII recognition sequence 
(5′…GG▼CC…3′) which is linked to the AvaII gain at the same nucleotide position in 
these haplogroups. In addition, HaeIII digestion of the fragment E was used to 
differentiate haplogroup W from all the other mitochondrial lineages including sister 
haplogroups N1b, N1e and I. Loss of HaeIII recognition sequence at the nt8996 due to 
the presence of a G8994A mutation in the mtDNA delineates haplogroup W (Torroni et 
al. 1996; Finnila et al. 2001b; Palanichamy et al. 2004), and is considered as a specific 
marker for this haplogroup (Figure 2.7.c and d). 
 
For better resolution of the African mitochondrial DNA belonging to the haplogroup 
L3, MboI digestion of the fragment E was applied to identify the subclade L3d which 
was previously described to have a T8618C mutation (Salas et al. 2002). This mutation 
causes loss of MboI recognition sequence (5′…▼GATC…3′) which is present in the 
CRS (accession NC_ 012920) (Figure 2.8.a and b).   
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In order to recognise mtDNA belonging to the haplogroup K and to differentiate it from 
all the other mitochondrial lineages including its ancestral haplogroup U, HaeII 
restriction digestion of the fragment E was performed. A definitive RFLP marker for 
haplogroup K and its sister clade U8 was evidenced by loss of HaeII cut site (5′. (A/G) 
GCGC
▼ 
(T/C).3′) at the nucleotide position 9052 resulting from a G9055A mutation, 
which was described earlier as being specific to the mitochondrial haplogroup K and its 
sister clade U8 (Macaulay et al. 1999; Derbeneva et al. 2002; Herrnstadt et al. 2002; 
Achilli et al. 2005; Gonzalez et al. 2006) (Figure 2.8.c and d).  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 2.7: Restriction digestion analysis of the fragment E of the mitochondrial genome 
(nt8024 and 9231) (part I). Blue and brown horizontal arrows represent forward and reverse 
primers respectively. Numbers shown above the horizontal bars represent the nucleotide 
positions and numbers below are the expected lengths of the restriction digestion products. 
Longitudinal red bars represent the restriction cut sites. A plus sign (+) indicates a new cut site 
and a minus sign (−) indicates loss of a recognition sequence. Models a. and b. represent 
products of AvaII restriction digestion and models c. and d. represent HaeIII digestion products. 
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(a) illustrates the CRS between nucleotide positions 8024 and 9231 showing no recognition 
sequences for AvaII restriction enzyme, and (b) represents an example of mtDNA belonging to 
any of the four mitochondrial haplogroups (N1b, N1e, I and W) with their characteristic G8251C 
mutation leading to the occurrence of an AvaII recognition site. (c) illustrates the same region of 
the CRS having six HaeIII cut sites at the given nucleotide positions, and (d) represents an 
example of mtDNA belonging to haplogroup W which is identified by loss of HaeIII cut sites at 
8252 and 8996 resulting from G8251A and G8994A mutations respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8: Restriction digestion analysis of the fragment E of the mitochondrial genome 
(nt8024 and 9231) (part II). Blue and brown horizontal arrows represent forward and reverse 
primers respectively. Numbers shown above the horizontal bars represent the nucleotide 
positions and numbers below are the expected lengths of the restriction digestion products. 
Longitudinal red bars represent the restriction cut sites. A plus sign (+) indicates a new cut site 
and a minus sign (−) indicates loss of a recognition sequence. Models a. and b. represent 
products of MboI restriction digestion and models c. and d. represent HaeII digestion products. 
(a) represents the CRS between the nucleotide positions 8024 and 9231 having three internal 
cut sites for MboI endonuclease, and (b) illustrates an example of mtDNA belonging to L3d 
subclade with its specific mutation at position 8618 by having a cytosine base rather than a 
thymine one causing loss of MboI recognition sequence. For HaeII digestion, (c) represents the 
CRS of the same region having one internal cut site at 9052 which is lost in (d) as an example 
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of mtDNA belonging to haplogroup K or its sister clade U8 with its characteristic G9055A 
mutation. 
 
 
2.3.3.7 RFLP analysis of the fragment F of the mitochondrial genome (nt9921-
11150) 
  
Mitochondrial DNA fragment F (1230bp) (nt9921- 11150) was amplified using Mt F 
forward and Mt F reverse primers (Table 2.4). This region of the mitochondrial genome 
includes several important RFLP diagnostic markers for different mitochondrial 
haplogroups, and so fragment F was subjected to a series of individual restriction 
digestions with DdeI, AluI, HinfI and TaqI restriction enzymes. 
 
DdeI restriction digestion splits the mitochondrial DNA haplogroups into two big sets 
according to the type of the nucleotide base at position 10398, which can produce a 
DdeI recognition sequence (5′…C▼TNA_G…3′) by being guanosine, or alternatively it 
can be an adenosine base causing loss of that cut site (Figure 2.9.a and b). Gain of 
10398 DdeI cut site occurs in most of the relatively old mitochondrial DNA 
haplogroups including the African haplogroup L (Torroni and Wallace 1994; Chen et al. 
1995b), the two macro-haplogroups M and N (Richards et al. 2003; Nelson et al. 2007; 
Maji et al. 2009), in addition to a number of N derived lineages either as a direct 
descendant like haplogroup I or indirect descendants as J and K1 haplogroups 
(Macaulay et al. 1999; Tolk et al. 2001). All the other mitochondrial haplogroups 
(including haplogroup H, to which the CRS belongs) lack this DdeI cut site (Finnila et 
al. 2001b).  
 
For more specific identification of the mitochondrial haplogroups, AluI restriction 
digestion was performed on the same region of the mtDNA. The CRS of that region 
according to Andrews et al. (1999) had three internal cut sites for AluI 
(5′…AG▼CT…3′), however, mtDNA belonging to the haplogroup M is characterised 
by a C10400T mutation (Yao et al. 2002; Richards et al. 2003; Li et al. 2007; Maji et al. 
2009) which in conjunction with the previously mentioned A10398G mutation produce 
an additional AluI cut site (Figure 2.9.c and d). A different AluI restriction digestion 
pattern was detected in mtDNA belonging to haplogroup I due to the occurrence of the 
diagnostic T10034C mutation (Palanichamy et al. 2004; Derenko et al. 2007; Van Oven 
and Kayser 2009) producing an additional AluI recognition sequence (Figure 2.9.e). 
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To further aid the assignment of mtDNA to the African haplogroup L5, HinfI restriction 
digestion of fragment F was performed. The digestion pattern of the mtDNA belonging 
to haplogroup L5 differs from that of the CRS due to the presence of the characteristic 
T10810C mutation (Chen et al. 1995b; Alves-Silva et al. 2000) which produces an 
additional HinfI cut site (5′…G▼ANT_C…3′) at nt10806 (Figure 2.10.a and b). 
 
For fine resolution of the mitochondrial haplogroup L3 and defining its subclade L3b, 
another RFLP marker was screened for by performing TaqI restriction digestion of the 
fragment F. An extra TaqI cut site (5′…T▼CG_A…3′) occurs at position 10084 in the 
mitochondrial subclade L3b compared to the CRS resulting from the characteristic 
A10086G mutation (Chen et al. 1995a; Alves-Silva et al. 2000; Richards et al. 2003; 
Rosa et al. 2004) (Figure 2.10.c and d). 
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Figure 2.9: Restriction digestion of mitochondrial DNA fragment F (nt9921-11150) (part I). 
Blue and brown horizontal arrows represent forward and reverse primers respectively. Numbers 
shown above the horizontal bars represent the nucleotide positions and numbers below are the 
expected lengths of the restriction digestion products. Longitudinal red bars represent the 
restriction cut sites. A plus sign (+) indicates a new cut site and a minus sign (−) indicates loss 
of a recognition sequence. (a) and (b) represent products of DdeI restriction digestion and (c), 
(d) and (e) represent the AluI digestion patterns. (a) illustrates the CRS with the three 
characteristic DdeI cut sites along the fragment F together with an adenosine base at 10398, 
and (b) shows the digestion pattern of the old mitochondrial haplogroups (L, M, N, I, J and K1)in 
which a guanosine base is present at nt10398 leading to an additional DdeI recognition 
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sequence. AluI digestion pattern of the CRS between nt9921 and nt11150 is illustrated in (c) 
showing three internal cut sites. (d) highlights the different digestion pattern shown in the 
mitochondrial haplogroup M resulting from the characteristic C10400T mutation which produces 
a new cut site. (e) represents mtDNA belonging to haplogroup I with its characteristic T10034C 
mutation resulting in a novel AluI recognition sequence.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10: Restriction digestion of mitochondrial DNA fragment F (nt9921-11150) (part 
II). Blue and brown horizontal arrows represent forward and reverse primers respectively. 
Numbers shown above the horizontal bars represent the nucleotide positions and numbers 
below are the expected lengths of the restriction digestion products. Longitudinal red bars 
represent the restriction cut sites. A plus sign (+) indicates a new cut site and a minus sign (−) 
indicates loss of a recognition sequence. (a) and (b) represent the different HinfI digestion 
patterns and (c) and (d) illustrate the different TaqI digestion products. (a) shows the pattern 
resulting from HinfI digestion of the CRS along this region of the mitochondrial genome, and (b) 
represents an example of mtDNA belonging to haplogroup L5 with the characteristic T10810C 
mutation producing an additional HinfI recognition site. (c) illustrates the products of TaqI 
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restriction digestion of the CRS between nt9921 and nt11150 showing three internal cut sites, 
and (d) represents an example of mitochondrial subclade L3b sequence with the characteristic 
A10086G mutation producing an additional TaqI recognition sequence.  
2.3.3.8    RFLP analysis of the fragment G of the mitochondrial genome (nt12077-
13812) 
 
The product of the PCR amplification of the mitochondrial genome using Mt G forward 
and Mt G reverse primers (Table 2.4), fragment G (1736bp) (nt12077-13812) was 
digested with BamHI, AluI and HincII restriction enzymes, separately. Digestion 
patterns were analysed and compared to those patterns resulting from the corresponding 
digestions of the CRS of the mitochondrial genome according to Andrews et al. (1999). 
 
BamHI restriction digestion was used to specifically identify the mitochondrial 
haplogroup T [a European lineage, originated in the Near East approximately 46,500 
years ago and is currently most prevalent in Europe (~10.5%) (Richards et al. 1998; 
Helgason et al. 2001)]. Haplogroup T is characterised by a G13368A mutation 
producing a novel BamHI recognition sequence (5′…G▼GATC_C…3′) at position 
13366 which is not present in the CRS (Figure 2.11.a and b); (Torroni et al. 1996; 
Macaulay et al. 1999; Finnilä and Majamaa 2001). 
 
Both AluI and HincII restriction digestions of the fragment G were performed to 
identify the mitochondrial haplogroup C, a descendant of the macro-haplogroup M 
which is found in Northeast Asia and is considered as one of the main mitochondrial 
haplogroups found in the indigenous peoples of the Americas (Tamm et al. 2007; 
Achilli et al. 2008). Identification of the haplogroup C was based on the detection of the 
characteristic A13263G mutation which is considered as a diagnostic marker for this 
haplogroup according to the MITOMAP database at (www7). Resulting from the 
A13263G mutation, a novel AluI recognition sequence (5′…AG▼CT…3′) is produced 
(Figure 2.11.c and d) and a previously known HincII cut site (5′.GT (T/C) 
▼
 (A/G) 
AC.3′) is lost (Figure 2.11.e and f) compared to the corresponding digestion patterns of 
the CRS.     
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Figure 2.11: Restriction digestion of mitochondrial DNA fragment G (nt12077-13812). Blue 
and brown horizontal arrows represent forward and reverse primers respectively. Numbers 
shown above the horizontal bars represent the nucleotide positions and numbers below are the 
expected lengths of the restriction digestion products. Longitudinal red bars represent the 
restriction cut sites. A plus sign (+) indicates a new cut site and a minus sign (−) indicates loss 
of a recognition sequence. (a) illustrates BamHI digestion products of the CRS with no 
recognition sequence for BamHI , and (b) represents an example of mtDNA belonging to 
haplogroup T with its characteristic G13368A mutation producing a novel BamHI cut site. 
Shown in (c) is the CRS (nt12077-13812) as digested by the AluI restriction enzyme with four 
cut sites. (d) represents an example of mtDNA belonging to haplogroup C which has a different 
AluI digestion pattern resulting from the diagnostic A13263G mutation that produces an 
additional AluI recognition sequence. Represented in (e) is the digestion pattern of the CRS 
produced by HincII restriction enzyme with three internal cut sites, and (f) illustrates an example 
of mtDNA haplogroup C with its specific A13263G mutation causing loss of HincII at that 
position. 
2.3.3.9  AccI and MseI restriction digestions of the fragment H of the   
mitochondrial genome (nt14253-14857) 
 
Mitochondrial DNA fragment H (605bp) was amplified using Mt H forward and Mt H 
reverse primers (Table 2.4). The nucleotide extension of fragment H was designed so as 
to include two important RFLP markers that were detected with AccI and MseI 
restriction enzymes. 
 
The CRS of the mtDNA (accession number NC_012920) lacks AccI recognition 
sequence (5′.GT
▼ 
(A/C)
 
(T/G) AC.3′) in the specified region of the fragment H (nt14253 
− 14857), and hence the digestion reaction does not cut the original PCR product 
(Figure 2.12.a). Mitochondrial DNA belonging to the haplogroup X (a direct 
descendant of the macro-haplogroup N) was reported to have a T14470C mutation 
which produces a novel AccI recognition sequence (Figure 2.12.b) (Reidla et al. 2003; 
Kivisild et al. 2006; Derenko et al. 2007). 
 
MseI restriction digestion of the fragment H was used to differentiate the mitochondrial 
haplogroup HV and all its descendants (including haplogroup H) from all the other 
mitochondrial lineages. That is based on the presence of a cytosine base at nt14766 in 
the haplogroup HV instead of a thymine base in all the other elderly derived 
mitochondrial lineages, which causes loss of the MseI cut site (5′…T
▼
TAA...3′) (Figure 
2.12.c and d) (Macaulay et al. 1999; Maca-Meyer et al. 2001; Achilli et al. 2004; 
Malyarchuk et al. 2005). 
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Figure 2.12: Restriction digestion of mitochondrial DNA fragment H (nt14253-14857). Blue 
and brown horizontal arrows represent forward and reverse primers respectively. Numbers 
shown above the horizontal bars represent the nucleotide positions and numbers below are the 
expected lengths of the restriction digestion products. Longitudinal red bars represent the 
restriction cut sites. A plus sign (+) indicates a new cut site and a minus sign (−) indicates loss 
of a recognition sequence. (a) and (b) represent AccI digestion products of the fragment H of 
the mitochondrial genome and (c) and (d) illustrate the products of MseI restriction digestion of 
the same region. (a) represents the CRS (nt14253 − nt14857) with no AccI recognition 
sequence, and (b) illustrates an example of mtDNA belonging to the haplogroup X with the 
characteristic T14470C mutation which produces a new AccI cut site. Shown in (c) is a 
representation of mtDNA belonging to any mitochondrial haplogroup other than HV and its 
descendants (including haplogroup H) in which a thymine base is present at nucleotide position 
14766 producing an MseI recognition sequence. (d) illustrates the mitochondrial haplogroups 
HV and its descendants with a cytosine base at nt14766 causing loss of MseI cut site at that 
position.   
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2.3.3.10 AluI and HinfI restriction digestions of the fragment I of the mitochondrial 
genome (nt15312-149) 
 
Mitochondrial DNA fragment I (1407bp) (nt15312 − 149) was amplified using Mt I 
forward and Mt I reverse primers (Table 2.4). This region of the mtDNA contains two 
important RFLP markers that further aid the assignment of two closely related 
mitochondrial lineages, haplogroups T and J. To screen for these markers, the fragment 
I was digested with AluI and HinfI restriction enzymes individually. 
 
AluI restriction digestion was used to confirm the assignment of the mitochondrial 
haplogroup T, which was previously obtained through BamHI digestion of the fragment 
G (Figure 2.11.b). Mitochondrial DNA belonging to haplogroup T is characterised by 
an A15607G mutation producing a novel AluI cut site (5′…AG▼CT…3′) which is not 
present in the CRS (Figure 2.13.a and b); (Torroni et al. 1996; Macaulay et al. 1999; 
Finnilä and Majamaa 2001). Therefore, gain of AluI and BamHI at nucleotide positions 
15606 and 13366, respectively are considered as definitive RFLP markers for the 
haplogroup T.    
  
HinfI digestion of the fragment I was performed to confirm the assignment of the 
mitochondrial haplogroup J and to differentiate it from its sister clade, haplogroup T 
and the others. Mitochondrial haplogroup J is characterised by a C16069T mutation 
which disrupts the HinfI recognition sequence (5′…G▼ANT_C…3′) that is present in 
the CRS (Figure 2.13.c and d); (Macaulay et al. 1999; Maca-Meyer et al. 2001; Logan 
2009; Van Oven and Kayser 2009). Therefore, loss of HinfI cut site at nt16066 is 
considered as a diagnostic marker for the haplogroup J.  
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Figure 2.13: Restriction digestion of mitochondrial DNA fragment I (nt15312-149). Blue 
and brown horizontal arrows represent forward and reverse primers respectively. Numbers 
shown above the horizontal bars represent the nucleotide positions and numbers below are the 
expected lengths of the restriction digestion products. Longitudinal red bars represent the 
restriction cut sites. A plus sign (+) indicates a new cut site and a minus sign (−) indicates loss 
of a recognition sequence. (a) represents the AluI digestion products of the CRS, and (b) 
illustrates an example of mtDNA belonging to haplogroup T with its specific A15607G mutation 
that produces an additional AluI cut site. Represented by (c) is the CRS as digested by HinfI 
restriction enzyme showing six internal cut sites. (d) illustrates mtDNA belonging to haplogroup 
J with its characteristic C16069T mutation causing disruption of the HinfI recognition sequence 
at nt16066. 
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2.3.4 Screening for A12308G mutation as a diagnostic marker for the 
mitochondrial haplogroups U and K 
 
2.3.4.1   Mispairing PCR  
 
Mitochondrial haplogroups U and K have been described to have a characteristic 
A12308G mutation which specifically enables the differentiation of these mitochondrial 
lineages from many others (Torroni et al. 1996; Achilli et al. 2005). This mutation was 
screened for by the mispairing PCR technology, in which the mitochondrial DNA was 
amplified between the nucleotide positions 12221 and 12334 using a mismatched 
reverse primer. The mispairing PCR product size was 114bp. The reverse primer bound 
its 3′ end next to the nucleotide position 12308 and included a nonpairing nucleotide G 
at position 12312. When the A12308G mutation is present, in conjunction with the 
mismatched primer sequence, a new EcoRI restriction site (5′…G▼AATT_C…3′) is 
generated (Figure 2.14). Sequences of the primers were obtained from Lauber et al. 
(1991) whose study was concerned with mutations in the mitochondrial tRNA genes as 
a frequent cause of the neuromuscular diseases. 
 
The primer sequences were as follows; 
Ser-For: 5′-GAACTGCTAACTCATGCCCCCCATGT-3′                                                                                                                                                                              
(Corresponding to the mitochondrial nucleotide positions 12221 to 12245) 
 
Leu-Rev: 5′-CTTTTATTTGGAGTTGCACCAGAATT-3′                                       
(Corresponding to the mitochondrial nucleotide positions 12309 to 12334)  
 
The PCR reaction mixtures were prepared in 500µl sterile nuclease-free PCR tubes 
(Eppendorf) as follows: 
 
-  5x Phusion HF buffer (Finnzymes)                                                   10.0µl  
-  MgCl2 (25mM; Promega)                                                                    2.0µl 
-  DeoxyNTP mixture (10mM; Promega)                                               2.0µl 
-  Bovine Serum Albumin (BSA) (10 mg/ml; Promega)                        2.0µl  
-  Ser-For primer (100pmol/µl)                                  1.0µl 
-  Leu-Rev primer (100pmol/µl)                                                         1.0µl 
-  Phusion High-Fidelity DNA polymerase (2u/µl; Finnzymes)            0.5µl 
-  Nuclease free water to final volume of 50µl  
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All the constituents were then added to the processed dried discs of the blood samples 
on FTA cards (as previously described in section 2.1.2) in sterile 500µl PCR tubes after 
which the tubes were placed into the thermal cycler.                                    
 
The PCR conditions were as follows: 
Initial Denaturation                  98
o
C               30 sec                  1 cycle 
Denaturation                             98
o
C              10 sec 
Annealing                                 65
o
C              20 sec                  30 cycles 
Extension                                  72
o
C              30 sec 
Final Extension                         72
o
C              5 min                  1 cycle 
 
Small volumes (5µl) of the PCR products were separated using a 2.5% (w/v) agarose 
(Bioline) gel containing 1x SYBR Safe DNA gel stain (Invitrogen) (in 1x TAE buffer), 
along with hyper ladder V (Bioline) as a molecular marker and run for 45min at 100V. 
114bp bands were then visualised using an ultraviolet (UV) transilluminator and gel 
documentation system (Syngene). 
 
2.3.4.2    EcoRI restriction digestion of the mispairing PCR product 
 
To determine whether the mtDNA sample contained the definitive mutation (A12308G) 
for the mitochondrial haplogroups U and K, the products of the mispairing PCR were 
digested with EcoRI restriction enzyme (Promega). MtDNA belonging to haplogroups 
U and K were cut by EcoRI due to presence of a guanosine base at nt12308 which in 
conjunction with the mispairing reverse primer (Leu-Rev) produce an EcoRI restriction 
site that cuts the PCR product (114bp) into two fragments of 88bp and 26bp (Figure 
2.14.a). The PCR products of samples not belonging to haplogroups U and K lack 
EcoRI cut sites due to presence of an adenosine base at the nucleotide position 12308 
which does not constitute an EcoRI recognition sequence even in conjunction with the 
mispairing primer sequence (Figure 2.14.b).   
 
The EcoRI digestion reaction was prepared as described early in section 2.3.4, and all 
the constituents were incubated at 37
o
C for 2 hours. The products of digestion were 
separated on a 3.5% (w/v) agarose gel stained with SYBR Safe, along with hyper ladder 
V as a molecular marker and DNA fragments were visualised using the UV 
transilluminator and gel documentation system (Syngene).   
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Figure 2.14: Sequences and EcoRI digestion of the mitochondrial DNA mispairing PCR 
products (nt12221-12334). Shown in dark blue is the sequence of the forward primer (Ser-For) 
and in brown is the complementary sequence of the reverse primer (Leu-Rev) with the 
mispairing nucleotide in turquoise. The nucleotide position 12308 is shown in green. (a) shows 
an example of mtDNA belonging to the haplogroup U or K (nt12221 − 12334) with the 
characteristic A12308G mutation in conjunction with the mismatched primer sequence 
producing an EcoRI cut site. Shown in (b) is the corresponding region of the CRS of the 
mitochondrial genome with an adenosine base at nt12308 and absence of EcoRI recognition 
sequence in conjunction with the mismatched primer. 
 
 
 
 
 
 
GAACTGCTAACTCATGCCCCCATGTCTAACAACATGGCTTTCTCAACTTTTAAAGGA
TAACAGCTATCCATTGGTCTTAGGCCCCAAAAATTCTGGTGCAACTCCAAATAAAAG
b.
EcoRI digestion
AAATTC
12308
114bp
12312
Mispairing PCR Product Sequence
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GAACTGCTAACTCATGCCCCCATGTCTAACAACATGGCTTTCTCAACTTTTAAAGGA
TAACAGCTATCCATTGGTCTTAGGCCCCAAGAATTCTGGTGCAACTCCAAATAAAAG
a.
▼
EcoRI digestion
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▼
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Mispairing PCR Product Sequence
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2.3.5 Summary of the mitochondrial haplogroup specific RFLP markers   
 
The total of 26 diagnostic RFLP markers that were used in the current study to enable the assignment of the mitochondrial DNA haplogroups in the 
Egyptian population is summarised in Table 2.7. 
 
Table 2.7: Diagnostic RFLP markers applied for the assignment of the mitochondrial DNA haplogroups. Nucleotide positions for RFLP markers represent the 
first base of the recognition sequence on the heavy strand and not the actual cut site. A plus sign (+) indicates gain of an enzyme cut site and a minus sign (−) 
indicates loss of an enzyme cut site. All diagnostic markers are indexed to the CRS (accession number NC_012920).  
PCR product 
Nucleotide 
position 
Length 
(bp) 
Diagnostic SNPs RFLP marker(s) Haplogroup(s) 
Fragment A 451-827 377 A663G + 663 HaeIII A 
Fragment B 1489-2690 1202 
G1719A − 1715 DdeI N, I and X2 
T2352C + 2349 MboI L1b and L3e 
Fragment C 3314-4732 1419 
C3594T + 3592 HpaI L0, L1, L2, L5 and L6 
T4216C + 4216 NlaIII JT 
G4580A − 4577 Nlalll V 
Fragment D 4875-7335 2461 
C5178A − 5176 AluI D 
C7028C − 7025 AluI H 
Fragment E 8024-9231 1208 
G8251A + 8251 AvaII/ − 8251 HaeIII N1b, N1e, I and W 
T8618C − 8616 MboI L3d 
G8994A − 8994 HaeIII W 
G9055A − 9055 HaeII K 
Fragment F 9921-11150 1230 
T10034C + 10032 AluI I 
A10086G + 10084 TaqI L3b 
A10398G + 10394 DdeI L, M, N, I, J and K1 
C10400T/ A10398G +  10397 AluI M 
T10810C + 10806 HinfI L5 
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Table 2.7: continue 
 
PCR product 
Nucleotide 
position 
Length 
(bp) 
Diagnostic SNPs RFLP marker(s) Haplogroup(s) 
Fragment G 12077-13812 1736 
A12308G + 12308 EcoRI* U and K 
A13263G − 13259 HincII C 
A13263G + 13262 AluI C 
G13368A + 13366 BamHI T 
Fragment H 14253-14857 605 
T14470C + 14465 AccI X 
C14766C − 14766 MseI HV** 
Fragment I 15312-149 1407 
A15607G + 15606 AluI T 
C16069T − 16066 HinfI J 
 
* EcoRI digestion was performed following mispairing PCR amplification of the mtDNA as will be discussed in section 2.3.4. 
** Loss of MseI cut site is considered as a diagnostic marker for haplogroup HV and all its descendants including haplogroup H to which the CRS belongs. 
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2.3.6 Development of a new strategy for RFLP analysis of the human 
mitochondrial genome  
 
Following screening of the whole mitochondrial genome for the complete set of the 26 
haplogroup specific RFLP markers in a representative number of the Egyptian blood 
samples on the FTA cards (n= 64) and based on the results obtained, eighteen of these 
markers were selected for screening of the remaining samples (n=197). A highly 
efficient specific scheme was designed to enable rapid and successful assignment of the 
Egyptian blood samples to well established mitochondrial DNA haplogroups (Figure 
2.15). 
 
The scheme was primarily based on splitting the mitochondrial DNA samples into two 
big sets of mitochondrial lineages based on presence or absence of a DdeI cut site at 
position 10394 which differentiates the old mitochondrial lineages, mainly the African 
L haplogroups and the two macro-haplogroups M and N from the more recently derived 
mitochondrial lineages, including the haplogroup H to which the CRS belongs. 
Following that, a certain sequence of highly specific restriction analyses was performed 
to enable a definitive assignment of the mitochondrial DNA haplogroups (Figure 2.15).   
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Figure 2.15: The workflow of the RFLP analysis of the human mitochondrial genome. The 
flowchart shows the sequence of the restriction digestion analyses that was followed to screen 
the Egyptian mtDNA samples for haplogroup specific RFLP markers aiming at fulfilment of rapid 
and successful haplogroup assignment.  
 
 
 
Fragment B
Fragment C
Fragment D
Fragment E
Fragment F
Fragment G
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1 
2 
3 
Screening for 
DdeI at 10394
+10394 DdeI −10394 DdeI
Screening for 
HpaI at 3592
MboI at 2349
+ 3592 HpaI
− 2349 MboI
+ 3592 HpaI
+ 2349 MboI
− 3592 HpaI
+ 2349 MboI
Haplogroups
L0 /L1/ L5/ L2/ L6
Haplogroup
L1b
Haplogroup
L3e
− 3592 HpaI
− 2349 MboI
Screening for 
AluI at 10397
+ 10397 AluI− 10397 AluI
Screening for 
DdeI at 1715
Haplogroup M
+ 1715 DdeI− 1715 DdeI
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AvaII and HaeIII
at 8251
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NlaIII at 4216
HinfI at 16066
− 8251 AvaII
+ 8251 HaeIII
+ 8251 AvaII
− 8251 HaeIII
Haplogroup N1a Screening for 
AluI at 10032
− 10032 AluI+ 10032 AluI
Haplogroup I Haplogroup N1e
+ 4216 NlaIII
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− 4216 NlaIII
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Haplogroup K1
+ 9052 HaeII
− 12308 EcoRI
Haplogroup L3′4
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Figure 2.15: Continue. 
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2.3.7 Frequency distribution of the mitochondrial DNA haplogroups in the 
Egyptian population sample    
 
The frequency distribution of the different mitochondrial DNA haplogroups in the 
Egyptian population sample (n= 261) was determined. The frequency of each 
haplogroup was calculated by dividing the number of individuals assigned to this 
haplogroup by the total number of samples.  Finally, the maternal lineages of the 
modern Egyptian population was concluded and correlated to the previously reported 
mitochondrial genetic structure of the surrounding populations.  
 
2.4 Screening for the amelogenin Y (AMELY) deletion among the 
Egyptian population  
 
2.4.1 PCR amplification of AMELY   
The Egyptian male blood samples on FTA cards (n=131) were screened for AMELY 
deletion by PCR amplification of the amelogenin gene which is present on both the X- 
(AMELX, GenBank accession number M55418) and the Y- (AMELY, GenBank 
accession number M55419) chromosomes (Nakahori et al. 1991). The PCR was 
performed using the primers that were described by Sullivan and his colleagues and 
have been incorporated into most of the commonly used commercial STR multiplex kits 
(Sullivan et al. 1993; Butler 2005a; Goodwin et al. 2007). These primers were designed 
to bind to conserved regions on both homologues of the amelogenin gene and to delimit 
a 6bp deletion on the X- chromosome. Accordingly, the PCR of the two versions of the 
amelogenin gene produces fragments of 112bp and 106bp for AMELY and AMELX, 
respectively and subsequently allows the differentiation between the two homologues 
which is the basis for the DNA-based gender testing (Figure 2.16). 
The primer sequences were as follows: 
AMEL-For: 5′-CCCTGGGCTCTGTAAAGAATAGTG-3′ 
(Corresponding to the nucleotide positions 637553 to 637576 on the Y-chromosome 
and the nucleotide positions 2885578 to 2885601 on the X-chromosome) 
 
AMEL-Rev: 5′-ATCAGAGCTTAAACTGGGAAGCTG-3′ 
(Corresponding to the nucleotide positions 637664 to 637641 on the Y-chromosome 
and the nucleotide position 2885683 to 2885660 on the X-chromosome) 
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Nucleotide positions were derived from the whole genome sequences of the Y-
chromosome (NCBI reference sequence: NW_001842425.2) and the X-chromosome 
(NCBI reference sequence: NW_001842360.1) 
 
 
 
 
 
 
 
 
 
 
Figure 2.16: A Schematic of the PCR amplification of a specific region of the amelogenin 
gene on the Y and X chromosomes. The blue and the brown bars represent the AMEL-
forward and reverse primers respectively. Shown at the top is an illustration of the PCR product 
of AMELY having 6bp (represented by the yellow bar) more than that of AMELX. The PCR 
product sizes of AMELY and AMELX were 112bp and 106bp, respectively. 
 
The constituents of the PCR reaction mixture were prepared in 500µl sterile PCR tubes 
as follows: 
 
-  5x Phusion HF buffer (Finnzymes)                                                   10.0µl  
-  MgCl2 (25mM; Promega)                                                                   2.0µl 
-  DeoxyNTP mixture (10mM; Promega)                                              2.0µl 
-  Bovine Serum Albumin (BSA) (10 mg/ml; Promega)                       2.0µl  
-  AMEL-For primer (100pmol/µl)                                 0.5µl 
-  AMEL-Rev primer (100pmol/µl)                                            0.5µl 
-  Phusion High-Fidelity DNA polymerase (2u/µl; Finnzymes)           0.5µl 
-  Nuclease free water to final volume of 50µl                                     
 
The listed components were added to sterile thin-walled 500µl eppendorf tubes 
contained the processed dried discs (as previously described in section 2.1.2). A positive 
control was always included in the experiment in which a processed female blood 
sample on FTA micro-card was used as a template. A negative control was also taken 
throughout the whole experiment with a processed blank disc replacing the blood 
stained disc. 
 
 
 
 
 
6bp
6bp 
deletion
AMELY
AMELX
112 bp
106 bp
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The PCR conditions for AMELY amplification were as follows: 
 
Initial Denaturation                  98
o
C               30 sec                  1 cycle 
Denaturation                             98
o
C              10 sec 
Annealing                                 65
o
C              20 sec                  30 cycles 
Extension                                  72
o
C              30 sec 
Final Extension                         72
o
C              5 min                  1 cycle 
2.4.2 Polyacrylamide gel electrophoresis for AMELY PCR products 
 
For good separation of the AMELY PCR products and accurate discrimination between 
the normal males and the AMELY-null males which give the same PCR product as 
females, 5% polyacrylamide gels were used. The main principle of the gel 
electrophoresis involves separation of the nucleic acid molecules according to their 
sizes (molecular weights) that influence the speed by which the molecules migrate 
through the gel having the smaller ones running faster. The polyacrylamide gel is 
characterised by having much smaller pore sizes than the agarose gel which is an 
important factor in determining the ability of the gel to resolve two similarly sized DNA 
fragments. Therefore, the main purpose behind the use of the polyacrylamide gel in this 
experiment was to enable the differentiation between the expected two fragments 
pattern of the normal male samples having two bands only 6bp apart and the single 
fragment pattern of the AMELY-null males simulating females.  
 
2.4.2.1 Preparation of the polyacrylamide gel 
 
Mini-PROTEAN Tetra Electrophoresis System (Bio-Rad) was used for the preparation 
of the polyacrylamide gel according to the manufacturers‟ instructions, which involved 
assembly of two clean and completely dry glass plates with 1.5mm vertical spacers in 
between for each gel. These assembled plates were then placed in a casting frame which 
was clamped into a casting stand ready for the separating gel solution to be poured in. 
The acrylamide separating gel mix was then prepared (Table 2.8) and was poured 
immediately between the two glass plates while trying not to trap any air bubbles as 
much as possible. A 10-well comb was then placed on the top between the two glass 
plates and the gel was then allowed to polymerize at room temperature for 30 to 45min. 
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Table 2.8: Preparation of the acrylamide separating gels. 
 
Constituents 5% gel 8% gel
(e) 
Acrylamide-bisacrylamide (29:1)
(a)
 1.992ml 3.192ml 
5x TBE buffer, pH 8.3
(b)
 2.4ml 2.4ml 
ddH2O 7.512ml 6.312ml 
10% APS (Sigma-Aldrich)
 (c)
 84µl 84µl 
TEMED (Sigma-Aldrich)
 (d)
 12µl 12µl 
(a) 
the 40% acrylamide stock (Sigma-Aldrich) contained N, N’-methylenebisacrylamide in a final 
ratio of 29:1 giving the suitable cross-linking ratio between the polyacrylamide chains. 
(b)
 5xTBE 
buffer contained 445mM Tris-base, 445mM boric acid and10mM EDTA.
 (c) 
10% (w/v) ammonium 
per sulphate was used to initiate the polymerization of acrylamide and bisacrylamide 
monomers. 
(d) 
N, N, N′, N′-tetramethylethylenediamine was the last constituent to be added to 
the polyacrylamide separating gel mix as a great enhancer and stabilizer to the polymerization 
reaction.
 (e) 
8% polyacrylamide gel was used for separation of AluI restriction digestion products 
of fragment D of the mitochondrial genome (Figure 2.6.a). 
 
2.4.2.2 Loading of samples and running the gel 
 
Once the separating gel had polymerized, the two glass plates with the gel in between 
were placed in the electrophoresis running chamber and submerged with the running 
buffer (1x TBE buffer; 89mM Tris-base, 89mM boric acid, 2mM EDTA; pH 8.3) and 
the comb was then taken out. Pre-stained hyper ladder V (Bioline) was first loaded onto 
the gel as a molecular marker to determine the size of the PCR fragments. A volume of 
7µl of the AMELY PCR product was mixed with 1.4µl 6x loading dye (0.25% (w/v) 
bromophenol blue, 40% (w/v) sucrose, 4ml (v/v) TE buffer and 10.8ml of 0.1% (v/v) 
DEPC-treated water) and loaded onto the gel. A female AMELY PCR product was run 
along the male samples on each gel as a control. In addition, a negative control was also 
run to rule out any possibility of contamination which might affect the results. 
Electrophoresis was performed at 40V for 90min-2hrs after which the dye front almost 
ran off the gel to ensure the adequate separation of the bands.   
 
2.4.2.3  Staining of the polyacrylamide gel and visualisation of the AMELY PCR   
products  
 
Once the electric current was stopped, the running buffer was then discarded and the 
glass plates were taken out. After which, the two plates were detached using a plastic 
wedge and the gel was ready for staining. The acrylamide gel was then immersed in 
1xTBE buffer containing 3x SYBR Safe DNA gel stain (Invitrogen) for 15-20min. 
DNA fragments were visualised using UV transilluminator and gel documentation 
system (Syngene). 
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3. THE UTILITY OF FTA CARDS IN FORENSIC 
INVESTIGATIONS 
 
3.1 Introduction 
 
Following the growing demand for the DNA analysis in many areas, such as diagnostic 
screening, drug monitoring, medical genetics and forensic investigations, various 
methods of DNA extraction have been adopted, including the standard Phenol-
chloroform organic extraction, Chelex extraction, and FTA
TM
 cards (Butler 2005c). 
Each technique has several advantages and disadvantages regarding the time and the 
effort needed to complete the analysis, the cost and the risk of health hazards, as well as 
the quality and the quantity of the DNA yield. Among these techniques, FTA
TM 
cards 
have lately gained popularity among researchers due to their particular advantages over 
the other traditional methods of biological sample storage and DNA extraction.  
 
FTA
 TM
 cards are chemically treated paper, characterised by their ability to store a wide 
range of biological samples at room temperature for many years, on which the DNA 
remains stable and protected against degradation and microbial infections (Fujita and 
Kubo 2006). FTA cards can be loaded with a minimal volume of DNA-containing 
sample which is particularly important when dealing with precious, limited volume 
forensic samples. FTA cards provide a valuable tool for non-invasive sample collection 
that is particularly useful in high-throughput population studies which involve analysis 
of a large number of samples (Seah et al. 2003; Wong et al. 2007; Saunier et al. 2009). 
Owing to the non-invasive characteristics, FTA cards are more suitable for molecular 
epidemiologic studies involving paediatric populations (Beckett et al. 2008). 
 
Sample collection and storage using FTA cards is a simple process which does not 
require sophisticated environmental conditions, and hence they can be used for self 
collection, field sample collection (Smith and Burgoyne 2004) and crime scene sample 
retrieval, ensuring safe delivery of samples to the laboratory. The ease of transportation 
of the DNA samples using FTA cards has a great impact on the population studies 
which deal with samples from different populations, and hence samples can be easily 
and safely transported between countries. FTA technology facilitates collection of 
samples from geographically isolated populations and enables transport by mail for 
molecular analysis (Guio et al. 2006). 
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Processing of DNA samples on FTA cards is a simple procedure which involves 
punching a small disc (1.2 or 2mm) out of the card, which then undergoes a simple 
washing in situ while the impurities being washed away. The DNA is retained on the 
disc and is ready to be included in the subsequent analysis with no need to transfer 
samples between tubes, and thus the risk of contamination is minimised. 
 
The aim of this part of the study was to evaluate FTA cards for mitochondrial DNA 
testing and to assess their efficiency for collection, storage and transportation of DNA 
containing samples which would further aid the mitochondrial DNA analysis in the 
Egyptian population. The long term DNA storage capabilities of the FTA cards were 
investigated by performing DNA purification of blood samples stored on FTA cards for 
varying length of times (ranging from 6 months up to 4 years). In addition, the standard 
PCR protocol was modified to enable fast mitochondrial DNA analysis which would 
impose a direct impact on various applications.  
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3.2 Results 
 
3.2.1 DNA purification of blood samples on FTA cards  
 
3.2.1.1 Evaluation of the DNA quantity contained in one processed disc of blood 
stained FTA cards  
 
The DNA quantity contained in one disc area of the blood loaded FTA cards was 
assessed (Figure 3.1). A good DNA yield (as evidenced by PCR amplification and gel 
electrophoresis) (Figure 3.2) was obtained after processing 1.2-mm discs of the stained 
areas of the FTA cards using method-1 of the washing procedures (Methods; Table 2.1), 
which followed the manufacturer’s instructions, by performing three washes with FTA 
purification reagent and two washes with TE
-1
 buffer. Washing was considered 
successful when the processed disc turned clear. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Whatman FTA kit. A is a whole blood sample on FTA micro-card 
(Cat.No.WB120310), B is a Harris Uni-Core Micro-Punch with 1.2 mm steel tip (Cat. No. 
WB1000028), C is a cutting mat, and D is the FTA Purification Reagent.  
 
 
 
 
 
 
 
 
 
Figure 3.2: PCR products of mitochondrial hypervariable regions (HVI and HVII) 
amplification from whole blood samples on FTA micro-cards. PCR products were 
separated by electrophoresis on 2% agarose gel. A100 bp DNA ladder was used as a molecular 
marker (Lane M). Labelled lanes 1-5 represent HVI PCR products (444bp) of five Egyptian 
blood samples, while 6-10 represent HVII PCR products (415bp) of the same blood samples. 
Lanes 11 and 12 represent positive and negative control samples respectively. 
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This washing protocol, however, did not produce consistent results with all blood 
samples, which means that not all samples gave a good DNA yield after being 
processed using method-1. Similar results were obtained when bigger discs (2-mm) 
were considered (Figure 3.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: PCR products of mitochondrial HVI region amplification following the use of 
one processed disc of the blood stained FTA cards as DNA template. Samples were 
separated by electrophoresis on 2% agarose gel. A 100 bp DNA ladder was used as a 
molecular marker (Lane M). Gel (a) shows PCR products of HVI amplification following the use 
of 1.2-mm disc of each sample as DNA template. Lanes 1-7 contained PCR products of 
different Egyptian blood samples and Lane 8 contained a positive control. Gel (b) shows HVI 
PCR products following the use of 2-mm disc as a template. Lanes 1-5 contained HVI PCR 
products of different blood samples on FTA cards and lane 6 represents a positive control. Both 
gels showed failed PCR amplification of one sample which means that DNA purification of these 
samples from the FTA cards were not successful.   
 
3.2.1.2 Evaluation of the DNA yield following the use of multiple processed blood 
stained discs as DNA template in one PCR reaction   
 
Following failure to amplify from some blood samples, and as a trial to increase the 
available DNA, varying numbers of 1.2-mm discs (2, 3 or 4 discs) were processed 
together (using method 1 for washing procedures) in a single tube and used collectively 
as a template in one PCR reaction. This approach showed an improvement in the DNA 
yield of some, but not all samples (Figure 3.4). These results proved that the previous 
unsuccessful PCR amplification of some samples was not due to limited DNA 
concentration on the disc but caused by presence of inhibitors in blood.   
 
 
M          1          2           3          4           5      6           7           8
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100 bp ladder
M              1                    2                 3         4                 5                  6          
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Figure 3.4: PCR products of mitochondrial HVI region amplification following the use of 
three 1.2-mm discs of each sample in one PCR reaction. PCR products of mitochondrial HVI 
amplification of 11 different blood samples (Lanes; 1-11) were separated by electrophoresis on 
2% agarose gel. A 100bp DNA ladder was used as a molecular marker (Lane M) and a human 
placenta DNA was amplified as a positive control (Lane 12). Both the brightness and thickness 
of the DNA bands clearly demonstrated the variability of the DNA yield between different 
samples.  
 
3.2.1.3 Investigation of the homogeny of the DNA distribution on the FTA cards 
following direct blood application  
 
In order to investigate the DNA distribution across the stained area of the card, 10 discs 
(1.2-mm) were randomly punched out of the same card and placed in separate PCR 
tubes. Discs were processed separately (using method-1) and then were placed in 
separate PCR reactions. The obtained results revealed that the DNA was almost equally 
distributed all over the FTA card, as discs of the same sample showed an equivalent 
DNA yield, as evidenced by PCR amplification of the mitochondrial hypervariable 
region (HVI) (Figures 3.5). This approach also showed that the previous unsuccessful 
PCR amplification of some samples was not due to variable distribution of the blood 
samples on the cards, as the failure was consistent for all discs from the same card 
(Figure 3.6).  
 
 
 
 
 
 
 
 
 
Figure 3.5: PCR products of mitochondrial HVI amplification of 10 discs of the same 
blood sample on an FTA card. HVI PCR products (444bp) were separated by electrophoresis 
on 2% agarose gel. Lane M contained the molecular marker (100 bp DNA ladder). Lanes 1-10 
contained the PCR products obtained following the use of 10 discs of the same blood sample 
on the FTA card. A positive control sample was run in lane 11. A relatively same quality of the 
DNA yield was obtained from all discs as evidenced by the PCR amplification products.  
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Figure 3.6: PCR amplification products of 10 discs of a previously unsuccessfully tested 
blood sample on an FTA card. HVI PCR products (444bp) were separated by electrophoresis 
on 2% agarose gel. Lane M contained the molecular marker (100 bp DNA ladder). Lanes 1-10 
contained the PCR products obtained following the use of 10 discs of the same blood sample 
on the FTA card. A positive control sample was run in lane 11. None of the discs showed 
evidence of DNA amplification.  
 
3.2.2 Modifications of the washing protocol for DNA purification of blood 
samples on the FTA cards 
 
After short term storage of whole blood samples on the FTA cards (~6 months), 
method-1 of the washing procedures was used for DNA purification, according to the 
manufacturer’s instructions, by performing three washes with FTA purification reagent 
and two washes with TE
-1
 buffer, but was no longer effective in purifying DNA from 
cards, and discs did not become clear after these series of washes. PCR reactions almost 
always failed after this period of time. This failure was mainly attributed to the 
continuous presence of inhibitors in blood, such as haematin and any other non-DNA 
materials, which over time became fixed to the FTA cards and resisted all the washing 
steps. To overcome this increasing difficulty in removing all non-DNA materials that 
inhibited the PCR reactions, several modifications of the manufacturer’s washing 
protocol were performed for DNA purification of these stored blood stained cards with 
the aim of removing such PCR inhibitors (in consultation with Whatman technical 
support).  
 
These modified protocols for processing the cards (Methods; Table 2.1) are briefly 
mentioned below: 
 
 Method 2; an increase in the number and the duration of washes using the same 
purifying solutions. 
 Method 3; an intermediate washing step using 200-µl of 0.3M Na2CO3 for 5 
minutes. 
 Method 4; an intermediate washing step using 500-µl of 5% SDS (Sodium 
Dodecyl Sulfate) for 5 minutes. 
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Unfortunately, all these different processing methods that were used for DNA 
purification from whole blood on FTA cards were not sufficient for elimination of 
haematin and other possible non-DNA materials that were consistently causing 
inhibition of the PCR.  
 
3.2.3 Effect of modification of the PCR reaction mix in elimination of persistent 
PCR inhibition    
 
Bovine Serum Albumin (BSA) is effective in overcoming inhibition in enzymatic 
reactions. Addition of BSA to the PCR reaction mix was shown to be effective in 
elimination of the PCR inhibition caused by the presence of haematin and/or other 
inhibitor(s). To further validate the effective role of BSA in eliminating such inhibitors, 
6 months-36 months old samples on FTA cards were processed using the four different 
washing protocols and subjected to PCR amplification using the modified PCR master 
mix.  Methods 2, 3, and 4 showed evidence of successful DNA amplification (and thus 
purification) without any significant difference between them. However, method-1 
which was originally recommended by Whatman, failed to yield DNA from these stored 
samples (Figure 3.7). Therefore, it was concluded that the longer the samples were 
being stored on the FTA cards, more stringent processing was required, and BSA 
became an essential component of the PCR reaction mix in such circumstances.     
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: PCR products of mitochondrial HVI amplification of whole blood samples on 
FTA cards following DNA purification using different washing protocols. HVI PCR 
products were separated on 2% agarose gel. A 100 bp DNA ladder was used as a molecular 
marker (Lane M). Human placental DNA was amplified as a positive control and was loaded in 
lane 5. Lane 1 contained the HVI PCR product of a 36 months old blood sample on an FTA card 
processed using method-1 of the washing protocols. No evidence of DNA amplification was 
detected. Lanes 2-4 contained HVI PCR products (444bp) of the same long term stored blood 
sample after using methods 2, 3 and 4 of DNA purification respectively. The strong band 
intensities of all the three PCR products which are very similar to the positive control indicated 
the preservation of highly concentrated DNA in such long term stored samples.  
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400bp 444bp
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3.2.4 Evaluation of the role of FTA cards in preservation of the DNA integrity  
 
With the successful DNA purification following long term storage (up to 4 years) of 
blood samples on FTA cards, and verification of the effective role of such cards in 
preservation of the DNA quantity, further analysis was performed in order to assess 
their capabilities of preservation of the DNA. For this, the complete mitochondrial 
hypervariable region was amplified in one PCR reaction using HVI Forward and HVII 
Reverse primers (Methods; Table 2.2). The obtained results revealed successful 
amplification of 1024bp of the mitochondrial hypervariable region denoting 
preservation of good quality DNA of the blood samples on FTA cards following long 
term storage at room temperature (Figure 3.8).    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: PCR products of the whole mitochondrial hypervariable region as an 
indication of a good quality DNA preservation. PCR products of mitochondrial hypervariable 
region amplification of 13 long term stored blood samples on FTA cards were separated by 
electrophoresis on 1% agarose gel. Hyper ladder II was used as a DNA molecular marker. 
Human placental blood was amplified as a positive control and was run in lane 14. Variation in 
the band intensities was observed between samples that might be attributed to the variation of 
blood sample volume applied to the FTA cards which had a direct impact on the presence and 
concentration of inhibitors.  
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3.3 Discussion 
 
3.3.1 FTA
TM
 cards as a method for biological sample collection and DNA 
purification 
 
Following the successful use of FTA cards for blood sample collection in previous 
published studies (Mai et al. 2004; Park et al. 2008; Tomas et al. 2008; Sultan et al. 
2009; Untoro et al. 2009), the current study supported the use of such technology as a 
simple and easy method for blood sample collection, storage, shipment, and DNA 
extraction. However, effort conducted in this study to counteract the continuous 
presence of PCR inhibitors in blood, highlights the guidelines of loading blood samples 
on FTA cards including (i) the sample volume should not exceed 200µl and (ii) the 
importance of the application of blood to the card to ensure even distribution over the 
defined sample area using a micropipette. These two key points are also essential to 
avoid overloading the matrix at any site, where the integrated chemicals will not be 
sufficient for preservation of nucleic acids. These crucial aspects of sample application 
to the FTA cards have never been addressed in previous studies which involved the use 
of FTA cards for collection of various range of biological samples. From the obtained 
results, it was evident that DNA purification could not be considered complete until the 
discs turned blank at the end of the washing steps. 
 
3.3.2 FTA punch size as a template in PCR amplification 
 
In the current study, the use of 1.2-mm and 2-mm FTA discs as DNA templates in PCR 
amplifications was investigated using different reaction volumes (25µl, 50µl and 
100µl). The results shown indicate that 1.2-mm blood stained discs contain sufficient 
quantities of genomic DNA for PCR reaction volumes up to 100µl. These results are 
consistent with other studies which involved successful use of 1.2-mm discs of blood 
samples spotted on FTA cards (Seah et al. 2003; Suematsu and Isohashi 2006), whereas, 
others have used the bigger (2-mm) discs in their studies (Becker et al. 2004; Morrison 
et al. 2007; Pezzoli et al. 2007; Park et al. 2008). According to the results obtained 
throughout this study, it was clearly evident that the use of bigger discs did not improve 
the quality of the PCR products; meanwhile, the risk of involving more potential 
inhibitors in the reaction was increased. In addition, the use of bigger discs of samples 
stored on FTA cards in a single experiment means wasting more of the available 
samples. This is particularly important in forensic investigations which in many 
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circumstances deal with limiting DNA samples. Therefore, 1.2-mm discs are considered 
advantageous for forensic applications.  
 
3.3.3 Cross contamination hazards when using FTA
TM
 cards technology 
 
According to the manufacturer‟s instructions, it was recommended to punch blank discs 
from non-stained areas of the cards in between different samples to avoid cross 
contamination hazards. In the current study, no DNA contamination was detected in the 
negative control punch discs, whereas others have shown punch crossover 
contamination when DNA was amplified from negative control punch discs (Jefferies et 
al. 2007). Accordingly, they recommended punching out six negative control discs 
using a sterile filter paper between each two different samples. That was not essentially 
required in the current work, since no DNA contamination was detected in any of the 
negative control samples throughout all the experiments.  
 
3.3.4 Relief of persistent PCR inhibition 
 
Several compounds in blood were suggested to be PCR inhibitors, namely, heme, 
leukocytes, and anticoagulants (Akane et al. 1994; Morata et al. 1998). Haemoglobin 
and lactoferrin are the major PCR inhibitors in erythrocytes and leukocytes, respectively 
(Al-Soud and Radstrom 2001). In this study, amplification inhibition was a persistent 
problem, particularly after long term storage of the blood samples on FTA cards. 
Several modifications of the washing protocol were performed; however, they did not 
solve the issue of PCR inhibition. The PCR facilitator Bovine Serum Albumin (BSA) is 
characterised by high binding potentials which enable it to bind to the possible PCR 
inhibitors in blood such as heme, which would rather bind to the DNA polymerase 
causing its inactivation and thus PCR inhibition (Kreader 1996). Based on the results 
obtained by this study as well as others (Akane et al. 1994; Powell et al. 1994; Al-Soud 
and Radstrom 2001), BSA was shown to be highly effective in reducing PCR inhibition. 
Subsequently, BSA was considered as an essential constituent of the PCR master mix 
when using Whatman FTA method for DNA extraction from blood.  
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3.3.5 Long term DNA storage potentials of the FTA
TM
 cards  
 
Following addressing the issue of persistent PCR inhibition, mitochondrial 
hypervariable regions were successfully amplified from samples stored on FTA cards 
over long periods of time (6 - 48 months), thus demonstrating that FTA cards are a 
suitable medium for long term storage and preservation of the nucleic acids at room 
temperature. This finding is in agreement with the data obtained by a previous study 
which involved direct STR typing of 1-2 year old blood samples stored on FTA cards 
(Park et al. 2008). Similarly, no variation of genomic DNA quantification was detected 
by analysis of the same blood samples over a period of one year after being stored on 
FTA cards (Pezzoli et al. 2007). Others have shown contradictory results when they 
could not process blood stained FTA discs after being stored for more than 9 months 
(Becker et al. 2004). Indeed, the current study faced a real difficulty in DNA 
purification from blood samples stored on FTA cards for longer than 6 months, 
nonetheless that did not hinder the progress of the project particularly after inclusion of 
the BSA as an essential constituent of the PCR reaction mix. Hence, it is concluded that 
the longer the samples are stored on the FTA cards, the more difficult it will be to purify 
DNA from them. 
 
3.3.6 Conclusion 
 
FTA cards were successfully used for blood sample collection, storage, shipment and 
DNA extraction. Several guidelines for the use of FTA cards for DNA purification were 
approached. This study justified and extended the utility of FTA cards to the routine 
forensic case work that would save a lot of labour for genomic DNA extraction, which 
was inevitable in conventional genetic screening. This relatively new method was 
shown to be rapid, simple and inexpensive, and it conferred a reduced risk for cross-
contamination due to minimum manipulation of samples during extraction. Moreover, 
since FTA cards have the advantage of using minimal amounts of blood samples, they 
are recommended as a standard tool for genetic identification studies, especially when 
high throughput analysis is required. 
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4. ANALYSIS OF THE MITOCHONDRIAL HYPERVARIABLE 
REGIONS IN AN EGYPTIAN POPULATION SAMPLE 
 
4.1 Introduction  
 
The genetic sequence of the human mitochondrial DNA is of particular interest to 
forensic analyses that are concerned with human identification and population genetics 
(Budowle et al. 2002). For identification purposes, mtDNA is advantageous over the 
nuclear genome due to the fact that it is present in high copy number in each somatic 
cell, and thus is highly recoverable from degraded samples from which nuclear DNA is 
not (Robin and Wong 1988). This is particularly important in victim identification 
following mass disasters. In addition, mtDNA is inherited down the maternal line with 
non-recombination characteristics, and thus is treated as a single locus or a haplotype 
(Giles et al. 1980; Lightowlers et al. 1997; Primorac and Schanfield 2000). The primary 
sequence of the human mitochondrial genome (16.5 kb) was first determined in 1981 
and was known as the Anderson Reference Sequence (Anderson et al. 1981). However, 
following improvement in DNA sequencing technology, in 1999, several minor errors 
were identified and corrected to derive the Cambridge Reference Sequence (CRS) 
(Andrews et al. 1999). This sequence was primarily derived from an individual of 
European descent and has been used as the standard reference sequence in all the 
mitochondrial DNA population studies. The majority of these population studies 
involved analysis of two hypervariable regions of the mitochondrial genome, HVI and 
HVII. These regions reside in the control region of the mitochondrial genome and have 
the highest mutation rate within the mitochondrial DNA, and thus more likely to differ 
between individuals (Howell et al. 2007). Variations in the hypervariable regions are 
mainly attributed to mutations and have been largely used to assess the diversity and 
heterogeneity among and within different population groups (Asari et al. 2007; Mabuchi 
et al. 2007; Gonzalez et al. 2008; Turchi et al. 2009).  
 
The MtDNA database is growing rapidly, with more than six thousand complete 
mitochondrial DNA sequences available (www9). The frequency of different 
mitochondrial DNA haplotypes within a population group can be used to assess the 
weight of evidence of matching between an evidence sample and a known reference 
sample (Budowle et al. 1999; Holland and Parsons 1999). Analysis of the mtDNA 
haplotypes within population groups gives information about the maternal ancestry of 
these populations and the possible admixture between different populations irrespective 
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of the geographic barriers. Despite being continuously growing, the high quality 
mtDNA database is mainly constituted by mitochondrial sequences originating from the 
West Eurasia and the Asian sub-continent, whereas populations from the African 
continent are still underrepresented (Turchi et al. 2009).  
 
The aim was to analyse the mitochondrial DNA hypervariable regions of 261 adult 
Egyptians, and to establish a database of Egyptian mitochondrial DNA haplotypes. 
These mitochondrial haplotypes can then be used for assessment of the mitochondrial 
nucleotide diversity, and heterogeneity among the studied population group. For this, 
the mitochondrial HVI and HVII regions were amplified from blood samples on FTA 
cards and sequenced between the nucleotide positions 16024-16365 and 73-340, 
respectively. Mitochondrial haplotypes were determined and statistical measures 
including nucleotide diversity and random match probability were calculated. The most 
common polymorphic sites in the HVI region were identified and the frequency of each 
SNP was calculated. The utility of the mitochondrial hypervariable region data for 
forensic DNA analysis was investigated. The Egyptian mitochondrial haplotypes were 
assigned to known haplogroups which served to identify the maternal ancestry of the 
modern Egyptian population and to uncover their genetic relationships to other 
neighbour populations.  
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4.2 Results 
 
4.2.1 PCR amplification of the mitochondrial hypervariable regions (HVI and 
HVII) 
 
DNA was successfully purified from all the Egyptian blood samples (n=261) that were 
previously stored on FTA cards. A 1.2-mm processed dried disc of each blood sample 
was used as a template in all the subsequent analysis. The present study involved 
analysis of blood samples stored on FTA cards from 6 months up to 48 months old. 
Mitochondrial hypervariable regions (HVI and HVII) were PCR amplified between the 
nucleotide positions 16024-16365 and 73-340, respectively according to the Cambridge 
Reference Sequence (CRS) (accession number NC_012920) using primers indicated in 
Materials and Methods.  
 
4.2.1.1 Conventional PCR  
 
Mitochondrial hypervariable regions were amplified separately using the modified PCR 
master mix together with the traditional short primers (~20mer) (Methods; Table 2.2). 
HVI F and HVI R primers were used for HVI amplification producing a product size of 
444bp and for HVII amplification; HVII F and HVII R primers were used producing a 
415bp PCR product. Conventional thermal cyclic conditions, as described in section 
2.2.1.3, were used and the run was completed in two hours. PCR products were 
analysed by agarose gel electrophoresis (Figure 4.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Conventional PCR products of the mitochondrial hypervariable regions 
amplification. PCR products were separated by electrophoresis on 2% agarose gel. 100 bp 
DNA ladder was used as a molecular marker; Lane M. HVI PCR products (444bp) of three 
Egyptian blood samples on FTA cards were separated in lanes 1-3 and HVII PCR products 
(415bp) of the same samples were separated in lanes 4-6.  
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Following successful DNA purification from blood samples on FTA cards and 
amplification of the mitochondrial hypervariable regions in two separate PCR reactions 
using a duplicate set of processed discs of each sample, both mitochondrial 
hypervariable regions were simultaneously amplified in one PCR reaction using one 
disc of each sample instead of two. The use of a single disc for mitochondrial 
hypervariable regions amplification aimed at reduction of the initial volume of the DNA 
template that would be required for the analysis, which would have a major impact on 
forensic investigations where the amount of a sample may be an issue. The two 
mitochondrial hypervariable regions were amplified as a multiplex using the two region 
specific pairs of primers (HVI F, HVI R, HVII F and HVII R; Table 2.2). The results of 
the multiplex PCR showed preferential amplification of the HVI region over the HVII 
region which was less successfully amplified (Figure 4.2). In order to assess the quality 
of the DNA in samples stored on FTA cards, the whole mitochondrial hypervariable 
region between the mitochondrial nucleotide positions 16024 and 340 was amplified as 
one fragment (1024bp) using HVI F and HVII R primers (Figure 4.3).   
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: PCR products of multiplex and individual amplification of mitochondrial HVI 
and HVII regions. PCR products were separated by electrophoresis on 2% agarose gel. A 100 
bp DNA ladder was used as a molecular marker. Lanes 1 and 2 contained PCR products of HVI 
(444bp) and HVII (415bp) respectively.  Lane 3 contained products of a multiplex PCR in which 
the two pairs of short primers were used resulting in two bands of sizes 444 and 415bp 
corresponding to HVI and HVII regions respectively.  
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Figure 4.3: Analytical gel showing products of PCR amplification of the mitochondrial 
control region as one fragment. The whole mitochondrial hypervariable region was PCR 
amplified as one fragment and the PCR products were separated on 1% agarose gel. 1Kb DNA 
ladder was used as a molecular marker in lane M. Lanes 1-9 contained the PCR amplification 
products (1024bp) of nine Egyptian blood samples. Lane 10 contained the positive control in 
which human placental DNA was used as a template.   
 
4.2.1.2 Rapid PCR amplification of mitochondrial hypervariable regions  
 
Following successful PCR amplification of the mitochondrial hypervariable regions 
using the conventional thermal cyclic conditions which required approximately two 
hours to be completed, there was a demand to modify these cyclic conditions and to 
develop a rapid method for amplification of the mitochondrial hypervariable regions 
which would have a direct impact on forensic investigations. For this, two pairs of 
newly designed long primers (~30mer) which were characterised by high Tm values 
were used (Methods; Table 2.2). These high Tm values enable the primers to anneal at 
high temperature at which the DNA polymerase was highly active, therefore it was 
possible to combine the annealing and the extension steps at 72
o
C, and hence to shift 
from three-step PCR protocol to two-step PCR protocol. This results in considerable 
reduction in the total run time. In addition, the use of high initial denaturation 
temperature at 98
o
C as recommended by Sullivan et al.(2006), helped to reduce the 
initial denaturation time down to 30 seconds instead of 5 minutes, while ensuring proper 
denaturation of DNA template on FTA cards. Three more parameters of the PCR cyclic 
conditions were optimised to achieve the target of rapid amplification of the 
mitochondrial hypervariable regions including, the length of time for denaturation at the 
beginning of each cycle, the number of cycles, and the duration of the final elongation. 
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4.2.1.2.1  Optimising the length of time for denaturation at the beginning of 
each cycle 
 
Modification of the length of time for denaturation was performed via amplification of 
the mitochondrial hypervariable region I (HVI) of the same blood sample on FTA card 
in six different PCR tubes (1.2-mm processed disc in each tube as DNA template) with 
identical PCR constituents. These amplification reactions were performed under the 
same thermal cyclic conditions except for the cyclic denaturation time which was 
subjected to a gradient reduction from 45 seconds down to 5 seconds while keeping all 
the other thermal cyclic conditions unchanged. The results showed successful 
amplification of the mitochondrial HVI in all the six PCR reactions, without any 
significant difference between the products of any of them (Figure 4.4). Therefore, a 
decision was made to use 5 seconds as the appropriate time for denaturation. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Analytical gel showing optimisation of the cyclic denaturation time. HVI PCR 
products were separated by electrophoresis on 2% agarose gel. A 100 bp DNA ladder was 
used as a molecular marker (Lanes; M1and M2). Lanes 1-6 show HVI PCR products (size= 
444bp) following the use of different cyclic denaturation times as follows; lane 1 (45 seconds), 
lane 2 (30 seconds), lane 3 (20 seconds), lane 4 (15 seconds), lane 5 (10 seconds) and lane 6 
(5 seconds).  No significant difference was detected among the different PCR products. 
 
4.2.1.2.2  Optimising the number of cycles 
 
To further reduce the total run time of the PCR program, different numbers of cycles 
were tested. Mitochondrial HVII region of one blood sample on FTA card was 
amplified in five different PCR tubes (1.2-mm processed disc in each tube as DNA 
template) with identical PCR constituents. The thermal cyclic conditions of all the five 
amplification reactions were kept the same except for the number of cycles. Different 
numbers of cycles were tested from 28 cycles up to 40 cycles in order to determine the 
minimal number of cycles that would give good quality PCR products and hence the 
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shortest possible run time of the PCR. The obtained results showed that 30 cycles were 
appropriate to obtain an adequate amplification product without smearing (Figure 4.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Analytical gel showing optimisation of the number of cycles. HVII PCR 
products were separated by electrophoresis on 2% agarose gel. A 100 bp DNA ladder was 
used as a molecular marker; lane M.  Lanes 1-5 show HVII PCR products (size= 415bp) 
following the use of different number of cycles as follows; lane 1 (28 cycles), lane 2 (30 cycles), 
lane 3 (32 cycles), lane 4 (35 cycles) and lane 5 (40 cycles). The bigger the number of cycles 
used, the more smearing was observed on the gel. The use of 28 cycles produced a relatively 
less bright band than all the others reflecting less DNA concentration. The use of 30 cycles 
produced a relatively bright band (lane 2) reflecting a good DNA concentration with no 
smearing.  
 
4.2.1.2.3  Optimising the duration of final extension 
 
As a final step to further reduce the PCR run time, the duration of final elongation was 
assessed, by performing two different PCR reactions for multiplex amplification of the 
mitochondrial hypervariable regions (HVI and HVII) of a blood sample on FTA card 
using a 1.2-mm processed disc in each tube. All the PCR parameters were kept the same 
for both reactions, including the thermal cyclic conditions as well as the master mix 
constituents which included the whole set of the four long primers (Methods; Table 2.2). 
The only difference between the two reactions was the time of final extension which 
was tested at 1 and 5 minutes. The obtained results showed that there was no significant 
difference between the PCR products of the two reactions (Figure 4.6), and hence it 
was concluded that 1 minute was an adequate time for the final extension. 
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Figure 4.6: Analytical gel showing optimisation of the final extension time. PCR products 
of multiplex amplification of the mitochondrial hypervariable regions HVI and HVII were 
separated by electrophoresis on 2% agarose gel. A 100 bp DNA ladder was used as a 
molecular marker; lane M. PCR products show 2 bands of sizes; 444bp and 415bp 
corresponding to HVI and HVII regions respectively. Lane 1 shows multiplex PCR products 
following 1 minute of final extension and lane 2 shows multiplex PCR products following 5 
minutes of final extension. No significant difference was detected between the products of the 
two reactions. 
 
4.2.1.2.4  Final protocol of rapid PCR  
 
From the previously mentioned experimental work, a new protocol for rapid PCR 
amplification of the mitochondrial hypervariable regions, HVI and HVII was developed. 
This protocol enabled amplification of the mitochondrial hypervariable regions from 
blood samples on FTA cards within a period of 30 minutes. It is also worth noting that 
this rapid protocol was developed using Gotaq DNA polymerase which is commonly 
used in the conventional PCR programs. This rapid protocol was reproducible using 
different thermal cyclers (TECHNE GENUIS TC 3000X, TECHNE GENUIS TC-512, 
LABNET, and PIKO
®
) demonstrating that the protocol was not machine dependent. 
Optimised thermal cyclic conditions for the rapid PCR were summarised in Table 4.1. 
It is now possible to amplify mitochondrial HVI and HVII regions in a short period of 
time which will aid forensic investigations as well as the development of protocols for 
undergraduate teaching. 
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Table 4.1: A summary of rapid PCR protocol. 
 
PCR stage Temperature Duration 
1 cycle of 
Initial denaturation 
 
98
o
C 
 
30 sec 
30 cycles of 
Denaturation 
Annealing/ Extension               
 
92
o
C   
72
o
C    
 
5 sec 
30 sec 
1 cycle of 
Final Extension                        
 
72
o
C 
 
1 min 
Total run time   ~ 30 min 
 
 
4.2.1.3 DNA purification of the PCR products 
 
Following successful amplification of the mitochondrial hypervariable regions of all the 
Egyptian blood samples (n=261), PCR products were purified using Wizard
®
 SV Gel 
and PCR Clean-Up Purification System (Promega) (Methods, section 2.2.1.5). Success 
of the purification process was verified for all samples by electrophoresis on a 1% 
agarose gel (Figure 4.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: Mitochondrial hypervariable region PCR products after DNA purification. PCR 
products of the whole hypervariable region were purified using Wizard
®
 SV Gel and PCR 
Purification System (Promega) and 3µl of each sample was separated by electrophoresis on 1 
% agarose gel. 1Kb DNA ladder was used as a molecular marker; lane M. Lanes 1-6 contained 
purified hypervariable region PCR products (1024bp) of six Egyptian blood samples. The band 
intensities revealed successful DNA purification. 
 
 
 
    
1kb DNA ladder
Mitochondrial hypervariable region PCR products after DNA purification
1024bp
1000bp
750bp
500bp
1500bp
250bp
M                 1                    2                   3                  4                    5                   6   
Chapter 4: Mitochondrial hypervariable region analysis in the Egyptian population 
 115 
4.2.2 Mitochondrial hypervariable region sequence analysis and haplotype 
determination  
 
4.2.2.1 Sequencing results of the mitochondrial hypervariable regions 
 
Purified PCR products of the mitochondrial hypervariable regions from all the Egyptian 
blood samples were sequenced using the two pairs of short primers (HVI F, HVI R, 
HVII F and HVII R) that have been used in the conventional PCR (Methods, Table 
2.2) and samples were run on an ABI 3730 capillary sequencer. The sequencing data 
was obtained using Applied Biosystems Sequence Scanner Software v1.0.  It was 
possible to obtain complete HVI sequences between the mitochondrial nucleotide 
positions 16024 and 16365 for all samples (n=261). However, a reliable sequence of the 
complete HVI specified region was occasionally difficult to obtain via one sequencing 
reaction, in which case a partial sequence was the result. This partial sequence was 
always obtained whenever a length polymorphism was detected at the poly cytosine 
stretch spanning the nucleotides 16184-16188 and 16190-16193. In the Cambridge 
Reference Sequence a thymine base is present at nt16189 in the middle of the poly C 
stretch separating 5Cs before and 4Cs after. When a T16189C transition occurs, it 
results in a stretch of 10 or more cytosines in a row which further predisposes to length 
polymorphism due to replication slippage. Such length polymorphism results in a 
mixture of length variants (mtDNA copies of varying lengths) which always disrupt the 
sequence downstream. These variants are either already present in the original DNA 
sample or generated in the sequencing reaction itself. Two other mutations (A16182C 
and A16183C) may occasionally be present that further increases the length of the poly 
C stretch and hence augment the sequencing difficulty (Figure 4.8a and 4.8b). To 
tackle this problem, sequencing of the two strands was always required. Moreover, 
double sequencing of the same strand in two separate sequencing reactions was 
occasionally performed to ensure that the mtDNA sequence information was reliable.  
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Figure 4.8a: Snapshots of HVI electropherograms between the nucleotide positions 
16166 and 16214 showing the difference between the Cambridge Reference Sequence 
and sequences with length polymorphisms. Electropherogram (a) represents the CRS 
between the nucleotide positions 16166 and 16214 having 16182A, 16183A and 16189T and 
showing a good quality sequence after the C-stretch zone. Electropherogram (b) represents an 
example of HVI sequences having A16182C, A16183C and T16189C mutations and showing a 
quick drop of the sequence quality immediately after the poly C stretch due to presence of a 
mixture of length variants. Electropherograms were extracted form the sequencing results 
obtained during the present study. 
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Figure 4.8b: Variations in the poly-C stretch of the mitochondrial hypervariable region I 
causing sequencing difficulty. i) is the Cambridge Reference Sequence between nucleotides 
16180-16214. i) is not a problem with sequencing, and ii) represents 1 variant, which then does 
cause difficulties for the sequencing. These sequencing difficulties are due to mitochondrial 
mutations at positions 16182, 16183, and 16189 that lead to a long poly-C stretch (≥ 12C). 
Different molecules of the same DNA sequence show different lengths of poly-C either 
produced by length heteroplasmy or generated during the sequencing reaction itself. The 
resulting sequence ii) is a mixture of these varying-length molecules with a remarkable 
reduction in the sequence quality immediately after the poly-C stretch.       
 
For the mitochondrial hypervariable region II analysis, mtDNA was sequenced between 
the nucleotide positions 73 − 340 in approximately 30% of samples (n=78). Sequencing 
of the two strands was performed to ensure a reliable sequencing data especially for 
samples with length polymorphism at the poly C stretch region spanning the nucleotides 
303-309 and 311-315 which always caused sequencing difficulty (Figure 4.9). Based 
on the analysed sequencing data (see section 4.2.2.4), the calculated random match 
probability of the HVII haplotypes and the actual role that HVII haplotypes played in 
the mitochondrial haplogroup assignment (which was an integral part of this project), 
the protocol of the hypervariable region analysis was modified to only include 
nucleotide position 73 instead of the whole extension of the HVII region.  In the CRS 
there is an adenosine base at nucleotide position 73 (Andrews et al. 1999), which 
AAAACCCCCTCCCCATGCTTACAAGCAAGTACAGC
AACCCCCCCCCCCC
CCCCCCCCCCCCCC
(14C)
CCCCCCCCCCCCC
(13C)
CCCCCCCCCCCC
(12C)
AACCCCCCCCCCCCATGCTTACAAGCAAGTACAGC
AACCCCCCCCCCCCCATGCTTACAAGCAAGTACAGC
AACCCCCCCCCCCCCCATGCTTACAAGCAAGTACAGC
i)
Single molecules with different lengths of poly-C stretch
AACCCCCCCCCCCCANGCTTNNAANTAAGTANAGN
ii)
1
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9
1
6
1
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represents a G to A mutation that occurred during modern human evolution from the 
most recent maternal ancestor. 73A is considered as a specific characteristic for the 
mitochondrial major haplogroup R0 and all its descendants including haplogroup H to 
which the CRS belongs (Brandstaetter et al. 2008; Alvarez-Iglesias et al. 2009). 
Interestingly, a similar G to A mutation was reported in one of the most ancient sub-
Saharan African lineages, L0a'b'f (Behar et al. 2008b). Hence, the nucleotide position 
73 was determined for all the Egyptian individuals (n=261) and used in conjunction 
with the HVI haplotypes for the mitochondrial haplogroup assignment and the 
nucleotide diversity assessment in the Egyptian population.   
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
Figure 4.9: Snapshots of HVII electropherograms between the nucleotide positions 296 
and 338 showing the impact of length polymorphisms on the sequencing results. 
Electropherogram (a) represents an example of HVII sequence between the nucleotide 
positions 296 and 338 showing an identical sequence to the CRS between the nucleotides 303-
310 with an overall good quality sequence. Electropherogram (b) represents an example of 
samples with two cytosine insertions after nt309 leading to a complete disruption of the 
sequence beyond that poly C stretch due to presence of a mixture of length variants. 
Electropherograms were extracted from the sequencing results obtained during the present 
study. 
 
 
a.
b.
310
309.2C
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4.2.2.2 Analysis of the sequencing results  
  
Mitochondrial HVI and HVII sequencing results were aligned against the Cambridge 
Reference Sequence. The CRS is the primary sequence of the human mitochondrial 
genome which was first determined in 1981 (Anderson et al. 1981) and following the 
advancement of the DNA sequencing technology, minor errors were identified and 
corrected in 1999 (Andrews et al. 1999). This reference sequence belongs to an 
individual of European descent, and has been used as a standard reference in all the 
mitochondrial DNA population studies. The sequence alignment was performed using 
the CLUSTALW analysis tool of Biology Workbench (www5). Mutations were 
identified whenever variations from the CRS were detected (Figure 4.10), and the 
mutation sites were numbered according to the revised version of the CRS obtained 
from the NCBI database (accession number NC_012920) and hence the mitochondrial 
haplotypes were concluded. HVI haplotypes and the nucleotide base at position 73 were 
determined for all samples that were unambiguously sequenced during the present study 
(n=261), whereas, complete HVII haplotypes were only determined for 30% of samples 
(n=78) (Table 4.4). 
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Figure 4.10: CLUSTALW analysis of five Egyptian mtDNA HVI sequences relative to the 
CRS using TEXSHADE tool at the Biology Workbench. Five Egyptian mtDNA sequences 
(sample numbers 28, 33, 50, 66, and 194) between the nucleotides 16024−16365 were aligned 
against the revised version of the Cambridge Reference Sequence. Dark brown boxes outline 
the CRS. The consensus line is shown at the bottom with an upper case character in case of all 
sequences are matching to the CRS and a lower case character indicates a conserved base 
with few variations between sequences.   
CLUSTALW analysis of Egyptian mitochondrial HVI sequences relative to the CRS 
(TEXSHADE) 
all match  conserved  variation 
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4.2.2.3 Sequence variations in the mitochondrial hypervariable regions   
 
Overall, a total of 113 polymorphic sites were reported in the mitochondrial HVI region 
(16024-16365) which characterised a total of 187 different Egyptian HVI haplotypes. 
These polymorphic sites varied greatly in their frequency in the analysed mtDNA 
sequences, ranging from occurring in 1 individual to 99 individuals. The average 
number of times for a variable character to occur was 9.2 times. Sites that showed the 
highest variability in the HVI region of the Egyptian mtDNA sequences, found in 20 
individuals or more, included 16126, 16129, 16172, 16183, 16189, 16223, 16249, 
16278, 16292, 16294, 16311, and 16362. Sites that showed lower rate of variability but 
still reported in 10 individuals or more included 16069, 16093, 16145, 16163, 16182, 
16186, 16187, 16192, 16209, 16210, 16224, 16256, 16270, 16296, and 16309 (Table 
4.2). In the HVII analysed sequences, a total of 42 polymorphic sites were reported 
which enabled identification of 62 different haplotypes. An A263G mutation was found 
in all sequences. The next common polymorphic sites in the HVII region were 73, 146, 
152, 195, and 303-315 occurring in 20 individuals or more. All singletons (a 
polymorphic site represented by a single variant sequence) were checked carefully to 
exclude sequencing errors. 
Chapter 4: Mitochondrial hypervariable region analysis in the Egyptian population 
 122 
Table 4.2: A full list of the polymorphic sites reported in the mitochondrial HVI sequences 
of 261 Egyptian individuals. Sites were numbered according to the Cambridge Reference 
Sequence numbering system (Andrews et al. 1999). N is the number of occurrences of the 
polymorphic site in the analysed mtDNA sequences (n=261) with the frequency percentage 
shown between brackets. Sites were ordered according to their frequency starting by the most 
common. Polymorphic sites reported in 10 individuals or more are shown in bold and italic. 
  
 
N  
(Frequency %) 
Polymorphic 
site 
N  
(Frequency %) 
Polymorphic 
site 
N  
(Frequency %) 
Polymorphic 
site 
      
99 (37.93) 16223 5 (1.92) 16124 2 (0.77) 16248 
86 (32.95) 16189        5 16153        2 16260 
71 (27.20) 16311        5 16167        2 16298 
65 (24.90) 16126        5 16188        2 16299 
50 (19.16) 16294        5 16219        2 16300 
45 (17.24) 16183        5 16230        2 16301 
41 (15.70) 16278        5 16261        2 16356 
29 (11.11) 16129        5 16274 1 (0.38) 16037 
28 (10.73) 16292        5 16324        1 16048 
22 (8.43) 16172        5 16343        1 16081 
      22  16249 4 (1.53) 16104        1 16092 
21 (8.05) 16362        4 16166        1 16096 
19 (7.28) 16192        4 16169        1 16107 
      19  16270        4 16181        1 16131 
18 (6.90) 16186        4 16265        1 16138 
17 (6.51) 16163        4 16271        1 16150 
16 (6.13) 16209        4 16291        1 16156 
14 (5.36) 16182        4 16304        1 16173 
      14  16224 3 (1.15) 16051        1 16201 
12 (4.60) 16187        3 16139        1 16221 
11 (4.21) 16069        3 16218        1 16222 
      11  16093        3 16234        1 16231 
      11  16256        3 16266        1 16233 
      11  16309        3 16318        1 16254 
10 (3.83) 16145        3 16325        1 16269 
      10  16210 2 (0.77) 16086        1 16286 
      10  16296        2 16134        1 16287 
9 (3.45) 16168        2 16136        1 16288 
       9 16176        2 16147        1 16305 
       9 16320        2 16164        1 16313 
8 (3.07) 16327        2 16174        1 16316 
       8 16355        2 16179        1 16317 
7 (2.68) 16148        2 16207        1 16319 
       7 16293        2 16213        1 16352 
       7 16359        2 16214        1 16354 
6 (2.30) 16067        2 16215        1 16357 
       6 16264        2 16239        1 16365 
5 (1.92) 16111        2 16240   
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4.2.2.4 Mitochondrial DNA haplotype analysis  
 
Following determination of the mitochondrial DNA sequence variations in the 
hypervariable regions, HVI haplotypes were analysed both individually and in 
combination with the available HVII data. Among the 261 analysed sequences and 
using the HVI data alone, a total of 187 different haplotypes were observed, of which 
151 (~81%) were seen only once during this study. Such a large number of unique 
mitochondrial haplotypes obtained via analysis of the mitochondrial HVI region alone 
indicates high mtDNA diversity and supports the use of the mitochondrial HVI region 
analysis for the identification purposes. The other 36 HVI haplotypes were shared 
between multiple individuals, of which 28 types were observed twice (Table 4.3) and 
(Figure 4.11a). The most commonly observed HVI haplotype, seen in 19 individuals, 
was identical to the CRS between the nucleotide positions 16024-16365. Among the 78 
analysed HVII sequences, a total of 62 different haplotypes were reported, of which 51 
(~82%) were unique to single individuals. The remaining 11 haplotypes were shared 
between multiple individuals. The most frequent HVII haplotypes, seen in 4 individuals, 
were (73G, 143A, 146C, 152C, 195C, 263G, 309.1C, 315.1C) and (73G, 263G, 309.1C, 
315.1C) (Tables 4.3 and 4.4) (Figure 4.11a). Combination of 261 HVI sequences and 
78 HVII sequences revealed a total of 207 different mitochondrial haplotypes, of which 
183 (~88%) were unique to single individuals and 24 haplotypes were observed more 
than once. In 78 individuals for whom both HVI and HVII sequences were available, no 
shared haplotypes were detected (Table 4.3) and (Figure 4.11b). Hence, it was 
concluded that the HVII data when combined with the HVI data increased the power of 
discrimination and enabled unique identification in 78 individuals.  
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Table 4.3: Diversity of mtDNA haplotypes in an Egyptian population sample. Number and 
frequency of the haplotypes were calculated for HVI and HVII data sets individually and in 
combination. Numbers of unique haplotypes in each category was shown in bold and italic. 
 
 
Number 
of times 
observed 
HVI 
(16024−16365) 
(n=261) 
HVII (73-340) 
(n=78) 
HVI + HVII 
(n=78) 
HVI +HVII 
(n=261)* 
Number of 
haplotypes 
Total 
Number of 
haplotypes 
Total 
Number of 
haplotypes 
Total 
Number of 
haplotypes 
Total 
         
1 151 151 51 51 78 78 183 183 
2 28 56 8 16 0 0 15 30 
3 2 6 1 3 0 0 4 12 
4 2 8 2 8 0 0 0 0 
5 0 0 0 0 0 0 3 15 
6 1 6 0 0 0 0 0 0 
7 1 7 0 0 0 0 1 7 
8 1 8 0 0 0 0 0 0 
14** 0 0 0 0 0 0 1 14 
19** 1 19 0 0 0 0 0 0 
Total 187 261 62 78 78 78 207 261 
 
* This data set involved HVI sequences and nucleotide position 73 for all samples (n=261) 
combined with 30% HVII data coverage (n=78). 
** The only HVI haplotype which was observed in more than 7 individuals was identical to the 
CRS with no mutations between the nucleotide positions 16024-16365. 
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Figure 4.11a: Diversity of mitochondrial HVI and HVII haplotypes in an Egyptian 
population sample. a) represents distribution of mitochondrial HVI haplotypes (nt16024-16365) 
in 261 adult Egyptians demonstrating high mtDNA diversity with approximately 81% of 
haplotypes unique to single individuals. The most frequent HVI haplotype was found in 19 
individuals and was identical to the CRS in the specified HVI region. b) represents distribution of 
mitochondrial HVII haplotypes (nt73-340) in 78 adult Egyptians with approximately 82% of 
haplotypes unique to single individuals. The most frequent haplotypes were shared by four 
individuals. 
a.
b.
 Diversity 
 Diversity 
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Figure 4.11b: Diversity of mitochondrial DNA haplotypes in an Egyptian population 
sample following combination of HVI and HVII data. a) represents distribution of 
mitochondrial DNA haplotypes following combination of 261 HVI sequences (nt16024-16365) 
and 78 HVII sequences (nt73-340). Approximately 88% of haplotypes were unique to single 
individuals in the analysed population sample. The most frequent haplotype was found in 14 
individuals and was identical to the CRS in the specified HVI region. b) represents distribution of 
mitochondrial DNA haplotypes in 78 individuals for whom complete HVI (16024-16365) and 
HVII (73-340) sequences were determined. No shared haplotypes were detected and hence 
unique identification in 78 individuals was achieved via combination of HVI and HVII sequencing 
data.  
a.
b.
 Diversity 
 Diversity 
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Table 4.4: Mitochondrial DNA sequence polymorphisms in the hypervariable region and haplogroup associations in a population sample of 261 Egyptian 
individuals.   
 
# Individuals
(a)
 Haplogroup
(b)
 HVI haplotype (16024−16365)
(c)
 
Nucleotide at 
postion 73 
HVII haplotype (74−340)
(c,d)
 
14 R0 CRS A ND 
7 U5a 16192T, 16256T, 16270T G ND 
5 R*  CRS G ND 
5 N1b 16145A, 16176G, 16223T, 16390A G ND 
5 L3f1b 16209C, 16223T, 16292T, 16311C G ND 
3 T1a 16126C, 16163G, 16186T, 16189C, 16274A, 16294T G ND 
3 T1a 16126C, 16163G, 16186T, 16189C, 16294T G ND 
3 M1 16129A, 16183C, 16189C, 16249C, 16311C G ND 
3 L1b 16126C, 16187T, 16189C, 16223T, 16264T, 16270T, 16278T, 16293G, 16311C G ND 
2 H5 16166G, 16189C,16304C A ND 
2 R0 16129A A ND 
2 R0 16356C A ND 
2 R0a1a  16126C, 16355T, 16362C A ND 
2 HV1 16067T A ND 
2 HV1 16067T, 16183G, 16327A A ND 
2 J 16069T, 16126C G ND 
2 J1b 16069T, 16126C, 16249C, 16261T, 16311C G ND 
2 T1a 16111A, 16126C, 16163G, 16186T, 16189C, 16294T G ND 
2 T2c 16126C, 16292T, 16294T G ND 
2 M1 16129A, 16183C, 16189C, 16223T, 16249C, 16311C, 16359C G ND 
2 M1 16183C, 16189C, 16249C, 16311C, 16327T G ND 
2 L3f1b 16172C, 16209C, 16223T, 16292T, 16311C G ND 
2 L3e2 16223T, 16320T G ND 
2 R11’B 16183C, 16189C, 16223T, 16311C G ND 
1 R0 16167T, 16269C, 16313T A 85A, 263G, 309.1C, 315.1C 
1 R0 16187A A 99G, 241C, 263G, 309.1C, 315.1C 
1 R0 16271C, 16311C A 146C, 263G, 315.1C  
1 R0 16210G, 16224C, 16292T A 263G, 309.1C, 315.1C 
1 R0 16126C, 16168T, 16172C, 16325C A 263G, 315.1C 
1 R0 16233G A ND 
1 R0 16219G A ND 
1 R0 16164G A ND 
1 R0 16167T A ND 
1 R0 16210G, 16224C A ND 
1 R0 16147A A ND 
1 R0 16172C A ND 
1 R0 16051G A ND 
1 R0 16183G, 16327A A ND 
1 R0 16355 A ND 
1 R0 16210G, 16224C, 16292T A ND 
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Table 4.4: (Continued) 
 
 
 
# Individuals
(a)
 Haplogroup
(b)
 HVI haplotype (16024−16365)
(c)
 
Nucleotide at 
postion 73 
HVII haplotype (74−340)
(c,d)
 
1 R0 16129A, 16265C, 16362C A ND 
1 R0 16270T A ND 
1 H20 16218T, 16316G A ND 
1 H2a2b 16218T, 16291T A 143A, 263G, 309.1C, 315.1C 
1 H20 16218T A 263G, 315.1C 
1 H14a 16256T, 16311C, 16352C A ND 
1 H6b 16234T, 16300G, 16362C. A ND 
1 R0a 16126C, 16362C A ND 
1 R0a 16126C, 16150T, 16168T, 16266T, 16362C A 99G, 263G, 309.1C, 315.1C 
1 R0a 16126C, 16271C, 16291T, 16362C A 204C, 263G, 315.1C 
1 R0a 16126C, 16271C, 16291T, 16362C A ND 
1 R0a 16107T, 16126C, 16172C, 16288C, 16291T, 16301T, 16362C A ND 
1 R0a 16126C, 16192A, 16278T, 16362C A ND 
1 R0a1a  16126C, 16355T, 16362C A 146C, 263G, 309.1C, 315.1C 
1 HV0 16093T, 16126C, 16221T, 16298C A 72C, 195C, 263G, 3069.1C, 315.1C 
1 HV1 16067T A 263G, 309.1C, 315.1C  
1 HV1 16067T, 16129A A ND 
1 R11’B 16181C, 16182C, 16183C, 16189C G 146C, 153G, 263G, 309.1C, 315.1C  
1 R11’B 16093C, 16104T, 16181C, 16182C, 16183C, 16189C G  ND 
1 R11’B 16104C, 16181C, 16182C, 16183C,16189C G 146C, 153G, 228A, 263G, 309.1C, 315.1C 
1 R11’B 16182C, 16183C, 16189C, 16223T G  ND 
1 R11’B 16104T, 16136C, 16183C, 16189C, 16223T G  ND 
1 R* 16169T, 16183C, 16189C, 16223T, 16278T G 146C, 153G, 263G, 315.1C 
1 R* 16210G, 16224C, 16292T G ND 
1 R* 16096d, 16270T G ND 
1 R 16124C, 16209C, 16223T G ND 
1 R 16092C, 16138G, 16223T G ND 
1 R 16126C, 16223T, 16240 G 152C, 195C, 262T, 263G, 315.1C 
1 R 16223T G 146C, 244G, 263G, 315.1C 
1 R 16223T G 152C, 189G, 195C, 263G, 309.1C, 315.1C 
1 R 16111A, 16210G, 16223T G ND 
1 R 16166G, 16172C, 16223T G ND 
1 R 16167T, 16223T G 150T, 189G, 200G, 263G, 315.1C 
1 R 16223T, 16264T, 16299G G 150T, 254C, 263G, 309.1C, 315.1C  
1 R 16182A, 16183A G 143A, 146C, 152C, 195C, 263G, 315.1C 
1 R 16081G, 16270T G ND 
1 T 16126C, 16294T G 263G, 309.1C, 315.1C 
1 T 16126C, 16136C, 16294T, 16324C G ND 
1 T 16126C. 16294T G ND 
1 T1 16051G, 16126C, 16189C, 16294T G ND 
1 T1a 16037G, 16093C, 16126C, 16163G, 16186T, 16189C G 152C, 263G, 309.1C, 315.1C 
1 T1a 16126C, 16186T, 16189C, 16294T G 200G, 263G, 309.1C, 315.1C 
1 T1a 16126C, 16139, 16163G, 16186T, 16189C, 16294T G 263G, 309.1C, 315.1C 
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Table 4.4: (Continued) 
   
 
# Individuals
(a)
 Haplogroup
(b)
 HVI haplotype (16024−16365)
(c)
 
Nucleotide at 
postion 73 
HVII haplotype (74−340)
(c,d)
 
1 T1a 16126C, 16139, 16163G, 16186T, 16189C, 16294T G 152C, 263G, 309.1C, 315.1C 
1 T1a 16126C, 16163G, 16186T, 16189C, 16294T G 263G, 309.1C, 315.1C 
1 T1a 16126C, 16163G, 16172C, 16186T, 16189C, 16298C G 263G, 272G, 309.1C, 315.1C 
1 T1a 16126C, 16139, 16163G, 16186T, 16189C, 16270T, 16271C, 16294T G 227, 263G, 309.1C, 315.1C 
1 T1a 16126C, 16163G, 16186T, 16189C G ND 
1 T1a 16126C, 16163G, 16172C, 16186T, 16189C, 16274A, 16294T G ND 
1 T1a 16126C, 16163G, 16172C, 16186T, 16189C,16294T G ND 
1 T2 16126C, 16294T, 16296T G ND 
1 T2 16126C, 16294T, 16296T, 16324C G ND 
1 T2 16126C, 16168T, 16294T, 16296T, 16311C. G ND 
1 T2 16126C, 16183C, 16189C, 16294T, 16296T  ND 
1 T2b 16126C, 16189C, 16294T, 16296T, 16304C, 16365T G ND 
1 T2b3a 16126C, 16292T, 16294T, 16296T, 16304C G 263G, 309.1C, 315.1C 
1 T2c 16126C, 16292T, 16294T, 16296T G ND 
1 T2c 16126C, 16174T, 16292T, 16294T G ND 
1 T2e 16126C, 16153A, 16192T, 16294T, 16296T, 16311C G 150T, 185A, 199C, 263G, 309.1C, 315.1C 
1 T2e 16126C, 16153A, 16294T, 16296T, 16324C G ND 
1 T2e 16126C, 16153A, 16294T, 16296T G ND 
1 T2e 16126C, 16153A, 16278T, 16294T G ND 
1 
J 16069T, 16126C, 16169T G 
146C, 150T, 195C, 235G, 263G, 295T, 
309.1C, 315.1C 
1 J 16069T, 16126C, 16311C G ND 
1 J 16069T, 16126C, 16362C G ND 
1 J 16069T, 16126C, 16248T, 16362C G ND 
1 J 16069T, 16126C, 16193T, 16239T, 16300G, 16309G G ND 
1 J1b 16069T, 16126C, 16145A, 16222T, 16261T, 16274A, 16311C G ND 
1 J1b 16069T, 16126C, 16145A, 16261T G ND 
1 U1b 16111T, 16249C, 16311C, 16327T G ND 
1 U1a'c 16183C, 16189C,16249C, 16292T, 16319A, 16357C G 199C, 263G, 285T, 309.1C, 315.1C  
1 U3 16168T, 16192T, 16343G G 150T, 263G, 309.1C, 315.1C 
1 U3 16343G G 150T, 263G, 315.1C 
1 U3 16343G G ND 
1 U3 16131C, 16168T, 16343G G ND 
1 U3 16210G, 16224C, 16292T, 16343G G ND 
1 U5 16167C, 16270T, 16311C G ND 
1 U5 16187T, 16192T, 16260T, 16270T G ND 
1 U5a 16192T, 16256T, 16270T G 263G, 315.1C  
1 U6a 16172C, 16219G, 16278T G 103A, 195C, 263G, 3096.1C, 315.1C 
1 U6a 16189C, 16219G, 16278T G 
103A, 146C, 195C, 207A, 263G, 309.1C, 
315.1C 
1 U6a1a 16172C, 16183C, 16189C, 16219G, 16278T G ND 
1 U6a4 16134G, 16172C, 16219G, 16278T G ND 
1 U7 16309G, 16318T, 16362C G 152C, 263G, 309d 
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Table 4.4: (Continued)  
 
 
# Individuals
(a)
 Haplogroup
(b)
 HVI haplotype (16024−16365)
(c)
 
Nucleotide at 
postion 73 
HVII haplotype (74−340)
(c,d)
 
1 U7 16126C, 16148T, 16309G, 16318T G 
99G, 146C, 151T, 152C, 195C, 263G, 
315.1C 
1 U7 16318T G  ND 
1 U8b 16179T, 16183C, 16189C, 16234T, 16324C G 195C, 263G, 309.1C, 315.1C, 324G 
1 U8b 16179T, 16183C, 16189C, 16234T, 16324C G  ND 
1 K 16224C, 16311C G 152C, 185A, 263G, 295A, 315.1C 
1 K 16224C, 16311C G 263G, 315.1C  
1 K 16174T, 16224C, 16311C G 146C, 263G, 315.1C 
1 K 16124C, 16172C, 16187T, 16224C, 16311C G 152C, 195C, 263G, 309.1C, 315.1C 
1 K 16176T, 16210G, 16224C G ND 
1 K 16172C, 16224C, 16256T, 16261T, 16311C G ND 
1 K1a1a 16093C, 16224C, 16311C G 195C, 263G, 315.1C  
1 K1a1a 16093C, 16224C, 16311C G 263G, 315.1C 
1 N/ L3* 16210G, 16223T, 16270T, 16311C G ND 
1 N/ L3* 16223T, 16311C G 199C, 204C, 214G, 250C, 263G, 315.1C 
1 N1a 16172C, 16223T, 16293T, 16311C, 16355T, 16362C G 146C, 244G, 263G, 315.1C 
1 N1a 16147G, 16172C, 16223T, 16248T, 16355T G  ND 
1 N1b 16145A, 16176G, 16223T, 16390A G 152C, 204C, 263G, 315.1C 
1 N1b 16145A, 16176G, 16223T, 16390A G 152C, 263G, 309.1C, 315.1C 
1 N1b 16145A, 16176G, 16210G, 16223T, 16390A G ND 
1 N1c 16201T, 16223T, 16265G G ND 
1 I1 16129A, 16223T, 16311C, 16391A G 152C, 199C, 204C, 250C, 263G, 315.1C 
1 W 16223T, 16292T G ND 
1 W6 16223T, 16292T, 16325C G ND 
1 W6 16192T, 16223T, 16292T, 16325C G ND 
1 X 16183C, 16189C, 16223T, 16254G, 16266T, 16278T G ND 
1 X 16183C, 16189C, 16223T, 16278T, 16305G G ND 
1 X 16134T, 16189C, 16223T, 16278T G 
153G, 189G, 195C, 225A, 263G, 309.1C, 
309.1C 
1 X 16183C, 16189C, 16223T, 16278T G 193C, 195C, 198A, 225A, 263G, 315.1C 
1 X2a1 16093C, 16189C, 16223T, 16265G, 16278T, 16311C G  ND 
1 M1a1 16129A, 16183C, 16189C, 16249C, 16311C, 16359C G 195C, 263G, 315.1C 
1 M1a1 16129A, 16183C, 16189C, 16249C, 16311C, 16359C G ND 
1 M1 16129A, 16156A, 16183C, 16189C, 16223T, 16249C, 16311C G 195C, 263G, 309.1C, 315.1C 
1 M1 16129A, 16183C, 16189C, 16223T, 16249C, 16311C G 152C, 183G, 195C, 258T, 263G, 315.1C 
1 M1 16129A, 16182C, 16183C, 16189C, 16223T, 16249C, 16311C G 195C, 263G, 309.1C, 315.1C 
1 M1 16129A, 16182C, 16183C, 16189C, 16223T, 16249C, 16311C G ND 
1 M1 16129A, 16182C, 16183C, 16189C, 16249C, 16311C G ND 
1 M1 16129A, 16182C, 16183C, 16189C, 16223T, 16240G, 16249C, 16311C G 150T, 195C, 263G, 315.1C 
1 M1 16129A, 16183C, 16189C, 16223T, 16264T, 16311C, 16359C  G ND 
1 M1 16183C, 16189C, 16223T, 16249C, 16260T, 16311C, 16320T G ND 
1 M1a1 16129A, 16183C, 16189C, 16223T, 16311C, 16359C G ND 
1 M1a1 16129A, 16153A, 16183C, 16189C, 16214A, 16223T, 16249C, 16311C, 16359C G 152C, 195C, 235G, 263G, 309.1C, 315.1C 
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Table 4.4: (Continued)  
 
 
# Individuals
(a)
 Haplogroup
(b)
 HVI haplotype (16024−16365)
(c)
 
Nucleotide at 
postion 73 
HVII haplotype (74−340)
(c,d)
 
1 M9 16223T, 16362C G ND 
1 L3b 16124C, 16223T, 16278T, 16362C G ND 
1 L3c 16223T, 16311C, 16362C G ND 
1 L3e1 16210G, 16223T, 16292T, 16327T G ND 
1 L3e1 16111T, 16167T, 16223T, 16327T G ND 
1 L3e2 16093C, 16126C, 16223T, 16299G, 16320T G ND 
1 L3e2 16223T, 16286T, 16320T G ND 
1 L3f1b 16209C, 16223T, 16292T, 16311C G 189G, 200G, 207A, 263G, 309.1C, 315.1C 
1 L3f1b 16189C, 16209C, 16223T, 16292T, 16311C G 189G, 200G, 263G, 315.1C 
1 L3f1b 16209C, 16214T, 16223T, 16292T, 16311C G 189G, 195C, 200G, 263G, 309.1C, 315.1C 
1 L3f1b 16093C, 16129A, 16148T, 16209C, 16223T, 16292T, 16311C, 16317 G 189G, 200G, 215G, 263G, 315.1C 
1 L3f1b 16209C, 16223T, 16311C G ND 
1 L3f1b 16124C, 16172C, 16209C, 16223T, 16266A, 16292T, 16311C G ND 
1 L3x1 16169T, 16189C, 16223T, 16256T, 16278T, 16311C G ND 
1 L2a 16189C, 16192T, 16223T, 16278T, 16294T, 16362C G 
143A, 146C, 152C, 195C, 263G, 309.1C, 
315.1C 
1 L2a 16189C, 16223T, 16278T, 16292T, 16294T G 
143A, 146C, 152C, 195C, 263G, 309.1C, 
315.1C 
1 L2a 16209C, 16223T, 16278T, 16294T, 16301T, 16311C, 16354T G 
143A, 146C, 152C, 189G, 195C, 263G, 
315.1C 
1 L2a 16093C, 16223T, 16278T, 16294T G 143A, 146C, 152C, 195C, 263G, 315.1C  
1 L2a 16189C, 16192T, 16223T, 16278T, 16294T G 
143A, 146C, 152C, 195C, 263G, 309.1C, 
315.1C 
1 L2a 16213A, 16223T, 16249C, 16265G, 16278T, 16294T G ND 
1 L2a 
16129A, 16182C, 16183C, 16189C, 16215G, 16223T, 16231C, 16278T, 16294T, 
16311C, 16355T 
G ND 
1 L2a 16223T, 16278T, 16294T, 16390A G ND 
1 L2a1 16169T, 16223T, 16239T, 16278T, 16294T, 16309G G 
143A, 146C, 152C, 189G, 195C, 263G, 
315.1C 
1 L2a1 16223T, 16278T, 16294T, 16309G G ND 
1 L2a1 16189C, 16192T, 16223T, 16278T, 16292T, 16294T, 16309G G 143A, 146C, 152C, 195C, 263G, 315.1C  
1 L2a1 16189C, 16192T, 16223T, 16278T, 16292T, 16294T, 16309G G ND 
1 L2a1 16189C, 16192T, 16223T, 16278T, 16294T, 16309G G ND 
1 L2a1 16093C, 16189C, 16223T, 16278T, 16294T, 16309G G ND 
1 L2a1 16093C, 16124C, 16189C, 16223T, 16278T, 16294T, 16309G G ND 
1 L2a1c1 16086C, 16189C, 16192T, 16223T, 16278T, 16294T G ND 
1 L2a1c1 16086C, 16189C,16223T, 16278T, 16294T G ND 
1 L2b 16129A, 16189C, 16213G, 16215A, 16223T, 16278T, 16311C G ND 
1 L4 
16129A, 16207T, 16166G, 16183d, 16187C, 16188T, 16223T, 16278T, 16355T, 
16362C. 
G ND 
1 L6 16048A, 16223T, 16224C, 16278T, 16311C G ND 
1 L2 16182C, 16183C, 16189C, 16223T, 16278T G 146C, 153G, 156T, 263G, 315.1C 
1 N3* 16182C, 16183C, 16189C, 16210G, 16224C, 16309G G  ND 
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Table 4.4: (Continued) 
 
 
 
# Individuals
(a)
 Haplogroup
(b)
 HVI haplotype (16024−16365)
(c)
 
Nucleotide at 
postion 73 
HVII haplotype (74−340)
(c,d)
 
1 L1b 16126C, 16187T, 16189C, 16223T, 16264T, 16270T, 16278T, 16293G, 16311C G 152C, 182T, 185T,189G,195C, 263G, 
3096.1C, 315.1C 
1 L0a 
16129A, 16148T, 16168T, 16172C, 16187T, 16188G, 16189C, 16223C, 16230G, 
16311C, 16320T 
A 
93G, 99G, 152C, 185A, 189G, 236C, 247A, 
263G, 315.1C 
1 L0a 
16129A, 16148T, 16168T, 16172C, 16187T, 16188G, 16189C, 16223T, 16230G, 
16278T, 16293G, 16311C, 16320T 
A 
93G, 95C, 185A, 189G, 236C, 247A, 263G, 
315.1C 
1 L0a 
16129A, 16148T, 16168T, 16172C, 16187T, 16188G, 16189C, 16223T, 16230G, 
16311C, 16320T, 16362C 
A ND 
1 L0a1c 
16148T, 16168T, 16172C, 16187T, 16188G, 16189C, 16223T, 16230G, 16287T, 
16293G, 16311C, 16320T 
A ND 
1 L0b 
16051G, 16129A, 16148T, 16164G, 16172C, 16173T, 16182T, 16183C, 16189C, 
16207G, 16209C, 16230G, 16278T, 16311C 
A ND 
      
(a) 
Number of individuals that shared the same mitochondrial haplotype within the studied population group.   
(b) 
Mitochondrial haplogroup assignment was performed primarily using the simple tree of the Genebase mtDNA Haplogroup Reference Guide_ April 2008 (V2.6) 
available at (www8) and then higher resolution of the haplogroup assignment was obtained via the Global human mtDNA phylogenetic tree_ Build 8 available at 
(www6). Haplogroup R0 was diagnosed whenever an adenosine base was detected at nt73 with absence of all other haplogroup specific mutations.  
(c) 
Haplotypes were annotated following the phylogenetic alignment method and the polymorphic sites were numbered according to the revised version of the CRS 
(accession number NC_012920). The suffixes A, G, C, and T indicate substitutions and d indicates a deletion. Insertions are indicated by a dot followed by the 
number and type of inserted nucleotide. Shown in blue are substitutions observed outside the specified HVI region. Shown in green is a substitution detected outside 
the specified HVII extension. Sequences that had no mutations in the HVI sequenced region compared with the reference sequence are labelled as CRS. 
Characteristic mutations for each haplogroup are shown in bold and italic.  
(d)
 ND means complete HVII sequence between the nucleotides 73−340 was not determined for that sample. 
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4.2.2.5 Statistical analysis  
 
To estimate the mitochondrial diversity and heterogeneity among the studied population group, 
statistical analysis of the hypervariable regions data was performed. Diversity indices included 
number of haplotypes, number of polymorphic sites, random match probability (RMP) and genetic 
diversity. The probability of randomly selecting two unrelated individuals with the same 
mitochondrial haplotype (RMP) was calculated using the equation p=∑x2, where x is the 
frequency of each mtDNA haplotype (Stoneking et al. 1991). It was found that the random match 
probability among the Egyptian population sample was relatively high when HVI and HVII data 
were analysed individually giving values of 2.34% and 3.22%, respectively, whereas combination 
of the two data sets significantly reduced the RMP to 1.28%. The genetic diversity in the 
mitochondrial hypervariable regions was calculated using the algorithm h= n(1−∑x2 )/(n−1), where 
n is the sample size and x is the frequency of each mtDNA haplotype (Nei and Tajima 1981). High 
genetic diversity (0.9911) was reported in the Egyptian population sample (n=261) when 
combined HVI and HVII data were analysed. Slightly lower diversities (0.9804 and 0.9803) were 
reported when HVI and HVII data were analysed individually. When complete HVI and HVII data 
were available (n=78), the genetic diversity was high (1.0000) (Table 4.5).  
 
Table 4.5: Diversity indices of the mitochondrial hypervariable region obtained by analysis of 
mtDNA sequences in an Egyptian population sample (n=261).  
  
Population Statistic 
HVI 
(16024-16365) 
(n=261) 
HVII  
(73-340) 
(n=78) 
HVI+HVII 
(n=78) 
Combined 
data (n=261)*  
Number of haplotypes  187 (36 shared) 62 (11 shared) 78 (0 shared) 207 (24 shared) 
Number of polymorphic 
sites 
113 42 120 155 
Random match 
probability 
2.34% 3.22% 1.28% 1.28% 
Genetic diversity 0.9804 0.9803 1.0000 0.9911 
 
* Included complete HVI sequences (16024-16365) and the nucleotide position 73 in all samples (n=261) 
combined with HVII sequences (73-340) in 30% of samples (n=78). 
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4.2.3 Mitochondrial haplogroup designation  
 
Mitochondrial DNA sequences (n=261) were all assigned to known mitochondrial 
haplogroups. The assignment was primarily performed according to the most updated 
global human mtDNA phylogenetic tree Build 8 (Van Oven and Kayser 2009) and 
guided by the haplogroup reference guide provided by the Genebase at (www8). Some 
haplogroups were easily diagnosed using HVI data (16024-16365) obtained by direct 
sequencing (particularly haplogroups L, M, N1a, N1b, U, K, J, T, R0a, and HV1), while 
in others, HVII information was required to confirm the haplogroup designation. 
Sequences that did not show any of the previously reported haplogroup specific 
mutations in the HVI region were allocated to haplogroup R0 or haplogroup R* 
according to the nucleotide base at position 73 either adenosine or guanosine, 
respectively (Table 4.4). Classified sequences were checked against the previously 
reported data sets from different population studies (Watson et al. 1997; Maca-Meyer et 
al. 2001; Kivisild et al. 2004; Salas et al. 2004; Behar et al. 2008a; Saunier et al. 2009). 
The haplogroup assignment of the mtDNA sequences based on the hypervariable region 
sequencing information was further confirmed and refined into sub-haplogroups via 
PCR-RFLP analysis of the mitochondrial genome, after which the frequency 
distribution of the different mitochondrial haplogroups in the studied population group 
was concluded (see Chapter 5). 
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4.2.4 Meta-analysis  
  
HVI sequencing data obtained from the present study was combined with two 
previously published Egyptian mtDNA sequence databases of 58 individuals from 
Gurna and Upper Egypt (Stevanovitch et al. 2004) and 277 individuals from Alexandria 
(Saunier et al. 2009). A database of 596 Egyptian HVI sequences (nt16024-16365) was 
generated. Overall, a total of 139 polymorphic sites were reported at the specified 
mitochondrial HVI region in the combined dataset. All the detected polymorphisms 
were previously reported in the mitochondrial DNA databases. These polymorphic sites 
varied greatly in their frequencies in the analysed sequences, ranging from occurring in 
1 individual to 234 individuals. Sites that showed the highest variability in the HVI 
region of the Egyptian mtDNA sequences, found in more than 10% of individuals, 
included 16126, 16129, 16183, 16189, 16223, 16278, 16294, and 16311. 
Approximately 23% of the reported polymorphisms (n=32) were found only once in the 
combined database of 596 Egyptian mtDNA sequences, and thus can be considered 
haplotype specific. Such unique polymorphisms increase the power of discrimination 
and provide a useful tool for individual identification (Table 4.6). 
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Table 4.6: Mitochondrial DNA polymorphic sites and frequencies reported in a combined dataset of 
596 Egyptian mitochondrial HVI sequences (nt16024-16365). Sites were numbered according to the 
Cambridge Reference Sequence numbering system (Andrews et al. 1999). N is the number of individuals in 
which the polymorphisms were detected and the frequency percentages are shown between brackets. 
Meta-analysis involved 261 HVI sequences from the present study, 277 sequences from Saunier et al. 
(2009), and 58  sequences from Stevanovitch et al. (2004). 
       N                                    
(Frequency %) 
Polymorphic 
site 
      N           
(Frequency %) 
Polymorphic 
site 
     N       
(Frequency %) 
Polymorphic 
site 
234 (39.26) 16223 10 (1.68) 16291 3 (0.50) 16239 
182 (30.54) 16189 10 16304 3 16240 
176 (29.53) 16311 10 16360 3 16254 
129 (21.64) 16126 9 (1.51) 16086 3 16287 
102 (17.11) 16294 9 16111 3 16288 
94 (15.77) 16129 9 16166 3 16290 
90 (15.10) 16183 9 16274 2 (0.34) 16164 
77 (12.92) 16278 9 16300 2 16221 
56 (9.40) 16362 9 16324 2 16295 
52 (8.72) 16172 9 16356 2 16299 
52 16292 8 (1.34) 16147 2 16316 
48 (8.05) 16249 8 16219 2 16344 
37 (6.21) 16093 8 16234 2 16357 
37 16209 8 16264 1 (0.17) 16048 
36 (6.04) 16069 8 16266 1 16066 
36 16187 8 16298 1 16081 
32 (5.37) 16145 7 (1.17) 16265 1 16085 
30 (5.03) 16224 7 16319 1 16092 
28 (4.70) 16192 7 16354 1 16096 
27 (4.53) 16163 6 (1.01) 16167 1 16107 
27 16186 6 16179 1 16114 
26 (4.36) 16176 6 16215 1 16120 
26 16182 6 16222 1 16123 
26 16296 6 16260 1 16131 
26 16320 6 16271 1 16137 
24 (4.03) 16148 6 16291 1 16138 
24 16270 6 16301 1 16140 
23 (3.86) 16309 6 16318 1 16156 
23 16359 5 (0.84) 16051 1 16173 
21 (3.52) 16168 5 16214 1 16201 
19 (3.19) 16067 5 16231 1 16229 
19 16256 5 16248 1 16233 
19 16343 5 16286 1 16235 
17 (2.85) 16355 4 (0.67) 16136 1 16243 
16 (2.68) 16188 4 16146 1 16245 
16 16261 4 16150 1 16259 
15 (2.52) 16230 4 16184 1 16269 
15 16327 4 16213 1 16305 
13 (2.18) 16193 4 16325 1 16313 
13 16293 3 (0.50) 16037 1 16317 
12 (2.01) 16104 3 16041 1 16321 
12 16124 3 16134 1 16335 
12 16153 3 16139 1 16337 
12 16169 3 16171 1 16352 
12 16218 3 16174 1 16365 
11 (1.85) 16210 3 16195   
10 (1.68) 16181 3 16207   
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The aforementioned mitochondrial DNA polymorphisms identified 384 different 
mitochondrial HVI haplotypes in the combined dataset, of which 306 (~80%) were 
unique to single individuals. Thus, analysis of the mitochondrial HVI sequences 
(nt16024-16365) solely enabled unique identification in 306 individuals. Such a large 
number of unique haplotypes indicates high mtDNA diversity in the Egyptian 
population and validates the utility of the mitochondrial HVI region analysis for human 
identification purposes. The remaining 78 haplotypes were reported in multiple 
individuals, of which 43 haplotypes were shared by 2 individuals and 11 haplotypes 
were shared by 3 individuals (Table 4.7). The most frequently reported mitochondrial 
DNA haplotype, seen in 40 Egyptians, was identical to the CRS in the specified HVI 
region. Mitochondrial HVI haplotypes shared by multiple individuals (n=78) were 
identified and their frequencies were determined in the three Egyptian mitochondrial 
DNA datasets individually and in combination (Table 4.8). The estimated random 
match probability and genetic diversity in the combined Egyptian dataset of 596 HVI 
haplotypes (nt16024-16365) were 2.08% and 0.9808, respectively. 
 
Table 4.7: Distribution of the mitochondrial DNA HVI haplotypes (nt16024-16365) in a 
combined Egyptian dataset of 596 individuals. HVI sequences were obtained from the 
present study (n=261) and two previously published Egyptian datasets of 58 individuals from 
Gurna and Upper Egypt (Stevanovitch et al. 2004) and 277 individuals from Alexandria (Saunier 
et al. 2009). 
 
 
 
Number of HVI 
haplotypes 
Number of individuals  
sharing the same haplotype 
Total number of 
individuals 
306 1 306 
43 2 86 
11 3 33 
11 4 44 
4 5 20 
1 6 6 
3 7 21 
2 8 16 
1 9 9 
1 15 15 
1 40 40 
Total= 384  Total= 596 
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Table 4.8: Mitochondrial DNA HVI haplotypes repeatedly reported in a combined dataset of 596 Egyptian mitochondrial HVI sequences (nt16024-16365). 
Data were obtained from the present study (n=261) and two previously published mitochondrial DNA datasets of 277 (Saunier et al. 2009) and 58 (Stevanovitch et 
al. 2004) Egyptian individuals. Numbers of individuals sharing the same haplotypes were determined in both the individual databases as well as the combined 
dataset. 
 
Haplogroup
(a)
 HVI haplotype (16024−16365)
(b)
 
Present study 
(n=261) 
Alexandria 
(n=277)
(c)
 
Gurna and 
Upper Egypt 
(n=58)
(d)
 
Combined dataset 
(n=596) 
R0 CRS 19 19 2 40 
N1b 16145A, 16176G, 16223T 7 5 3 15 
L3f1b 16209C, 16223T, 16292T, 16311C 6 3 0 9 
HV1 16067T 3 5 0 8 
U5a 16192T, 16256T, 16270T 8 0 0 8 
R0 16104T, 16181C, 16182C, 16183C, 16189C 2 5 0 7 
U3 16343G. 2 4 1 7 
M1 16129A, 16183C, 16189C, 16223T, 16249C, 16311C, 16359C 2 5 0 7 
T1a 16126C, 16163G, 16186T, 16189C, 16294T 4 2 0 6 
J 16069T, 16126C 2 2 1 5 
M1 16129A, 16183C, 16189C, 16249C, 16311C 3 2 0 5 
K1a1a 16093C,16224C, 16311C 2 2 1 5 
I 16129A, 16223T, 16391A 0 4 1 5 
H6 16362C 0 4 0 4 
T1a 16126C, 16163G, 16186T, 16189C, 16274A, 16294T 3 1 0 4 
T 16126C, 16294T 2 2 0 4 
J 16069T, 16126C, 16311C 1 3 0 4 
K 16224C, 16311C 2 2 0 4 
M1a1 16129A, 16183C, 16189C, 16249C, 16311C, 16359C 2 2 0 4 
M1 16129A, 16182C, 16183C, 16189C, 16223T, 16249C, 16311C 2 2 0 4 
M1 16129A, 16189C, 16223T, 16249C, 16311C, 16359C 0 3 1 4 
L0a1b 
16129A, 16148T, 16168T, 16172C, 16187T, 16188, 16189C, 16223C, 16230G, 16311C, 
16320T 
1 0 3 
4 
L1b 16126C, 16187T, 16189C, 16223T, 16264T, 16270T, 16278T, 16293G, 16311C 4 0 0 4 
L2a1 16189C, 16192T, 16223T, 16278T, 16292T, 16294T, 16309G 2 2 0 4 
R0 16145A, 16150T, 16218T 0 3 0 3 
R0 16218T 1 2 0 3 
R 16223T 2 1 0 3 
HV1 16067T, 16183G, 16327A 2 1 0 3 
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Table 4.8: (Continued).     
Haplogroup
(a)
 HVI haplotype (16024−16365)
(b)
 
Present study 
(n=261) 
Alexandria 
(n=277)
(c)
 
Gurna and 
Upper Egypt 
(n=58)
(d)
 
Combined dataset 
(n=596) 
T1a 16111A, 16126C, 16163G, 16186T, 16189C, 16294T 2 1 0 3 
T2 16126C, 16294T, 16296T, 16324C 1 1 1 3 
N1a 16147G, 16172C, 16223T, 16248T, 16311C, 16355T 0 2 1 3 
M1 16183C, 16189C, 16223T, 16249C, 16260T, 16311C, 16320T 1 2 0 3 
M1a1 16129A, 16183C, 16189C, 16223T, 16311C, 16359C 1 1 1 3 
L3c 16223T, 16311C, 16362C 1 1 1 3 
L3f1b 16189C, 16209C, 16223T, 16292T, 16311C 1 2 0 3 
H2a1 16354T 0 2 0 2 
HV1 16067T, 16356C 0 2 0 2 
R0 16355T, 16362C 0 2 0 2 
R0 16166G, 16189C,16304C 2 0 0 2 
R0 16129A 2 0 0 2 
R0 16356C 2 0 0 2 
R0 16210G, 16224C, 16292T 2 0 0 2 
R0 16218T, 16291T 1 1 0 2 
R0a 16126C, 16362C 1 1 0 2 
R0a 16126C, 16192A, 16278T, 16362C 1 1 0 2 
R0a 16126C, 16271C, 16291T, 16362C 2 0 0 2 
R0a 16126C, 16304C, 16362C 0 2 0 2 
R0a1a  16126C, 16355T, 16362C 2 0 0 2 
R11'B 16183C, 16189C, 16223T, 16311C. 2 0 0 2 
R* 16129A, 16183C, 16189C, 16215G 0 2 0 2 
J 16069T, 16126C, 16169T. 1 1 0 2 
J1 16069T, 16126C, 16249C, 16261T, 16311C 2 0 0 2 
J1 16069T, 16126C, 16193T, 16300G 0 2 0 2 
J1b1 16069T, 16126C, 16145A, 16172C, 16222T, 16261T 0 2 0 2 
T 16126C, 16294T 0 2 0 2 
T2 16126C, 16146G, 16147T, 16171T, 16292T, 16294T, 16296T 0 2 0 2 
T2 16126C, 16153A, 16294T, 16296T 0 2 0 2 
T2c 16126C, 16292T, 16294T, 16296T 1 1 0 2 
T2c 16126C, 16292T, 16294T 2 0 0 2 
T1a 16126C, 16139, 16163G, 16186T, 16189C, 16294T. 2 0 0 2 
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Table 4.8: (Continued).     
Haplogroup
(a)
 HVI haplotype (16024−16365)
(b)
 
Present study 
(n=261) 
Alexandria 
(n=277)
(c)
 
Gurna and 
Upper Egypt 
(n=58)
(d)
 
Combined dataset 
(n=596) 
U3 16184T, 16319A, 16343G 0 2 0 2 
U4 16261, 16356 0 0 2 2 
U6a 16172C, 16219G, 16278T. 1 1 0 2 
U7 16309G, 16318T, 16362C 1 1 0 2 
U8b 16179T, 16183C, 16189C, 16234T, 16324C 2 0 0 2 
K 16174T, 16224C, 16311C 1 1 0 2 
K1a 16176T, 16224C, 16311C 0 2 0 2 
I 16093, 16129, 16223 0 0 2 2 
I1 16129A, 16223T, 16311C 1 1 0 2 
M1 16183C, 16189C, 16249C, 16311C, 16327T 2 0 0 2 
L1c2 
16093C, 16129A, 16187T, 16189C, 16223T, 16265C, 16278T, 16286G, 16294T, 16311C, 
16320T, 16360T 0 2 0 2 
L1c3 16093C, 16129A, 16183C, 16189C, 16215G, 16223T, 16278T, 16294T, 16311C, 16360T 0 2 0 2 
L2a 16189C, 16192T, 16223T, 16278T, 16294T 1 1 0 2 
L2a1 16189C, 16223T, 16278T, 16294T, 16309G 0 2 0 2 
L3e2 16223T, 16320T 2 0 0 2 
L3f1b 16172C, 16209C, 16223T, 16292T, 16311C 2 0 0 2 
L3d 16111T, 16124C, 16223T 0 2 0 2 
L3* 16169, 16193, 16195, 16266, 16301 0 0 2 2 
 
(a) 
Mitochondrial haplogroup assignment was performed primarily using the simple tree of the Genebase mtDNA Haplogroup Reference Guide_ April 2008 (V2.6) 
available at (www8) and then higher resolution of the haplogroup assignment was obtained via the Global human mtDNA phylogenetic tree_ Build 8 available at 
(www6). Haplogroup R0 was diagnosed whenever an adenosine base was detected at nt73 with absence of all other haplogroup specific mutations.  
(b) 
Haplotypes were annotated following the phylogenetic alignment method and the polymorphic sites were numbered according to the revised version of the CRS 
(accession number NC_012920). The suffixes A, G, C, and T indicate substitutions.  
(c) Data obtained from Saunier et al. (2009). 
(d) Data obtained from Stevanovitch et al. (2004) in which the polymorphic sites were reported without specifying the nucleotide variations. 
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4.3 Discussion 
 
Mitochondrial DNA has long been used for the human identification and population 
genetics due to its peculiar characteristic advantages over the nuclear genome, including 
the high copy number in each somatic cell, the maternal mode of inheritance with non-
recombination characteristics and the high mutation rate. The mitochondrial DNA 
database is currently enriched with over six thousand complete mtDNA sequences and 
is continuously growing. However, the current database does not include equivalent 
representatives of all populations and ethnic groupings, those of African descent are 
currently underrepresented compared to European and Asian populations. Egypt has a 
characteristic geographic location among three continents: Africa, Asia, and Europe and 
thus its population structure might have been affected by several waves of modern 
human migration in and out of Africa (Coudray et al. 2009). In addition, Egypt has been 
ruled by several populations throughout its vast history including the Greeks, Romans, 
Arabs, Turks, French and British (Saunier et al. 2009). Therefore, admixture between 
the original Egyptian population and all the previous ruling populations was expected to 
occur and subsequently to affect the genetic structure of present day Egyptians. The 
present study investigated the mitochondrial diversity and heterogeneity among 261 
adult Egyptians (randomly selected and therefore thought to be maternally unrelated) 
through analysis of the mitochondrial hypervariable regions which have been 
extensively investigated in many other population groups.        
 
4.3.1 Rapid  PCR 
 
The present study developed an optimised laboratory protocol for rapid PCR 
amplification of the mitochondrial hypervariable regions from blood samples stored on 
FTA cards (Whatman). This protocol involved the use of newly designed long 
oligonucleotides (~30mer) which enabled combination of annealing and extension steps 
at 72
o
C and thus to shift from a three-step PCR protocol to a two-step one. The PCR 
thermal cyclic conditions were also optimised to further reduce the amplification time. 
The final optimised protocol allowed the amplification reaction to be completed in a 
short period of time (30 mins) compared to the 2-3 hours conventional PCR program. 
This rapid PCR amplification has proven to be a reliable and easily reproducible 
procedure for dealing with a large number of samples in a short period of time and thus 
it has a direct application in population studies which require high throughput analyses. 
The robustness of the rapid PCR technique can be verified by comparing sequence 
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quality of amplicons produced by this protocol to those produced via conventional PCR 
programs. Such a rapid PCR protocol has a direct impact on forensic investigations in 
which the time is an important factor. It can also play an effective role in forensic 
science undergraduate laboratories.  
 
4.3.2 Sequence variations in the mitochondrial hypervariable regions  
  
The present study involved analysis of the mitochondrial DNA variations in an 
Egyptian population sample (n=261) collected from Alexandria, which is the second 
largest city in Egypt residing on Egypt‟s north coast bordering the Mediterranean Sea 
and representing the major seaport connecting the country to Europe and Asia. Analysis 
of the mitochondrial hypervariable region sequences has revealed a large number of 
sequence variations relative to the Cambridge Reference Sequence (CRS) in both the 
HVI and HVII regions of the mitochondrial genome. Overall, a total of 113 
polymorphic sites were reported in 261 mitochondrial HVI sequences (16024-16365) at 
varying frequencies. The average number of times for a variable character to occur was 
9.2, which is higher than the average reported in other populations such as the U.S and 
European Caucasians (6.7) (Allard et al. 2002) and East Asian populations (4.5) (Allard 
et al. 2004). Sites that showed the higher rate of variations, seen in 20 individuals or 
more, included nucleotides 16126, 16129, 16172, 16183, 16189, 16223, 16249, 16278, 
16292, 16294, 16311, and 16362. All these sites (except 16126, 16223, 16249, and 
16294) were previously reported with a high rate of variability in the SWGDAM 
mtDNA dataset of 1771 U.S and European Caucasians (Allard et al. 2002). All these 
sites (except 16249) were previously described as mutational hotspots in the human 
evolutionary studies (Stoneking et al. 1991; Wakeley 1993; Meyer et al. 1999). Among 
78 HVII sequences (73-340), a total of 42 polymorphic sites were reported with varying 
frequencies. An A to G mutation at position 263 was detected in all HVII sequences, 
this finding is not surprising as occurrence of adenosine at that position is a specific 
character to the CRS (Finnila et al. 2001b; Maca-Meyer et al. 2001). The next common 
polymorphic sites reported in HVII region were 73, 146, 152, 195, and 303-315 
occurring in 20 individuals or more. These findings are fully consistent with other 
population studies which involved analysis of the mitochondrial HVII sequence 
variations (Allard et al. 2002; Poetsch et al. 2003; Barbosa et al. 2008).  
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4.3.3 Mitochondrial haplotype analysis  
  
In the present study, a database of 261 Egyptian mitochondrial hypervariable region 
sequences was established. A total of 187 HVI haplotypes were identified with a 
percentage number of haplotypes K (number of haplotypes/number of samples) 72%. 
This percentage of haplotypes based on HVI analysis is slightly low compared to 
previous studies which involved 68 Egyptians from Mansoura and Asuit (K=85%) 
(Krings et al. 1999) and 34 from Gurna (K=88%) (Stevanovitch et al. 2004). However, 
this difference can be easily attributed to the small sample size in the previous studies. 
Other population studies which involved HVI analysis in a relatively similar sample 
size have reported much lower haplotype percentages, 64% in Singapore Malays (Wong 
et al. 2007) and 63% in Japanese population (Asari et al. 2007). Analysis of HVII in 78 
individuals revealed 62 haplotypes with a percentage (K) 79%. When combined with 
HVI data for those individuals, the total number of haplotypes increased to 78 giving a 
percentage (K) 100%. Such a high haplotype percentage was not previously reported in 
any other population studies and it indicates a very high level of diversity in the studied 
population group. Merging of the available HVII data (n=78) with the full set of HVI 
sequences (n=261) increased the overall number of mtDNA haplotypes characterised in 
the present study to 207 giving a haplotype percentage (K) of 79%. However, this 
percentage is not to be compared to other studies because the HVII sequences were not 
determined for all samples. Approximately 81% (151) and 82% (51) of the reported 
HVI and HVII haplotypes, respectively, were unique to single individuals. The other 
haplotypes were shared between multiple individuals. The most frequently reported 
HVI haplotype, seen in 19 individuals out of 261, was identical to the CRS between the 
nucleotides (16024-16365). Consistent results were reported by a coincident study, 
which involved analysis of the control region in 277 Egyptians, where they reported the 
same highly frequent haplotype (identical to the CRS in the specified HVI region) in 19 
individuals (Saunier et al. 2009). A similar finding was also previously reported in the 
North of Portugal (Lima et al. 2006).  
 
4.3.4 Diversity indices 
 
Diversity measures were estimated based on the HVI and HVII data individually and in 
combination. The random match probability of the HVI and HVII haplotypes were 
estimated to be 2.34% and 3.22%, respectively. Similar values were reported in a 
previous study which involved analysis of the mtDNA variations in 124 Japanese 
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individuals, where the estimated RMP was 2.24% and 2.68% for HVI and HVII, 
respectively (Mabuchi et al. 2007). A higher RMP (4.2%) was reported among 142 HVI 
haplotypes from the North of Portugal (Lima et al. 2006), whereas lower values (1.25% 
and 1.57%) were reported in 167 HVI and HVII Brazilian haplotypes, respectively 
(Barbosa et al. 2008). In the present study, combination of HVI and HVII sequencing 
data of 78 individuals reduced the RMP to 1.28%, which is in the average of many other 
population studies that reported values of 1% (Banerjee et al. 2005; Egyed et al. 2007) 
and 1.29% (Lima et al. 2006). Compared to other North African populations, the 
estimated RMP in the present study is significantly lower than the those reported in 64 
Tunisians (2.1%) and 56 Moroccans (2.1%) (Turchi et al. 2009). However, a much 
lower RMP value was recently reported in 277 Egyptians (0.49%) which can be 
attributed to the analysis of the whole extension of the control region between the 
nucleotides 16024-576 compared to analysis of the individual HVI and HVII regions 
performed in the present study (Saunier et al. 2009). The genetic diversity h was 
estimated as 0.9804 and 0.9803 for HVI and HVII, respectively. These values are very 
similar to other population studies in which the statistical analysis of the HVI and HVII 
data was performed individually (Asari et al. 2007; Mabuchi et al. 2007). When HVI 
and HVII data were combined in the present study (n=78), the genetic diversity was 
estimated to be 1.0000 which is comparable to the diversity reported in the previous 
Egyptian database of 277 individuals which was estimated to be 0.9986 (Saunier et al. 
2009). Similar sequence diversity values were reported in Jordanian population 
(Gonzalez et al. 2008), European populations (Poetsch et al. 2003; Lima et al. 2006), 
Asian populations (Imaizumi et al. 2002; Asari et al. 2007; Wong et al. 2007) and Brazil 
(Barbosa et al. 2008). For the combined HVI database (n=596), the estimated genetic 
diversity was 0.9808 which is very similar to the values reported in the Japanese 
population (Asari et al. 2007) and in the North of Portugal (Lima et al. 2006). Based on 
the general agreement regarding the high mtDNA diversity in Africa compared to other 
areas of the world (Jorde et al. 2000), it was expected to detect higher mitochondrial 
DNA diversity indices in the Egyptian population compared to European and Asian 
populations, but that did not occur. Unfortunately, most of the mitochondrial DNA 
population studies which involved characterisation of nucleotide variations in the 
mitochondrial hypervariable regions and estimation of the genetic diversity were more 
concerned with populations outside Africa, which did not allow a comparison between 
the mitochondrial genetic diversity in the Egyptian population and other populations in 
Africa. 
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4.3.5 Conclusion 
 
An optimised laboratory protocol for rapid PCR amplification of the mitochondrial 
hypervariable regions was developed. This rapid PCR has a direct impact on forensic 
investigations as well as forensic science undergraduate laboratories. A database of 261 
Egyptian mitochondrial HVI sequences (nt16024-16365) was established. This database 
contained a total of 113 polymorphic sites, of which those with higher frequencies were 
determined. A total of 187 HVI haplotypes were identified, of which 151 (~81%) were 
unique to single individuals. The most frequently reported HVI haplotype was identical 
to the Cambridge Reference Sequence at the specified HVI region. For a subset of 78 
Egyptian individuals, both HVI (nt16024-16365) and HVII (nt73-340) haplotypes were 
determined and no shared mitochondrial haplotypes were reported. These findings 
confirm that sequence polymorphism of the control region of the human mtDNA could 
be highly informative in forensic casework, particularly when HVI and HVII data 
combined together which increases the power of discrimination. The genetic diversity h 
was estimated to be 0.9804 and 0.9803 for HVI and HVII respectively.  The probability 
of two random individuals to have the same HVI haplotypes or HVII haplotypes were 
determined at 2.34% and 3.22% respectively. Overall, a diverse genetic structure of the 
Egyptian population was reported via detection of a large number of unique HVI 
haplotypes. 
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5. PCR-RFLP SCREENING OF THE WHOLE 
MITOCHONDRIAL GENOME IN THE EGYPTIAN 
POPULATION SAMPLE 
 
5.1 Introduction 
 
Maternally inherited mitochondrial DNA has been extensively used as a powerful tool 
for understanding the demographic history of human populations. The rapidly growing 
mtDNA database with more than six thousand complete mitochondrial DNA sequences 
available enabled further investigation of the mitochondrial nucleotide variations and 
better understanding of the phylogenetic trees of the human mitochondrial DNA. 
Numerous studies have revealed the link between certain sets of mutations and specific 
mitochondrial lineages that were found to be continental specific. These mitochondrial 
mutations represent variations relative to the Cambridge Reference Sequence of the 
mitochondrial genome which belongs to an individual of European descent, and has 
been used as the standard reference sequence in all the mitochondrial DNA population 
studies.  These mutations are distributed throughout the mitochondrial genome (~16Kb) 
including both coding and non-coding regions with particular accumulation in the non-
coding hypervariable regions. Different studies focussed on different parts of the 
molecule with little or no attention paid to the rest of it. Several mitochondrial DNA 
studies were more concerned with the nucleotide variations in the mitochondrial 
hypervariable regions, HVI and HVII and their application for identification of the 
different mtDNA lineages and their maternal ancestry. Despite being commonly used 
for differentiation between mitochondrial lineages, hypervariable region data do not 
always provide sufficient information for haplogroup identification. The nucleotide 
polymorphisms in the coding region play an essential role in the mitochondrial 
haplogroup assignment, particularly for those lineages which do not have specific 
diagnostic mutations in their hypervariable region sequences. For example, the main 
European haplogroup H can only be identified by detection of a 7028C mutation 
causing loss of AluI cut site, due to lack of any other specific markers in the 
hypervariable region. Thus, in studies which involved analysis of the hypervariable 
region sequences solely, haplogroup H was mainly identified by the absence of the 
other haplogroup specific mutations. Similarly, identification of the African subclade 
L3e can only be confirmed via detection of a T2352C mutation which produces a novel 
MboI cut site. Polymorphisms in the coding region of the mitochondrial genome are as 
important as the hypervariable region variations for accurate and reliable identification 
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of the mitochondrial DNA haplogroups. Therefore, the aim of that part of the project 
was to develop a new strategy for screening of the mitochondrial genome for the most 
informative and specific mutations using the PCR-RFLP technology for the purpose of 
mitochondrial haplogroup designation. This strategy was to be used for haplogroup 
identification of the Egyptian population (n=261) and to be validated by correlating the 
results of the FRLP screening with those obtained by hypervariable region analysis. The 
genetic structure of the Egyptian population was to be concluded based on the combined 
data from both hypervariable region analysis and mitochondrial genome RFLP 
screening. This genetic structure was to be correlated to the published population 
databases. The relative matrilineal contributions of Europeans, Asians and Africans to 
the present day Egyptians were to be determined, and thus the genetic relationship 
between Egypt and the surrounding populations was to be concluded.         
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5.2 Results 
 
5.2.1 Multiplex PCR amplification of 11Kb of the mitochondrial genome as nine 
fragments 
 
The specified nine regions (A-I) of the mitochondrial genome (Chapter 2, Figure 2.2) 
were successfully amplified from all the Egyptian blood samples (n=261) that were 
previously stored on FTA cards and processed using method 3 of the washing 
procedures (Chapter 2, Table 2.1). The amplification reaction was performed via a 
multiplex PCR which was performed in two stages: the first stage reaction involved the 
use of a 1.2-mm dried processed disc of each sample as a DNA template and nine pairs 
of primers and the second stage involved the use of the first-stage PCR product as a 
template and the region specific pair of primers (Figure 5.1). Products of the second -
stage PCR were all separated by gel electrophoresis (Figures 5.2-5.6).  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Steps of multiplex PCR amplification and RFLP analysis of the mitochondrial 
genome.  
 
 
 
 
 
 
 
 
Figure 5.2: PCR amplification products of the fragment A of the mitochondrial genome 
(nt451-827). PCR products of the fragment A (377 bp) were separated on 2% agarose gel. A 
100 bp DNA ladder was used as a molecular marker (Lane M). Lanes 1-5 show PCR products 
of five Egyptian samples. 
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Figure 5.3: PCR amplification products of four regions (B, C, E, and I) of the 
mitochondrial genome. PCR products were separated by electrophoresis on 1% agarose gel. 
A 1Kb DNA ladder was used as a molecular marker (Lane M). Lanes 1-5 show the PCR 
products of the fragment B (nt1489-2690) of five Egyptian samples with a product size of 
1202bp. Lanes 6-10 show the PCR products of the fragment C (nt3314-4732) of the same 
Egyptian samples with a product size of 1419bp. Lanes 11-15 show the PCR products of the 
fragment E (nt8024-9231) with a product size of 1208bp. Lanes 16-20 show the PCR products 
of the fragment I (nt15312-149) with a product size of 1407bp. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: PCR amplification products of fragment F and Fragment G of the 
mitochondrial genome. PCR products were separated by electrophoresis on 1% agarose gel. 
A 1Kb DNA ladder was used as a molecular marker (Lane M). Lanes 1-10 show the PCR 
products of the fragment F (nt9921-11150) of 10 Egyptian samples with a product size of 
1230bp. Lanes 11-20 show the PCR products of the fragment G (nt12077-13812) of the same 
samples with a product size of 1736bp. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5: PCR amplification products of fragment E and Fragment D of the 
mitochondrial genome. PCR products were separated by electrophoresis on 1% agarose gel. 
A 1Kb DNA ladder was used as a molecular marker (Lane M). Lanes 1-10 show the PCR 
products of the fragment E (nt8024-9231) of 10 Egyptian samples with a product size of 
1208bp. Lanes 11-20 show the PCR products of the fragment D (nt4875-7335) of the same 
samples with a product size of 2461bp. 
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Figure 5.6: PCR amplification products of the fragment H of the mitochondrial genome 
(nt14253-14857). PCR products of the fragment H (605 bp) were separated on 2% agarose gel. 
A 100 bp DNA ladder was used as a molecular marker (Lane M). Lanes 1-9 show PCR 
products of nine Egyptian samples. 
 
5.2.2 Restriction digestions of the PCR products (RFLP analysis) 
 
A pilot study was performed in order to identify what mitochondrial DNA haplogroups 
were in the Egyptian population. These preliminary experiments involved screening of 
64 Egyptian individuals for all the previously described haplogroup specific RFLP 
markers (Bailliet et al. 1994; Macaulay et al. 1999; Alves-Silva et al. 2000; Finnila et al. 
2001b; Tolk et al. 2001), which meant that the PCR products of the specified nine 
regions of the mitochondrial genome were subjected to a total of 26 restriction 
digestions for each sample.  
 
5.2.2.1 HaeIII restriction digestion of the fragment A of the mitochondrial 
genome (nt451-827) 
 
The PCR product of the fragment A (377bp) was digested with HaeIII endonuclease to 
screen for an A663G mutation which is specific to the mitochondrial haplogroup A and 
leads to gain of a new HaeIII recognition sequence.  All the screened samples lacked 
that mutation (Figure 5.7). 
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Figure 5.7: HaeIII digestion products of the fragment A of the mitochondrial genome 
(nt451-827). Digestion products were separated on 2% agarose gel by electrophoresis. A 100 
bp DNA ladder was used as a molecular marker (Lane M). Lanes 1-5 show HaeIII digestion 
products of five Egyptian samples. None of samples contained a HaeIII cut site and thus the 
PCR products remained at the same size of 377bp. 
 
5.2.2.2 DdeI and MboI restriction digestions of the fragment B of the 
mitochondrial genome (nt1489-2690) 
 
The PCR products of the fragment B (1202bp) were digested with DdeI endonuclease to 
screen for a G1719A substitution which characterises the mitochondrial haplogroups N, 
I and X2. This mutation disrupts the DdeI recognition sequence at that position and 
hence a DdeI cut site is lost (Figure 5.8). The same PCR products were digested with 
MboI endonuclease to screen for a T2352C mutation which specifies the African 
mitochondrial subclades L1b and L3e. This mutation produces a novel MboI cut site 
(Figure 5.9). 
 
 
 
 
 
 
 
 
 
 
Figure 5.8: DdeI digestion products of the fragment B of the mitochondrial genome 
(nt1489-2690). Digestion products were separated on 3.5% agarose gel. A 100 bp DNA ladder 
was used as a molecular marker (Lane M). Lanes 1-9 show DdeI digestion products of nine 
Egyptian samples. All samples (except sample in lane 5) showed identical digestion pattern to 
that of the CRS. Lane 5 showed a sample belonging to mitochondrial haplogroup N, I or X2 due 
to loss of a DdeI cut site produced by a G1719A mutation. 
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Figure 5.9: MboI digestion products of the fragment B of the mitochondrial genome 
(nt1489-2690). Digestion products were separated on 1% agarose gel. A 1Kb DNA ladder was 
used as a molecular marker (Lane M). Lanes 1-9 show MboI digestion products of nine 
Egyptian samples. All samples (except sample in lane 8) did not show any evidence of digestion 
and retained the product size of 1202bp. Lane 8 contained a sample belonging to mitochondrial 
haplogroup L1b or L3e as evidenced by a new MboI cut site resulting from a T2352C mutation 
and producing two bands of sizes 860 and 342 bp. Note full length DNA fragment in lane 8 most 
likely indicates incomplete digestion of PCR product. 
 
5.2.2.3 HpaI and NlaIII restriction digestions of the fragment C of the 
mitochondrial genome (nt3314-4732) 
 
PCR products of the fragment C (1419bp) were digested with HpaI endonuclease to 
screen for the African specific C3594T mutation which produces a new HpaI 
recognition sequence. This cut site gain is a diagnostic marker of the major African 
mitochondrial haplogroups L0, L1, L2, L5 and L6 (Figure 5.10). The same PCR 
products were digested with NlaIII endonuclease to screen for a T4216C mutation 
which is specific to mitochondrial haplogroup JT and its descendants. This mutation 
leads to a new NlaIII cut site which characteristically identifies the haplogroup JT 
(Figure 5.11). NlaIII digestion of the fragment C was also used to screen for a G4580A 
mutation which causes loss of an NlaIII cut site. This mutation is diagnostic to 
mitochondrial haplogroup V (Figure 5.11). 
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Figure 5.10: HpaI digestion products of the fragment C of the mitochondrial genome 
(nt3314-4732). Digestion products were separated on 1% agarose gel. A 1Kb DNA ladder was 
used as a molecular marker (Lane M). Lanes 1-5 show HpaI digestion products of five Egyptian 
samples. All samples (except sample in lane 2) lacked an HpaI cut site and retained the PCR 
product size of 1419bp. Sample in lane 2 belonged to one of the major African mitochondrial 
DNA haplogroups as evidenced by gain of an HpaI cut site resulting from the African specific 
C3594T mutation leading to cutting of the PCR product into two bands of sizes 1140 and 279 
bp.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11: NlaIII digestion products of the fragment C of the mitochondrial genome 
(nt3314-4732). Digestion products were separated on 2.5% agarose gel. A 100 bp DNA ladder 
was used as a molecular marker (Lane M). Lanes 1-9 show NlaIII digestion products of nine 
Egyptian samples. All samples (except samples in lanes 2, 4, and 9) showed a digestion pattern 
identical to that of the CRS. Samples in lanes 2, 4, and 9 showed an additional NlaIII cut site 
resulting from a T4216C mutation which is diagnostic to the mitochondrial haplogroup JT. None 
of samples showed loss of NlaIII cut site relative to the CRS digestion pattern which is a 
diagnostic marker of the mitochondrial haplogroup V. 
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5.2.2.4 AluI restriction digestion of the fragment D of the mitochondrial genome 
(nt4875-7335) 
 
The PCR products of the fragment D (2461bp) were digested with AluI endonuclease to 
screen for loss of AluI cut site at position 7028 which is a specific diagnostic RFLP 
marker to the mitochondrial haplogroup H to which the CRS belongs. AluI digestion 
was also used to identify haplogroup D which is characterised by a C5178A mutation 
leading to loss of AluI cut site at that position, however, none of the analysed Egyptian 
mtDNA samples showed that marker (Figure 5.12).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12: Analytical gel of AluI digestion products of the fragment D of the 
mitochondrial genome (nt4875-7335). Digestion products were separated on 8% 
polyacrylamide gel. Hyper ladder IV was used as a molecular marker (Lane M). Lanes 1-7 
showed digestion products of 7 Egyptian samples. Sample in lane 3 showed a different 
digestion pattern at the region outlined by a red box, where the 156bp band was lost and a new 
188bp band appeared due to loss of AluI cut site at 7028 and thus this sample was assigned to 
mitochondrial haplogroup H. None of samples showed the marker of haplogroup D which would 
be merging of the 408 and 186bp bands into a 594bp band. 
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Due to occurrence of several fragments that are very similar in size, the analysis of AluI 
digestion products of the fragment D was difficult and considered uncertain. To tackle 
this difficulty, a new primer was designed (Mt6067 F) and together with the original Mt 
D R reverse primer was used to amplify the modified version of the fragment D 
between the nucleotides 6067 and 7335 giving a product size of 1269bp (Figure 5.13). 
AluI digestion products of the modified fragment D were clearly separated by 
electrophoresis and unambiguously interpreted and hence, the Egyptian mtDNA 
samples were assigned to the mitochondrial haplogroup H with confidence (Figure 
5.14).      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.13: PCR amplification products of the modified version of the fragment D of the 
mitochondrial genome (nt6067-7335). PCR products of size 1269bp were separated on 1% 
agarose gel. A 1Kb DNA ladder was used as a molecular marker (Lane M). Lanes 1-9 show 
PCR products of nine Egyptian samples. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14: Analytical gel of AluI digestion products of the modified version of the 
fragment D of the mitochondrial genome (nt6067-7335). Digestion products were separated 
on 3.5% agarose gel. A 100 bp DNA ladder was used as a molecular marker (Lane M). Lanes 
1-12 show digestion products of twelve Egyptian samples. Samples labelled in red show a 
digestion pattern similar to the CRS by having the 188bp band which indicates loss of AluI cut 
site at position 7028 and thus these samples were assigned to the mitochondrial haplogroup H. 
The other samples (labelled in black) show the 156bp band which indicates that the AluI 
enzyme cut the 188bp fragment at position 7028.  
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5.2.2.5 RFLP analysis of the fragment E of the mitochondrial genome (nt8024-
9231) 
 
The PCR products of the fragment E (1208bp) contained several diagnostic RFLP 
markers. In order to screen for them all, the fragment E was individually digested with 
four endonucleases; AvaII, HaeII, HaeIII, and MboI.  AvaII and HaeIII restriction 
digestions were successfully used to screen for a G8251A mutation which characterises 
a group of mitochondrial lineages that represent direct descendants of the major macro-
haplogroup N, including N1b, N1e, I, and W. Egyptian individuals belonging to these 
mitochondrial lineages showed gain of a new AvaII cut site and loss of HaeIII cut site at 
the specified mutation position (Figures 5.15 and 5.16). HaeIII digestion also helped to 
specifically identify mitochondrial haplogroup W which is characterised by a G8994A 
mutation causing additional loss of HaeIII cut site at that position (Figure 5.16). In one 
individual (sample ID 217), the HaeIII cut site at 9025 was lost, which could be due to 
any mutation at nt9025-9028 (Figure 5.16, lane 3). A G to A mutation was previously 
reported at 9025 in the Polish population (Piechota et al. 2004) and a C9027G mutation 
was previously described in patients with MELAS syndrome (Mitochondrial Myopathy, 
Encephalopathy, Lactic Acidosis, and Strokelike Episodes) (Kobayashi et al. 1991; 
Eyre-Walker A et al. 1999).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15: AvaII digestion products of the fragment E of the mitochondrial genome 
(nt8024-9231). Digestion products were separated on 1% agarose gel. A 1Kb DNA ladder was 
used as a molecular marker (Lane M). Lanes 1-10 show digestion products of ten Egyptian 
individuals. All samples (except 8 and 9) showed evidence of an internal AvaII cut site in the 
fragment E which produced two bands of sizes 980 and 227bp and thus all these eight 
individuals were assigned to a group of N derived mitochondrial lineages including N1b, N1e, I, 
and W. The faint 1208bp bands seen in all digested samples represent some uncut products 
due to the presence of too much DNA in the PCR products as evidenced by the brightness of 
the other undigested PCR products in lanes 8 and 9. The 227bp bands ran out of the gel. 
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Figure 5.16: HaeIII digestion products of the fragment E of the mitochondrial genome 
(nt8024-9231).  Digestion products were separated on 3.5% agarose gel. A 100bp DNA ladder 
was used as a molecular marker (Lane M). In gel (a), all samples (except 3, 6, and 8) showed a 
digestion pattern identical to that of the CRS. Sample 6 showed a loss of the 228 and 141bp 
fragments which merged in a new 369bp fragment indicating loss of HaeIII cut site at position 
8251 which is a marker for haplogroups N1b, N1e, I and W. Sample 3 showed loss of the 204bp 
fragment which indicates loss of another HaeIII cut site at position 9025 but this was not a 
haplogroup specific marker. Also for sample 8 which showed an additional cut site between the 
nucleotides 8251 and 8393 by having a fragment smaller than 141bp, but this cut site again was 
not a haplogroup specific marker. In gel (b), all samples (except 6, and 8) showed a digestion 
pattern identical to that of the CRS. For samples 6 and 8, three bands (228, 156, and 141bp) 
were lost indicating loss of 2 HaeIII cut sites at 8251 and 8994 which identified those samples 
as belonging to mitochondrial haplogroup W. 
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MboI digestion of the fragment E was performed to screen for a T8618C mutation 
which identifies mitochondrial haplogroup L3d by causing loss of MboI cut sit at that 
position, however, none of the screened Egyptian samples belonged to this haplogroup. 
HaeII digestion of the fragment E was performed to differentiate between the 
mitochondrial haplogroup K and its ancestral haplogroup U. A characteristic G9055A 
mutation occurred in the mitochondrial haplogroup K and caused loss of HaeII cut site 
at that position which was considered as a diagnostic marker of this haplogroup in the 
present study (Figure 5.17).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.17: HaeII digestion products of the fragment E of the mitochondrial genome 
(nt8024-9231). Digestion products were separated on 1% agarose gel. A 1Kb DNA ladder was 
used as a molecular marker (Lane M). Lanes 1-16 showed digestion products of 16 Egyptian 
mtDNA samples. All samples (Except 1, 3, 9, and 16) showed an internal HaeII cut site in the 
fragment E as evidenced by cutting the PCR product into 2 fragments of sizes 1033 and 175bp. 
Samples 1, 3, 9, and 16 lost this HaeII cut site which was due to a G9055A mutation and hence 
they were assigned to mitochondrial haplogroup K.  
 
5.2.2.6 RFLP analysis of the fragment F of the mitochondrial genome (nt9921-
11150) 
 
The PCR products of the fragment F of the mitochondrial genome (1230bp) contained 
numerous RFLP markers which were proved to be very useful in designation of the 
different mitochondrial DNA haplogroups. Therefore, this region of the mtDNA was 
digested with four restriction enzymes individually; AluI, DdeI, HinfI, and TaqI. DdeI 
restriction digestion of the fragment F was used to classify the Egyptian mtDNA 
samples into two main categories of the mitochondrial haplogroups, one category 
included the old mitochondrial DNA lineages (African L, M, N, J and K1) and the other 
category included all the other more recently derived mitochondrial haplogroups. The 
old category was identified by having a DdeI cut site at position 10398 which was 
caused by an A10398G mutation, while those lacking this cut site were classified under 
the recent category of mitochondrial haplogroups (Figure 5.18).  
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Figure 5.18: DdeI digestion products of the fragment F of the mitochondrial genome 
(nt9921-11150). Digestion products were separated on 3.5% agarose gel. A 100bp DNA ladder 
was used as a molecular marker (Lane M). Lanes 1-12 show digestion products of twelve 
Egyptian mtDNA samples. Samples labelled in black showed a digestion pattern identical to that 
of the CRS, whereas samples in red showed an additional DdeI cut site as evidenced by the 
formation of a 238bp fragment, which was caused by an A10398G mutation, and thus were 
assigned to the category of old derived mitochondrial lineages (L, M, N, J, or K1).  
 
AluI digestion of the same region of the mtDNA was used to screen for a C10400T 
mutation which specifically characterises haplogroup M, and thus Egyptian individuals 
were assigned to mitochondrial haplogroup M when having both a DdeI cut site at 
10398 and an AluI cut site at 10400 (Figure 5.19). In addition, AluI digestion helped in 
the identification of mitochondrial haplogroup I which is characterised by a T10034C 
mutation that produces an additional diagnostic AluI cut site (Figure 5.19).  
 
 
 
 
 
 
 
 
 
 
Figure 5.19: AluI digestion products of the fragment F of the mitochondrial genome 
(nt9921-11150). Digestion products were separated on 3.5% agarose gel. A 100bp DNA ladder 
was used as a molecular marker (Lanes M). Lanes 1-8 and 9 show digestion products of nine 
Egyptian mtDNA samples. Samples 1 and 4-7 showed identical digestion pattern to that of the 
CRS while samples 2, 3, and 8 showed gain of a new AluI cut site relative to the CRS as 
evidenced by loss of the 366bp band and appearance of two new bands of sizes 203 and 
163bp. That was caused by a C10400T mutation, and thus these samples were assigned to 
mitochondrial haplogroup M. Sample 9 showed a different digestion pattern resulting from a 
T10034C mutation which produced a new AluI cut site that split the 313bp band into 202 and 
111bp bands and thus, it was assigned to haplogroup I. 
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To further aid the haplogroup assignment of the Egyptian mtDNA samples, the PCR 
products containing fragment F was digested with HinfI endonuclease. The African 
mitochondrial haplogroup L5 was identified when an additional HinfI cut site relative to 
the CRS was detected at position 10806 which was caused by a T10810C mutation 
(Figure 5.20). TaqI restriction digestion of the fragment F was performed to screen for 
an A10086G mutation which characterises mitochondrial haplogroup L3b, however, 
none of the screened Egyptian individuals showed that marker. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.20: HinfI digestion products of the fragment F of the mitochondrial genome 
(nt9921-11150). Digestion products were separated on 2.5% agarose gel. A 100bp DNA ladder 
was used as a molecular marker (Lane M). Lanes 1-7 show digestion products of seven 
Egyptian samples. All samples (except 1 and 5) showed a digestion pattern identical to that of 
the CRS. Samples 1 and 5 showed an additional HinfI cut site as evidenced by the production 
of a 368bp fragment which was caused by a T10810C mutation. Hence, these two samples 
were assigned to mitochondrial haplogroup L5. 
 
5.2.2.7 RFLP analysis of the fragment G of the mitochondrial genome (nt12077-
13812) 
 
The PCR products of the fragment G (1736bp) was digested with three restriction 
enzymes individually; AluI, BamHI, and HincII. To screen for a G13368A mutation 
which characterises mitochondrial haplogroup T, BamHI digestion was performed. 
Samples that showed an evidence of BamHI cut were assigned to haplogroup T (Figure 
5.21). Both AluI and HincII restriction digestions were performed to screen for an 
A13263G mutation which identifies mitochondrial haplogroup C. Such a mutation 
produces a novel AluI cut site and causes loss of a HincII cut site, however these 
markers were not detected among the screened Egyptian samples. 
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Figure 5.21: BamHI digestion products of the fragment G of the mitochondrial genome 
(nt12077-13812). Digestion products were separated on 1% agarose gel. A 1Kb DNA ladder 
was used as a molecular marker (Lane M). Lanes 1-10 show digestion products of 10 Egyptian 
samples. All samples (except 1, 7, and 10) did not show evidence of BamHI cut. The region G 
of samples 1, 7, and 10 contained an internal BamHI cut site as evidenced by having two bands 
of sizes 1290 and 446bp instead of having a single band of 1736bp which was caused by a 
G13368A mutation. Thus, these samples were assigned to mitochondrial haplogroup T. 
 
5.2.2.8 RFLP analysis of the fragment H of the mitochondrial genome (nt14253-
14857) 
 
The PCR products of the fragment H of the mitochondrial genome (605bp) were 
digested with AccI and MseI restriction enzymes which served to identify mitochondrial 
haplogroups X and HV, respectively. The Egyptian mtDNA samples were assigned to 
haplogroup X when they showed evidence of AccI cut in the fragment H which was 
caused by a haplogroup specific T to C mutation at position 14470 (Figure 5.22). MseI 
digestion was performed to identify mitochondrial haplogroup HV and all its 
descendants including haplogroup H to which the CRS belongs. Egyptian mtDNA 
samples were assigned to haplogroup HV and its descendants whenever they showed 
loss of an MseI cut site, which was caused by a C14766C mutation (Figure 5.23).  
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Figure 5.22: AccI digestion products of the fragment H of the mitochondrial genome 
(nt14253-14857). Digestion products were separated on 2% agarose gel. A 100bp DNA ladder 
was used as a molecular marker (Lane M). Lanes 1-5 show digestion products of five Egyptian 
samples. All samples (except sample 3) did not show evidence of AccI cut. Sample 3 showed 
cutting of the PCR product (605bp) into two fragments of sizes 390 and 215bp which was 
caused by a T14470C mutation and therefore, it was assigned to mitochondrial haplogroup X. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.23: MseI digestion products of the fragment H of the mitochondrial genome 
(nt14253-14857). Digestion products were separated on 2.5% agarose gel. A 100bp DNA 
ladder was used as a molecular marker (Lane M). Lanes 1-12 show digestion products of 
twelve Egyptian samples. Evidence of MseI cut site loss was detected in samples 7, 8, 10 and 
12 by showing a fragment of 269bp instead of 252bp which was caused by a C14766C 
mutation, while all other samples did not show a similar MseI cut site loss. Therefore, these four 
samples were assigned to mitochondrial haplogroup HV and its descendants.    
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5.2.2.9 RFLP analysis of the fragment I of the mitochondrial genome (nt15312-
149) 
 
The PCR products of the fragment I of the mitochondrial genome (1407bp) were 
digested with AluI and HinfI restriction enzymes to differentiate between two closely 
related mitochondrial DNA haplogroups, T and J. AluI digestion aimed to screen for an 
A15607G mutation which characterises the haplogroup T and was detected by detection 
of a novel AluI cut site relative to the CRS digestion pattern (Figure 5.24). HinfI 
digestion was performed to confirm assignment of the Egyptian mtDNA samples to 
haplogroup J through detection of a C16069T mutation which is specific to this 
haplogroup. This mutation causes loss of a HinfI cut site relative to the CRS digestion 
pattern (Figure 5.25). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.24: AluI digestion products of the fragment I of the mitochondrial genome 
(nt15312-149). Digestion products were separated on 3.5% agarose gel. A 100 bp DNA ladder 
was used as a molecular marker (Lane M). Lanes 1-9 show digestion products of nine Egyptian 
samples. All samples (except 2, 4, and 9) showed a digestion pattern identical to that of the 
CRS. Samples 2, 4, and 9 showed an additional AluI cut site which was evidenced by cutting 
the 467bp band into two bands of sizes 295 and 172bp. This new cut site was caused by an 
A15607G mutation and thus those three samples were assigned to mitochondrial haplogroup T.  
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Figure 5.25: HinfI digestion products of the fragment I of the mitochondrial genome 
(nt15312-149). Digestion products were separated on 3.5% agarose gel. A 100 bp DNA ladder 
was used as a molecular marker (Lane M). Lanes 1-7 show digestion products of seven 
Egyptian samples. All samples (except 3 and 7) showed a digestion pattern identical to that of 
the CRS. Samples 3 and 7 showed loss of a HinfI cut site as evidenced by absence of the 
640bp fragment and occurrence of a 705bp fragment. This cut site was lost due to the presence 
of a C16069T mutation which is specific to haplogroup J. Therefore, samples 3 and 7 were 
assigned to the mitochondrial haplogroup J.  
 
5.2.3 Screening for an A12308G mutation as a diagnostic marker to 
mitochondrial haplogroups U and K  
 
A new fragment of the mitochondrial genome (114bp) was amplified using mispairing 
PCR (Figure 5.26) aiming to screen for an A12308G mutation which in conjunction 
with the mispairing primer generates a new EcoRI restriction cut site. This mutation is 
specific to the mitochondrial haplogroups U and K. Therefore, the Egyptian individuals 
whose mtDNA showed an EcoRI cut site at that position were confidently assigned to 
haplogroups U and K (Figure 5.27).       
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Figure 5.26: Mispairing PCR amplification products of the mitochondrial DNA (nt12221-
12334). PCR products (114bp) were separated on 2.5% agarose gel. Hyper ladder V was used 
as a molecular marker (Lane M). Lanes 1-5 show PCR products of five Egyptian mtDNA 
samples. 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.27: EcoRI digestion products of the mispairing PCR (nt12221-12334). Digestion 
products were separated on 3.5% agarose gel. Hyper ladder V was used as a molecular marker 
(Lane M). Lanes 1-9 show digestion products of nine Egyptian samples. All samples (except 3, 
5, and 7) showed an EcoRI cut of the PCR product as evidenced by loss of the 114bp band and 
appearance of a new 88bp band. This cut site was produced by an A12308G mutation in 
conjunction with the mispairing primer, therefore, these Egyptian mtDNA samples were 
assigned to mitochondrial haplogroup U and K. The PCR products of samples 3, 5, and 7 
lacked an EcoRI cut as evidenced by having the same size band as the PCR product (114bp).    
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5.2.4 Development of a new strategy for RFLP analysis of the mitochondrial 
genome  
 
Following completion of the pilot study which involved screening of 64 Egyptian 
individuals for all the 26 haplogroup specific RFLP markers and consideration of the 
results obtained, a new strategy for RFLP analysis was developed. This new strategy 
involved screening of samples for only 18 RFLP markers in a specific sequence, which 
enabled rapid and successful assignment of all the Egyptian individuals to well 
established mitochondrial DNA haplogroups. The scheme was primarily based on 
splitting the mitochondrial DNA samples into two big sets of mitochondrial lineages 
based on presence or absence of a DdeI cut site at 10394 which differentiates the old 
mitochondrial lineages (haplogroups L, M, N, J and K1) from the more recently derived 
mitochondrial lineages (haplogroups H, HV, R0, R0a, T, U, K, X, and W). This scheme 
involved a certain sequence of restriction digestions in which the results of each 
digestion determined the following restriction digestion till identification of a certain 
mitochondrial DNA haplogroup was achieved (Figure 5.28). For example, step 1 was 
digestion of the PCR product of fragment F (nt9921-11150) of the mtDNA with DdeI 
restriction enzyme, if the sample had a DdeI cut site at 10394, then step 2 was digestion 
of fragment C (nt3314-4732) with HpaI restriction enzyme and fragment B (nt1489-
2690) with MboI restriction enzyme. Based on the digestion results, if the sample lacked 
an HpaI recognition sequence at 3592 and an MboI recognition sequence at 2349, then 
step 3 was digestion of fragment F with AluI restriction enzyme, if the sample had an 
AluI recognition sequence at 10397, then mitochondrial haplogroup M was identified 
(Figure 5.28). The developed strategy was validated by comparing the haplogroup 
assignment results obtained by the RFLP analysis to those obtained by mitochondrial 
hypervariable region analysis and it was proved to be a highly efficient scheme.  
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Figure 5.28: A schematic representation of the workflow of the RFLP analysis of the 
whole mitochondrial genome. The flowchart shows the sequence of the restriction digestion 
analyses that was followed to screen the Egyptian mtDNA samples for haplogroup specific 
RFLP markers aiming at fulfilment of rapid and successful haplogroup assignment.  
 
Fragment B
Fragment C
Fragment D
Fragment E
Fragment F
Fragment G
Fragment H
Fragment I
1 
3 
2 
Screening for 
DdeI at 10394
+10394 DdeI −10394 DdeI
Screening for 
HpaI at 3592
MboI at 2349
+ 3592 HpaI
− 2349 MboI
+ 3592 HpaI
+ 2349 MboI
− 3592 HpaI
+ 2349 MboI
Haplogroups
L0 /L1/ L5/ L2/ L6
Haplogroup
L1b
Haplogroup
L3e
− 3592 HpaI
− 2349 MboI
Screening for 
AluI at 10397
+ 10397 AluI− 10397 AluI
Screening for 
DdeI at 1715
Haplogroup M
+ 1715 DdeI− 1715 DdeI
Screening for 
AvaII and HaeIII
at 8251
Screening for 
NlaIII at 4216
HinfI at 16066
− 8251 AvaII
+ 8251 HaeIII
+ 8251 AvaII
− 8251 HaeIII
Haplogroup N1a Screening for 
AluI at 10032
− 10032 AluI+ 10032 AluI
Haplogroup I Haplogroup N1e
+ 4216 NlaIII
− 16066 HinfI
− 4216 NlaIII
+ 16066 HinfI
Haplogroup J Screening for 
HaeII at 9052
EcoRI at 12308
− 9052 HaeII
+ 12308 EcoRI
Haplogroup K1
+ 9052 HaeII
− 12308 EcoRI
Haplogroup L3′4
Next slide
                       Chapter 5: PCR-RFLP screening of the whole mitochondrial genome 
 168 
Figure 5.28: Continue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fragment B
Fragment C
Fragment D
Fragment E
Fragment F
Fragment G
Fragment H
Fragment I
Screening for 
BamHI at 13366
AluI at 15606
−10394 DdeI
Screening for
DdeI at 1715
− 13366 BamHI
− 15606 AluI
+ 13366 BamHI
+ 15606 AluI
Haplogroup T
+ 1715 DdeI − 1715 DdeI
Screening for
AvaII and HaeIII
at 8251
− 8251 AvaII
+ 8251 HaeIII
+ 8251 AvaII
− 8251 HaeIII
Haplogroup N1b Screening for 
AccI at 14465
+ 14465 AccI
Haplogroup X2
Screening for 
AccI at 14465
− 14465 AccI+ 14465 AccI
Haplogroup X Screening for 
HaeII at 9052
EcoRI at 12308
+ 9052 HaeII
+ 12308 EcoRI
− 9052 HaeII
+ 12308 EcoRI
+ 9052 HaeII
− 12308 EcoRI
Haplogroup U Haplogroup K Screening for
AvaII and HaeIII
at 8251
HaeIII at 8994
+ 8251 AvaII
− 8251 HaeIII
− 8994 HaeIII
− 8251 AvaII
+ 8251 HaeIII
+ 8994 HaeIII
Haplogroup W Screening for 
AluI at 7025
MseI at 14766
− 7025 AluI
− 14766 MseI
+ 7025 AluI
+ 14766 MseI
Haplogroup H
+ 7025 AluI
− 14766 MseI
Haplogroups
HV/ HV0/ HV1-5
Haplogroups
R*/ R0/ R0a
                       Chapter 5: PCR-RFLP screening of the whole mitochondrial genome 
 169 
5.2.5 Frequency distribution of the mitochondrial DNA haplogroups in the 
Egyptian population  
 
All the Egyptian individuals (n=261) were successfully assigned to well established 
mitochondrial DNA haplogroups using the developed strategy of RFLP analysis of the 
mitochondrial genome. To validate this newly developed scheme, the results obtained 
by RFLP analysis were compared to those obtained via mitochondrial hypervariable 
region sequencing. The final haplogroup identification of the Egyptian individuals was 
based on combined data from both analyses. The European lineages predominated and 
constituted around 62.5% of the Egyptian population sample, whereas the African 
origin was only reported in approximately 25%. A few representatives of the 
mitochondrial DNA Asian lineages were also detected (12.5%) (Table 5.1) (Figures 
5.29 and 5.30). The genetic structure of the modern Egyptians revealed a wide variety 
of mtDNA lineages represented by more than 20 different mitochondrial haplogroups 
with varying frequencies. This large number of mitochondrial DNA lineages denotes a 
high level of diversity in the studied population group. By estimation of the individual 
haplogroups frequencies, it was found that the European haplogroup T was the most 
frequent mitochondrial DNA lineage in the Egyptian population occurring at a 
frequency of 13.8%, followed by haplogroups L3 (12.6%), H (12.3%), U (~10%) and M 
(8.4%) (Table 5.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.29: Geographic distribution of the maternal ancestry of the modern Egyptians. 
The European mitochondrial DNA lineages were found in 62.5% of the Egyptian population 
sample while the African origin constituted less than 25%. Few Asian representatives were also 
reported.  
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Table 5.1: Mitochondrial DNA haplogroup frequencies in 261 Egyptian individuals and 
their geographic origin. Mitochondrial haplogroups are named according to the universal 
agreed nomenclature system (Van Oven and Kayser 2009). n is the number of individuals 
designated to each haplogroup.  
 
 
Haplogroup n  Frequency Haplogroup n  Frequency 
European    African   
H 32 0.123 L3 33 0.126 
HV 15 0.057 L4 1 0.004 
R0 3 0.011 L6 1 0.004 
R0a 9 0.034 L2 20 0.077 
J 11 0.042 L1 5 0.019 
T 36 0.138 L0 5 0.019 
U 26 0.1 Total 65 0.249 
K 8 0.031  Asian   
R* 13 0.05 M 22 0.084 
W 3 0.011 N1b 8 0.031 
X 6 0.023 N1a 2 0.008 
I 1 0.004 N1e 1 0.004 
Total 163 0.624 Total 33 0.127 
 
 
 
Figure 5.30: MtDNA haplogroup frequencies reported in an Egyptian population sample 
(n=261). Letters refer to mitochondrial haplogroups according the universal agreed 
nomenclature system (Van Oven and Kayser 2009). Identification of haplogroups was based on 
the hypervariable region data and RFLP markers. A diverse genetic structure was shown 
through detection of a large number of mitochondrial haplogroups with varying geographical 
origin. Continental specific haplogroups were labelled in different colours. The European 
mitochondrial haplogroup T was the most frequent lineage in the reported dataset followed by 
the haplogroups L3, H, U and M.   
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Data obtained from the present study was compared to haplogroup frequencies 
previously reported by analysis of the mitochondrial control region sequences of 277 
Egyptians, where haplogroup identification was only based on hypervariable region data 
(Saunier et al. 2009). There was a close consistency between the two datasets regarding 
the different geographic contributions to the maternal ancestry of the modern Egyptian 
population (Figure 5.31). Most of the mitochondrial DNA haplogroups were detected at 
relatively similar frequencies in the two datasets. Different frequencies were reported 
for haplogroups H, R0, T, J and I (Figure 5.32). These frequency differences can be 
partly explained by relying on the hypervariable region data solely for the haplogroup 
assignment in the previous study, which caused a statistical bias towards the frequency 
of haplogroup R0 against haplogroup H whose identification can be confirmed via 
detection of a C7028C mutation which was not available in the previous Egyptian 
population study. Haplogroup I was only reported once in the present study with a 
frequency of 0.4%, whereas it showed a higher frequency (3.2%) in the other dataset 
reported by Saunier and colleagues (2009). Haplogroup T was observed at a relatively 
high frequency (13.8%) compared to the earlier study (9.3%) and the opposite was true 
for haplogroup J which was slightly less frequent in the present study (4.2%) compared 
to the other dataset (7.2%) (Table 5.2).  
 
 
Figure 5.31: Comparison of the relative contributions of geographic specific mtDNA 
lineages observed in two Egyptian datasets. The European lineages included haplogroups 
H, HV, R0, R0a, J, T, U, K, X, W, I and R*. The African specific category included L0 and L1-6. 
The Asian origin was mainly represented by M1 and N1b haplogroups, in addition to few 
representatives of other N derived haplogroups; N1a and N1e.    
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Figure 5.32: Major haplogroup frequencies observed in the present study (n=261) 
compared to a previously published Egyptian dataset of similar sample size (n=277). 
Letters refer to mitochondrial haplogroups according the universal agreed nomenclature system 
(Van Oven and Kayser 2009). Haplogroup identification in the present study was based on both 
hypervariable region sequencing data and coding region data via RFLP analysis while 
haplogroups obtained from Saunier et al.(2009) was only based on the control region 
sequencing data.  
 
 
Data obtained from the two Egyptian population studies were combined and the overall 
haplogroup frequencies were estimated for the total of 538 Egyptians (Table 5.2). The 
combined dataset was predominated by the European lineages which constituted 65% of 
the combined Egyptian population (n=350), followed by the African lineages forming 
approximately 23% (n=122), and lastly showed a smaller contribution from Asian 
origin representing 12% (n=66). The most frequent haplogroup was L3 (12.5%) 
followed by haplogroups T (11.5%), U (9.5%), R0 (8.6%) and H (7.8%) (Figure 5.33). 
These combined dataset was then used for assessment of the genetic relationship 
between the Egyptian population and geographically related populations.   
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Table 5.2: Mitochondrial DNA haplogroup frequencies in two Egyptian population 
studies. Haplogroup frequencies were calculated for the two datasets individually and in 
combination.  
 
 
Haplogroup 
Present study 
(n=261) 
Published data* 
(n=277) 
Combined data 
(n=538) 
    
H  0.123 (32)   0.036 (10) 0.078 (42) 
HV  0.057 (15)   0.058 (16) 0.058 (31) 
R0         0.011 (3)   0.155 (43)  0.086 (46) 
R0a         0.034 (9) 0.018 (5) 0.026 (14) 
JT         0.000 (0) 0.004(1)      0.002 (1) 
J  0.042 (11)   0.072 (20) 0.058 (31) 
T  0.138 (36)   0.093 (26) 0.115 (62) 
U         0.100 (26) 0.09 (25) 0.095 (51) 
K         0.031 (8)   0.047 (13) 0.039 (21) 
R*  0.050 (13)   0.039 (11) 0.048 (26) 
N1b         0.031 (8) 0.022 (6) 0.026 (14) 
N1a 0.008 (2) 0.007 (2)      0.007 (4) 
N1e 0.004 (1) 0.000 (0)      0.002 (1) 
N 0.000 (0) 0.022 (6)      0.011 (6) 
W 0.011 (3) 0.007 (2)      0.009 (5) 
X 0.023 (6) 0.014 (4) 0.019 (10) 
I 0.004 (1) 0.032 (9) 0.019 (10) 
M  0.084 (22)   0.069 (19) 0.076 (41) 
L3  0.126 (33)   0.123 (34) 0.125 (67) 
L4 0.004 (1)         0.000 (0)      0.002 (1) 
L6 0.004 (1)         0.000 (0)      0.002 (1) 
L2   0.077 (20)    0.036 (10) 0.056 (30) 
L1 0.019 (5)  0.025 (7) 0.022 (12) 
L0 0.019 (5)  0.022 (6)      0.020 (11) 
             
* Data obtained from Saunier et al. (2009).  
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Figure 5.33: Graphical representation of major mitochondrial haplogroup frequencies in a 
combined data set of 538 Egyptians. Data obtained from the present study (n=261) was 
combined with data obtained by analysis of the mitochondrial control region sequences of 277 
Egyptians performed by another scientific group. Letters refer to mitochondrial haplogroups 
according to the universal agreed nomenclature (Van Oven and Kayser 2009). 
 
5.2.6 Mitochondrial genetic relationships between modern Egyptians and their 
neighbours 
 
The genetic relationship between modern Egyptians and geographically related 
populations was assessed by comparing their mitochondrial genetic structures to the 
Egyptian one. Populations involved in the comparison study included East Africa 
(Mozambique and Ethiopia), North West Africa (Tunisia, Algeria, Morocco and 
Mauritania), Near East (Jordan, Syria and Palestine) and South Europe (South Portugal, 
Spain and Italy). Using the previously published mtDNA datasets of these populations 
(Figure 5.34) (Table 5.3), the relative frequencies of the continental specific major 
mitochondrial DNA lineages were determined and compared to those reported in the 
combined Egyptian dataset. It was found that the Egyptian genetic make-up was 
unsurprisingly very similar to that of the North West African populations (Tunis, 
Algeria and Morocco) with relatively similar proportions of the major mitochondrial 
lineages L, M, N and R except for Mauritania which did not show Asian derived 
lineages (Figure 5.35).  
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Figure 5.34: Map of North Africa, South West Europe, and Near East showing the 
geographic relationship between Egypt and the populations included in the analysis. The 
geographic location of the different populations involved in the analysis is indicated by red 
circles. 
  
Table 5.3: Frequencies (%) of major mitochondrial haplogroups in the Egyptian 
population and geographically related populations. The (n) refers to the number of 
individuals involved in the study. For Egypt, Tunisia, and Morocco, frequencies were calculated 
based on combined datasets from two studies.  
 
    Haplogroup Frequencies (%)   
Population (n) R N M L References 
       
East Africa       
        Mozambique  416 0 0 0.2 99.5 Pereira et al. (2001)  
Salas et al. (2002)  
        Ethiopia  270 15.4 6 17 41.2 Kivilsid et al. (2004) 
North West Africa       
        Egypt  538 55.7 9.3 7.6 22.3 Present study  
Saunier et al. (2009) 
        Tunisia 111 53.1 1.8 2.7 39.6 Plaza et al. (2003) 
Turchi et al. (2009)  
        Algeria  47 57.3 2.1 12.8 27.7 Plaza et al 2003  
        Morroco 106 61.1 2.8 2.8 28.3 Plaza et al. (2003) 
Turchi et al. (2009) 
        Mauritania 30 56.5 0 0 43.5 Rando et al. (1998) 
Near East       
        Palestine 118 74 8 2 14 Gonzalez et al. (2008) 
        Jordan 101 75 9 5 10 Gonzalez et al. (2008) 
        Syria 119 87 6 0 7 Gonzalez et al. (2008) 
South Europe       
        South Portugal 59 88.3 3.4 0 3.4 Plaza et al.(2003) 
        Spain 312 84.5 8 0.3 2.9 Alvarez et al. (2007) 
        Italy 411 83.9 1.1 0.6 2.9 Plaza et al. (2003) 
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Figure 5.35: Frequency distribution of major mitochondrial DNA haplogroups in 
representative populations of North West Africa, East Africa, Near East and South West 
Europe. Major mitochondrial haplogroup R included all individuals belonging to haplogroups H, 
HV, R0, R0a, J, T, U, K, and R*. Macro haplogroup N included N1b, N1a, X, W, and I. Macro 
haplogroup M included M1. The African L haplogroup included members of haplogroups L0 and 
L1-6. The sample sizes are Mozambique (n=416), Ethiopia (n=270), Egypt (n=538), Tunisia 
(n=111), Algeria (n=47), Morocco (n=106), Mauritania (n=30), Palestine (n=118), Jordan 
(n=101), Syria (n=119), South Portugal (n=59), Spain (n=312), and Italy (n=411). 
 
To further assess the genetic variation between the North African populations, a more 
detailed comparison was performed to assess the frequency distribution of the 
mitochondrial DNA haplogroups in four population groups: Egyptians (n=538), 
Tunisians (n=111), Algerians (n=47), and Moroccans (n= 106) (Figure 5.36). 
Haplogroups H, HV, and R0 occurred at similar frequencies in the Egyptians and 
Tunisians with values of 25% and 27%, respectively, while higher values were reported 
in Algerians and Moroccans, 34% and 33.7%, respectively. The highest frequency of 
the European mitochondrial haplogroup T (11.5%) was reported in the Egyptian 
population and the lowest was reported in Moroccans (3.8%). Both Moroccans and 
Egyptians showed high frequencies of the European haplogroup U (excluding the 
subclade U6) with values of 8.5% and 8.2%, respectively, whereas Algerians showed 
the lowest frequency (2.1%). The European Haplogroup I was only found in the 
Egyptians and Tunisians at frequencies of 1.9% and 0.9%, respectively. Haplogroup X 
was shown in all North African populations at low frequencies with the highest at 2.8% 
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reported in Moroccans. The European haplogroup W was not found in North African 
populations except in the Egyptian group where it was reported at a frequency of 0.9%. 
Regarding the Asian derived mitochondrial lineages, haplogroup M1 was found in the 
Egyptian population at a frequency of 7.6% which is higher than the values reported in 
Tunisians and Moroccans (2.7% and 5.7%, respectively), but still lower than the 
reported frequency in Algerians (12.8%). Amongst all North Africans, the Egyptian 
population is the only group that showed Asian haplogroup N1 which was reported at a 
frequency of 4.6%. This can be attributed to the geographic location of Egypt near the 
Levantine Corridor which was thought to be an important route of modern human 
migrations from and to Africa (Rowold et al. 2007; Gonzalez et al. 2008). Among 
African specific haplogroups, L0 was only reported in the Egyptians and Tunisians at 
frequencies of 2% and 0.9%, respectively. Haplogroup L1 was less represented in the 
Egyptian population (2.2%) compared to the other North African groups which had a 
low of 6.3% in Tunisians and a high of 9.4% in Moroccans. Haplogroup L2 was 
reported at a much lower frequency in the Egyptian population (5.6%) compared to the 
frequency reported in Tunisians (14.4%). Similarly, haplogroup L3 was reported in 
12.5% of the Egyptian population which is lower than values reported in Tunisians and 
Algerians (18% and 14.9%, respectively). Overall, the African L haplogroups were less 
represented in the Egyptian population compared to the other North Africans. 
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Figure 5.36: Frequency distribution of mitochondrial DNA haplogroups in North African 
populations. The frequency of each mitochondrial haplogroup was calculated as a percentage 
considering the total for each population group as 100%. Sample sizes are Egypt (n=538), 
Tunisia (n=111), Morocco (n=106), and Algeria (n=47). For simplification, mitochondrial 
haplogroups H, HV, R0 and R0a were included in one big group at the bottom of each bar. The 
category of haplogroup U included all sub-haplogroups U1-U8 except U6 which was considered 
separately. Haplogroup identification was mainly based on hypervariable region sequencing 
data for all the studied populations except for the Egyptian population group (n=261) included in 
the present study in which haplogroup assignment was based on combined data from 
hypervariable region sequences and RFLP markers.  
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5.3 Discussion 
 
The main aim of this part of the study was to develop a new reliable strategy for 
screening of the mitochondrial genome for haplogroup specific variations using PCR-
RFLP technology. That strategy was to be used to further confirm the haplogroup 
assignment of the Egyptian mtDNA types that were previously identified using 
hypervariable region sequencing data. The overall mitochondrial genetic diversity of the 
Egyptian population was to be assessed and correlated to the previously published 
datasets. The geographic origin(s) of the maternal ancestry of present day Egyptians 
was (or were) to be concluded. The genetic relationship between modern Egyptians and 
their neighbours was to be determined.  
 
5.3.1 Development of a new strategy for analysis of mitochondrial nucleotide 
variations as a useful tool for haplogroup identification 
 
Mitochondrial hypervariable region data have been used for haplogroup identification in 
different population studies (Alvarez et al. 2007; Egyed et al. 2007; Barbosa et al. 2008; 
Saunier et al. 2009), however the use of hypervariable region sequences solely can 
result in an ambiguous mitochondrial phylogeny (Bandelt et al. 2000; Torroni et al. 
2000; Kivisild et al. 2002; Yao et al. 2002; Li et al. 2007). Therefore, combinations of 
hypervariable region sequencing data with coding region polymorphisms data can 
enhance the identification of mitochondrial DNA haplogroups with fine resolution and 
provide sufficient information for better understanding of the mitochondrial genetic 
backgrounds of different population groups.  
 
Many of the previous population studies which involved restriction analyses of the 
mitochondrial genome relied on amplification of the mtDNA as several fragments in 
different PCR reactions which necessitate an abundance of the DNA template (Chen et 
al. 1995b; Macaulay et al. 1999; Tolk et al. 2001; Li et al. 2007). In the present study, a 
new multiplex PCR amplification protocol was developed and successfully used to 
amplify 11Kb of the mitochondrial genome as 9 non-overlapping fragments in one 
reaction, using only a 1.2-mm processed disc of the blood stained FTA cards as DNA 
template. Using this protocol, the required volume of DNA samples for the whole 
analysis was significantly reduced and this enabled preservation of samples for 
subsequent investigations, a character which has a great value in forensic investigations 
which occasionally deal with limited sample volumes.   
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The newly developed strategy of RFLP analysis of the mitochondrial genome was 
primarily designed to suit any scientific laboratory even those lacking the highly 
advanced sequencing technologies. Thus, it can be easily used by all researchers, 
particularly in the developing countries, for analysis of mtDNA in different population 
groups. Despite the relatively rapid advancement in the sequencing technologies, many 
researchers groups all over the world, who are interested in mtDNA population studies, 
are still restricting the use of direct sequencing to the mitochondrial hypervariable 
regions while they are using different SNP detection techniques for analysis of the 
coding region of the mitochondrial genome (Kohnemann et al. 2008; Grignani et al. 
2009; Schlebusch et al. 2009).        
 
5.3.2 Selection of the most informative RFLP markers  
  
The present study included an important aspect which was selection of the most 
informative RFLP markers that could be effectively used for mitochondrial haplogroup 
identification in the Egyptian population. Several population studies have used lists of 
haplogroup specific RFLP markers (Chen et al. 1995b; Alves-Silva et al. 2000; 
Richards et al. 2000; Finnila et al. 2001b; Tolk et al. 2001; Salas et al. 2002; Richards et 
al. 2003; Stevanovitch et al. 2004) and others (Rowold et al. 2007; Shlush et al. 2008) 
have followed the basic classification scheme of Macaulay et al. (1999) which involved 
analysis of a very long list of RFLP markers, some of which were more informative 
than others. Some studies however did not include important haplogroup differentiating 
markers in their analysis, for example, in the study conducted to construct a 
phylogenetic network for the European mtDNA (Finnila et al. 2001b), identification of 
haplogroup W was based on two RFLP markers, +8251AvaII and −10394DdeI, which 
are not exclusive to haplogroup W since they also occur in its sister clades N1b, N1e, 
and I. A loss of HaeIII at position 8994 is more specific to haplogroup W as described 
earlier (Torroni et al. 1996). Similarly, Herrnstadt et al. (2002) reported a reticulation in 
the phylogenetic network among sequences belonging to haplogroups I, W, and X due 
to shared polymorphisms at positions 1719 and 8251, whereas they did not mention the 
polymorphism at postion 10032 which is specific to haplogroup I as described 
elsewhere (Chen et al. 1995b; Alves-Silva et al. 2000). Therefore, it was required to 
perform a preferential selection of the most informative RFLP markers to be included in 
the present analysis which would enable identification of mitochondrial haplogroups 
with fine resolution. Thus, a general list of 26 RFLP markers was developed and 
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applied to a pilot study which involved screening of 64 Egyptian individuals. Based on 
the findings obtained from the preliminary analysis, a smaller list of 18 RFLP markers 
was tailored to perform haplogroup assignment of the Egyptian individuals as 
accurately and as quick as possible through performing the restriction analyses in a 
defined order. The new developed scheme for RFLP analysis was proved to be reliable 
through comparison of results obtained by RFLP analysis to those obtained by 
hypervariable region sequencing.       
 
All the previous mitochondrial DNA studies which involved identification of 
haplogroup U and its descendant K via RFLP analysis used mispairing PCR technology 
to identify a characteristic A12308G mutation as described earlier (Torroni et al.1996). 
This mutation was described to constitute a new HinfI cut site in conjunction with the 
mismatched primer, however, by reviewing the mispairing primer sequence and the 
Cambridge Reference Sequence of the mtDNA, it was found that the produced 
restriction cut site using this particular mismatched primer was an EcoRI cut site instead 
of HinfI. Thus, the present study reported an error in the literature which has not been 
addressed by any other researchers before.   
  
5.3.3 Mitochondrial DNA haplogroup distribution in the Egyptian population 
 
Using the newly developed scheme of RFLP analysis, mtDNA of 261 Egyptian 
individuals were confidently assigned to established mitochondrial haplogroups. The 
overall genetic structure of present day Egyptians seems to be greatly influenced by the 
admixture between past Egyptians and all the previous ruling populations, as evidenced 
by a heterogeneous composition, with a mixture of more than 20 mtDNA haplogroups 
with varying racial backgrounds. This mixture of varying mitochondrial lineages 
reflects a mixed maternal ancestry of the Egyptian population which can also be a result 
of the peculiar geographic location of Egypt next to the Levantine Corridor. This 
Corridor was thought to be an important route of modern human migration from and to 
Africa, and subsequently Egypt might have been influenced by several waves of human 
migration (Rowold et al. 2007; Gonzalez et al. 2008).  
 
The European lineages constituted the main component of the genetic make-up of the 
Egyptian population since it was present in 62.5% of the analysed individuals, whereas, 
the African lineages were only present in approximately 25%. In addition, Asian 
derived lineages were also reported in 12.5% of the population. These figures are 
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comparable to the results obtained by a recent analysis of mitochondrial hypervariable 
region sequences of 277 Egyptians, where the European lineages constituted 67.5% and 
the African lineages were found in 20.5% of the population (Saunier et al. 2009). 
Amongst all the mitochondrial DNA lineages, the European mitochondrial haplogroup 
T was the most frequently reported (13.8%) in the present study. This haplogroup 
originated in the Near East approximately 46,500 years ago but was reported to be most 
prevalent in Europe with an average of 10.5% or even higher in some European 
populations (Richards et al. 1998; Helgason et al. 2001). Such a high frequency of 
haplogroup T in the Egyptian population raises a question regarding the universal 
agreed consideration of haplogroup T as being European. The distinction is that 
haplogroup T might probably be considered European due to its high frequencies in the 
current European populations, as opposed to its origin. The next common European 
haplogroup was H which represents the most frequent European haplogroup with an 
average of 45% or even more in some European populations. In the present study, 
haplogroup H accounted for 12.3% of the Egyptian lineages which is very similar to the 
average reported in Saudi Arabia (13%) (Achilli et al. 2004; Abu-Amero et al. 2007). 
The European Haplogroup U accounted for 10% of the Egyptian lineages, of which 
only 1.5% were members of haplogroup U6, which is an established North African 
lineage that was previously reported in Tunisians and Moroccans with frequencies of 
6.3 % and 4.7%, respectively (Rando et al. 1998; Macaulay et al. 1999; Plaza et al. 
2003; Turchi et al. 2009). The overall European haplogroups accounted for 62.5% of the 
Egyptian lineages which is close to the average in the Middle East where values of 74 
% and 75% were reported in Palestinians and Jordanians, respectively (Gonzalez et al. 
2008). Representation of the European lineages in East African populations was 
significantly low ranging from 15.4% in Ethiopia (Kivisild et al. 2004) down to 0% in 
Mozambique (Pereira et al. 2001; Salas et al. 2002). Therefore, the presence and the 
frequencies of European haplogroups in the Egyptian population sample clearly place 
Egypt distinct from sub-Saharan African populations, a finding which is consistent with 
another recent population study which considered Egypt as the closest African 
population to the Middle East (Gonzalez et al. 2008). 
 
The N derived mitochondrial haplogroups (N1a, N1b, N1e, W, X, and I) were found in 
a total of 8.1% of the Egyptian haplotypes that reported in the present study and in 9.3% 
in the combined Egyptian dataset (n=538). These figures are very similar to the 
frequencies reported in the Middle East, 9% in Palestine and 8% in Jordan (Gonzalez et 
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al. 2008). In contrast, haplogroups N1a, N1b, N1e, and W were not detected in North 
West Africa; Morocco, Tunisia, Algeria and Mauritania (Plaza et al. 2003; Turchi et al. 
2009). All these N derived lineages were also not found in Central and South East 
Africa (Kivisild et al. 2004; Gonzalez et al. 2008). Thus, the presence of these N 
derived lineages in the Egyptian population at such a high frequency clearly 
distinguishes Egypt from all the other African populations including those in the North 
West of Africa, and supports the presumed genetic relationship between Egypt and the 
Middle East. On the other aspect, presence of these haplogroups in Egypt proves that 
the maternal lineages originated in Asia have found a route to Africa either through the 
Mediterranean or the Levantine Corridor.  
 
Haplogroup M was found at a frequency of 8.4 % of the Egyptian lineages which was 
slightly higher than the frequency reported by a recent Egyptian population study 
(6.96%) (Saunier et al. 2009). In both studies, all the reported haplogroup M lineages 
belonged to the sub-haplogroup M1 except one case in each study which belonged to a 
different M lineage.  These findings are in contrast to an earlier study  which reported a 
low frequency (3%) of M1 in Egypt and Israeli Druze (Rowold et al. 2007). The most 
accepted hypothesis regarding the origin of haplogroup M1 states that this haplogroup 
originated in Asia but soon afterwards migrated back to Africa (Passarino et al. 1998; 
Maca-Meyer et al. 2001; Gonzalez et al. 2007). Therefore, the presence of M1 lineages 
at a high frequency in the present study was not surprising, since samples were collected 
from Alexandria city which is located on the Mediterranean coast. These findings are in 
support of the earlier suggestions of the preferred usage of the Levantine Corridor over 
the Horn of Africa for intercontinental gene flow. However, the previously reported 
high frequency of haplogroup M1 in Ethiopia (17%) was behind the early assumption 
that M1 lineage migrated out of Asia through the Horn of Africa (Kivisild et al. 2004; 
Rowold et al. 2007). The low frequency of M1 in Nubia and Sudan (3%) (Gonzalez et 
al. 2008) and the high frequency in Egypt (8.4%) and Algeria (12.8%) go with the 
alternative route of migration through the Levantine Corridor or the Mediterranean as 
suggested elsewhere (Olivieri et al. 2006).  
 
According to the present study, the general sub-Saharan Africa maternal gene flow to 
Egypt was around 25% which is in the range of other North African populations, 
Algeria (27.7 %) (Plaza et al. 2003) and Morocco (26.8 %) (Turchi et al. 2009), but is 
significantly lower than the African gene flow to Tunisia (48.4%) (Turchi et al. 2009) 
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and Mauritania (43.5%) (Rando et al. 1998). Dissection of the African lineages in the 
Egyptian population revealed that L3 was the most frequent haplogroup occurring at a 
frequency of 12.6 %. This is consistent with the recently reported frequency by another 
group (12.3%) (Saunier et al. 2009). This frequency falls in North African populations, 
14.9% in Algeria and 16% in Morocco (Plaza et al. 2003) and East African populations, 
16.4% in Ethiopia (Kivisild et al. 2004).  But, a higher frequency of haplogroup L3 was 
reported in Tunisia (20.3%) suggesting a stronger African gene flow to Tunisia 
compared to Egypt (Turchi et al. 2009). In the present study, L3 haplogroup was mainly 
represented by L3f1 and L3e clades. L3f is a rare mitochondrial lineage originated in 
East Africa and gave rise to L3f1 subclade which has spread at an early date into West 
Africa (Watson et al. 1997; Salas et al. 2002). L3e is the most ancient and widespread 
L3 lineage, originated ~ 45,000 years ago in Central Africa and it accounts for almost 
one third of all L3 types in sub-Saharan Africa (Bandelt et al. 2001; Salas et al. 2002).  
 
The next common African haplogroup was L2 with a frequency of 7.7%, all of which 
belonged to L2a subclade. Similar frequencies of L2 were reported in Algerians and 
Moroccans (6.4% and 6%, respectively) (Plaza et al. 2003) and higher frequencies were 
reported in Tunisians and Mauritanians (15.6% and 13.4%, respectively) (Rando et al. 
1998; Turchi et al. 2009). The most accepted hypothesis is that L2a subclade diverged 
out of the main L2 haplogroup ~55,000 years ago in West Africa and then dramatically 
expanded into South East Africa. This hypothesis was supported by the high frequencies 
of L2a reported in Mozambique (33%) (Pereira et al. 2001; Salas et al. 2002), Sudan 
(24%) (Gonzalez et al. 2008) and Ethiopia (13%) (Kivisild et al. 2004).  
 
Haplogroup L1 was only found in 1.9% of the Egyptian population, which is a very low 
frequency compared to North West Africa where frequencies of 10% , 10.9% and 
23.4% were reported in Moroccans, Tunisians, and Mauritanians, respectively (Rando 
et al. 1998; Plaza et al. 2003; Turchi et al. 2009). All the reported L1 lineages in the 
present study were L1b types. Such a low frequency of L1 in Egypt compared to the 
North West African populations supports the early assumption that L1 haplogroup 
originated in West Africa and gave rise to subclade L1b around 30,000 years ago which 
then diffused into North Africa through the coastal pathway (Salas et al. 2002). 
Haplogroup L0 is the earliest offshoot of the most recent common ancestor (MRCA) of 
the mtDNA tree in Africa which appears as a sister group to the branch that gives rise to 
all other haplogroups. L0 was reported in the present study at a frequency of 1.9% 
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which mainly belonged to L0a subclade. Consistent results were reported in Ethiopians 
where L0a constituted the majority of L0 lineages, however the frequency of L0 was 
much higher (7.8%) (Kivisild et al. 2004). A much higher frequency of L0 was reported 
in Mozambicans (30.5%) (Pereira et al. 2001; Salas et al. 2002). L0 was not found in 
Algerians and Moroccans (Plaza et al. 2003). The overall high diversity found in the 
Egyptian population agrees with the early human mtDNA studies which demonstrated 
that the highest mtDNA diversity in the world was found within Africa (Cann et al. 
1987; Vigilant et al. 1991; Chen et al. 1995a). 
 
5.3.4 Conclusion 
 
A new multiplex PCR protocol for amplification of 11Kb of the mitochondrial genome 
was developed and was used successfully to analyse a very restricted volume of DNA 
samples (1.2-mm disc). A new strategy was designed to facilitate PCR-RFLP analysis 
of the mitochondrial genome for the purpose of haplogroup assignment and was 
successfully applied to the Egyptian population sample (n=261). A heterogeneous origin 
of maternal lineages in the Egyptian population was reported via detection of a mixture 
of mitochondrial DNA haplogroups with varying racial backgrounds. Overall, a high 
diversity of the mitochondrial DNA was reported as evidenced by reporting over 20 
different mitochondrial DNA haplogroups. The genetic relationship between Egypt and 
its surrounding populations was uncovered and it was found that present day Egyptians 
were the closest African population to the Middle East and Europe with an overall 
62.5% European, 25% African, and 12.5% Asian mitochondrial lineages. 
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6. SCREENING FOR AMELOGENIN Y (AMELY) DELETION 
IN THE EGYPTIAN POPULATION 
 
6.1 Introduction 
 
Accurate gender determination is crucial in many scientific disciplines with particular 
interest to forensic investigations and prenatal diagnosis of X-linked recessive disorders. 
The amelogenin gene is the main tool in DNA-based gender tests and it represents an 
integral component of most PCR multiplexing kits that are routinely used for DNA 
profiling (for example, PowerPlex
®
16 Bio, PowerPlex
®
 ES,  AmpF/STR
® 
Identifiler
TM
, 
AmpF/STR
®
 Profiler Plus
TM
 ID, and AmpF/STR
®
 SEfiler
TM
). Gender determination is 
based on the differences between the two copies of the amelogenin gene on the X- and 
Y- chromosomes. Numerous length and sequence differences exist between the two 
homologues but the commonly used gender test is based on a 6bp deletion in intron 1 of 
the X-homologue. This difference can be easily detected using PCR amplification and 
gel electrophoresis (Kashyap et al. 2006; Cadenas et al. 2007). Despite being the most 
commonly used test for sex determination for many years, the last two decades have 
witnessed a failure of amelogenin typing in a small number of cases in certain 
populations leading to misidentification of males as females. These cases have raised a 
suspicion regarding the absolute reliability of the amelogenin test. Further investigations 
of the amelogenin null males revealed that amelogenin gene deletion was included in 
larger interstitial deletions on the short arm of the Y-chromosome ranging from several 
hundreds of bases up to 3.7Mb (Cadenas et al. 2007; Yong et al. 2007; Takayama et al. 
2009). These deletions were mainly explained by non-allelic homologous 
recombination (NAHR) between the proximal major repeat array of TSPY gene and the 
distal copy of TSPY immediately downstream of an IR3 inverted repeat (Lattanzi et al. 
2005; Jobling et al. 2007). These reported cases of amelogenin gene deletion were 
mainly associated with males originating from the Indian subcontinent, particularly 
those belonging to the haplogroup J2 Y-chromosome lineages (Yong et al. 2007). 
However, occurrence of amelogenin gene deletions through independent evolutionary 
events was suggested (Chang et al. 2007; Yong et al. 2007) and thus occurrence of 
amelogenin gene deletion in other ethnic groupings can not be excluded. Therefore, the 
aim of this part of the study was to screen 131 Egyptian males for amelogenin gene 
deletion on the Y-chromosome.  
Chapter 6: Screening for amelogenin Y deletion in the Egyptian population 
 187 
6.2 Results 
  
The amelogenin gene was PCR amplified in 131 males from Alexandria, Egypt using 
the standard pair of primers that are routinely used in PowerPlex
TM
 16 Kit (Promega). 
PCR products were separated by electrophoresis on 5% polyacrylamide gel (Figure 
6.1). The amelogenin gene copy on the X-chromosome has a 6bp deletion in the 
amplified region compared to its homologue on the Y-chromosome. Thus, the expected 
PCR products in males were two bands of sizes 106 and 112bp. If amelogenin gene was 
deleted on the Y-chromosome, then the PCR products would be simulating a female 
pattern with one band of 106bp.  
 
 
Figure 6.1: Products of PCR amplification of amelogenin gene. PCR products were 
separated by electrophoresis on 5% polyacrylamide gel. HyperLadder V was used as a 
molecular marker in lane M. Lanes 1-6 show PCR products of amelogenin gene amplification of 
6 Egyptian males. Lane 7 contained a negative control where no DNA was added to the PCR 
mix. Lane 8 shows PCR products of amelogenin gene amplification of a female blood sample. 
The male pattern is clearly distinguished from the female one by having two bands of sizes 106 
and 112bp whereas the female shows only one band of 106bp.  
 
By the end of the study, no evidence of amelogenin gene deletion was detected in the 
studied population group. 
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6.3 Discussion 
 
In the present study, no cases of amelogenin gene deletion were reported in 131 males 
from Northern Egypt as evidenced by PCR amplification of a specified region of the 
amelogenin gene on the short arm of the Y-chromosome.  A previous study involved 
typing of 17 Y-STR loci in 208 males from Upper (Southern) Egypt, four of which 
(DYS393, DYS456, DYS458, DYS19) are located on the short arm of the Y-
chromosome, no drop out was reported of any of these loci in the studied males, which 
demonstrates that at least there was no large interstitial deletion on the short arm of the 
Y-chromosome that might have included the amelogenin gene (Omran et al. 2008). 
However, the fact that the previously reported cases of amelogenin gene deletion 
occurred at a very low frequency, together with the small sample size included in the 
present study did not lead to an absolute exclusion of the existence of amelogenin gene 
deletion in the Egyptian population. Despite the fact that the majority of amelogenin 
gene deletion cases were reported in people originating from the Indian subcontinent 
(Yong et al. 2007), the very few cases of AMELY deletion reported in Spain (Bosch et 
al. 2002), Italy (Lattanzi et al. 2005), Austria (Steinlechner et al. 2002), and Israel 
(Michael and Brauner 2004), together with the suggested link between the North 
Mediterranean and the South Mediterranean coasts raises a suspicion of the possibility 
of existence of AMELY deletion in North Africa. Thus, a larger sample size of Egyptian 
males will be required to give a better overview of this issue.   
 
6.4 Conclusion 
 
To conclude, no amelogenin gene deletion was reported in 131 Egyptian males from 
Alexandria city as evidenced by PCR amplification and gel electrophoresis. The 
obtained results did not rule out the possibility of occurrence of amelogenin gene 
deletion in the Egyptian population and a larger sample size will be required for better 
estimates.  
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7. GENERAL DISCUSSION AND FUTURE WORK 
 
The main aims of the present study were to assess the mitochondrial nucleotide 
diversity and heterogeneity in the Egyptian population, and to establish a database of 
mitochondrial hypervariable region sequences in 261 adult Egyptians from Alexandria 
city, which would further enrich the global human mitochondrial DNA database. The 
present study also aimed to assign Egyptian mitochondrial DNA sequences to well 
known mitochondrial haplogroups, aided by PCR-RFLP analysis of the mtDNA, for 
which a novel strategy was to be developed. Other aims of the study included evaluation 
of the currently available techniques, namely FTA cards, for mitochondrial DNA testing 
and assessment of their efficiency for collection, storage and transportation of DNA-
containing samples which would further aid the development of forensic investigations. 
In addition, the present study aimed to screen 131 Egyptian males for amelogenin gene 
deletion on the Y-chromosome which was previously reported in certain populations.  
 
7.1 The utility of FTA cards in forensic investigations 
 
There are several methods for biological sample collection and DNA extraction, and 
each method has its own advantages and disadvantages. Of these, FTA card technology 
was extensively investigated during the present study. FTA cards were successfully 
used for human blood sample collection, storage and transportation. Several guidelines 
for the DNA purification using FTA cards technology were addressed. A 1.2-mm disc 
of blood stained FTA cards was shown to contain a sufficient quantity of DNA for PCR 
analysis, which means that a very limited sample volume is required, and thus the rest 
of the DNA sample can be saved for further investigations. Persistent PCR inhibition 
produced by unwashed inhibitor(s) in blood was eliminated through addition of Bovine 
Serum Albumin as a PCR enhancer. It was possible to amplify mitochondrial DNA 
from blood samples after being stored on FTA cards for up to 48 months. In the present 
study which involved analysis of several hundred blood samples on FTA cards, no cross 
contamination was detected in the negative control discs. Therefore, it was concluded 
that FTA card technology was highly advantageous over all the other methods of DNA 
extraction due to its special ability to amplify DNA from a very limited sample volume, 
its potential capability to preserve the integrity of DNA for a long period of time at 
room temperature, and fewer sample manipulation requirements with minimal or even 
no cross contamination risks. All these aforementioned features justify and extend the 
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utility of FTA cards to the routine forensic case work and genetic identification studies 
where high throughput analysis is required.  
 
7.2  Rapid PCR 
 
A new laboratory protocol for rapid PCR amplification of the hypervariable regions of 
mtDNA was developed. This protocol was optimised to enable the amplification 
reaction to be completed in a very short period of time using Gotaq DNA polymerase 
(Promega) without adversely affecting the quality of the PCR product. This protocol 
involved the use of newly designed long oligonucleotides (~30mer) which enabled 
combination of annealing and extension steps at 72
o
C, and thus a shift from the standard 
three-step PCR protocol to a two-step one. Reduction of the duration of each stage of 
the thermal cyclic conditions together with reduced number of cycles enabled a total 
reduction of the PCR run time from 2-3 hours of the conventional PCR protocol down 
to 30 minutes. This fast PCR protocol will have a direct impact on forensic 
investigations, forensic science undergraduate laboratories and population genetic 
studies which are usually dealing with a huge number of samples that usually take a 
long time to be processed, particularly when automation facilities are not available. 
 
7.3 Mitochondrial hypervariable region analysis and diversity 
measures in the Egyptian population 
  
Analysis of mitochondrial DNA has gained increasing popularity in the last two decades 
for its use in human identification purposes and population genetics. Mitochondrial 
nucleotide variations are currently widely used for tracing maternal lineages and 
determination of populations‟ diversities. The mtDNA database is growing rapidly since 
the first complete human mitochondrial genome sequence was reviewed in 1999 
(Andrews et al. 1999). However, mtDNA sequences of African origin are still under 
represented in the current database compared to those of European or Asian origin. 
When the present study was launched, there was little data about mtDNA variation in 
the Egyptian population. Therefore, analysis of the mitochondrial hypervariable region 
in 261 adult Egyptians was performed. A database of 261 mitochondrial HVI 
sequences, between nucleotides 16024-16365 and 78 HVII sequences between the 
nucleotides 73-340 was established. A total of 113 polymorphic sites were reported in 
the specified HVI region with varying frequencies. Those sites that showed the higher 
rate of variations agree with the mutational hotspots that were previously described in 
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the human evolution studies  (Finnila et al. 2001b; Maca-Meyer et al. 2001).  A total of 
187 different HVI haplotypes were identified with a haplotype percentage K 72% which 
is higher than the previously reported figures in Asian populations, 63% in Japan (Asari 
et al. 2007) and 64% in Singapore (Wong et al. 2007) and European populations, 59% 
in the North of Portugal (Lima et al. 2006) and 44% in Finland (Hedman et al. 2007). 
Analysis of 78 HVII sequences revealed 62 different haplotypes that were identified by 
42 polymorphic sites. Combination of HVII sequences with HVI sequences resulted in a 
total of 207 Egyptian mitochondrial haplotypes with a haplotype percentage K 79%. Of 
these mitochondrial types, 183 (~88%) were unique to single individuals, whereas the 
remaining 24 haplotypes were shared by multiple individuals. Such a large number of 
unique mitochondrial haplotypes indicates high mtDNA diversity and supports the use 
of the mitochondrial hypervariable region analysis for identification purposes. Of the 
shared mitochondrial haplotypes, fifteen were observed twice in the Egyptian 
population sample and 4 types were shared by three individuals. The remaining 5 
haplotypes were shared by more than three individuals. The most commonly observed 
mitochondrial haplotype in the Egyptian population was identical to the CRS in the 
specified HVI region (nt16024-16365). It is worth noting that for all the shared 
mitochondrial haplotypes, HVII sequence was not available and this match was only 
based on the 342bp of the HVI region. Among the unique mitochondrial haplotypes, 23 
haplotypes primarily shared their HVI sequences with one or more individuals, 
nonetheless, analysis of HVII sequences of these individuals discriminated between 
them. Hence, it was concluded that combination of HVI and HVII sequences increased 
the power of discrimination and showed an overall high level of mitochondrial diversity 
in the Egyptian population. These findings together with the characteristic features of 
the mtDNA regarding the high copy number per somatic cell and the maternal mode of 
inheritance support the use of mitochondrial hypervariable region analysis in the human 
identification purposes.  
 
The probability of randomly selecting two unrelated Egyptians with the same 
mitochondrial HVI or HVII haplotypes in the analysed population sample was estimated 
to be 2.34% and 3.22% respectively. These Random Match Probabilities were 
calculated based on HVI (n=261) and HVII (n=78) sequences individually. Whereas, 
when HVI and HVII data were combined together, the RMP was reduced to 1.28%, 
which again confirmed the value having both HVI and HVII sequences in order to 
achieve a high power of discrimination. The RMP reported herein is in the average of 
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many other populations, 1.29% in the North of Portugal (Lima et al. 2006) and 1% in 
Romania and Japan (Egyed et al. 2007; Mabuchi et al. 2007), putting in consideration 
that HVII sequences were only determined in 78 individuals and all the diversity 
measures were mainly influenced by HVI sequences solely.  Compared to other North 
African populations, the estimated RMP in the present study is significantly lower than 
the those reported in 64 Tunisians (2.1%) and 56 Moroccans (2.1%) (Turchi et al. 
2009). The genetic diversity h was estimated as 0.9804 and 0.9803 for HVI and HVII 
respectively. These values are comparable to the diversities reported in other population 
studies which considered HVI and HVII data individually (Asari et al. 2007; Mabuchi et 
al. 2007). In the subset of 78 Egyptians for which both HVI and HVII sequences were 
analysed, the genetic diversity was estimated as 1.000 which is comparable to the 
diversity recently reported in 277 Egyptians based on analysis of the whole control 
region (Saunier et al. 2009).    
 
7.4 Multiplex PCR amplification of 11kb of the human 
mitochondrial genome in one PCR reaction 
 
A new laboratory protocol for PCR amplification of nine fragments of the human 
mitochondrial genome was developed. This protocol was mainly designed to enable 
amplification of 11Kb of the mitochondrial genome from a limited DNA sample 
volume to be used for RFLP screening of the mtDNA. This newly developed protocol 
involved the use of one processed 1.2-mm blood stained FTA disc as DNA template. 
The nine targeted regions of the mitochondrial genome varied in length depending on 
the nucleotide positions of the selected mitochondrial haplogroup specific 
polymorphisms. The amplification was performed in two stages: the first stage involved 
multiplex amplification of the nine targeted regions using nine pairs of oligonucleotides 
which were newly designed in the present study, and the second stage involved 
amplification of the nine regions individually using the product of the first stage PCR as 
DNA template. This newly developed protocol was mainly designed to save DNA 
samples for further analysis which is particularly important in forensic investigations 
which not uncommonly deal with restricted sample volumes. This protocol was 
validated and proved to be reliable via its application to an Egyptian population sample 
of 261 individuals.   
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7.5 A new scheme for mitochondrial haplogroup assignment via 
PCR-RFLP analysis 
 
There are numerous mitochondrial DNA polymorphisms that were previously described 
and have been used for haplogroup identification (Macaulay et al. 1999; Finnila et al. 
2001b), however, some of these nucleotide variations are less specific than others. In 
addition, the global human mitochondrial DNA phylogenetic tree is continuously 
updated with better resolution classification of the mitochondrial lineages (Van Oven 
and Kayser 2009). Therefore, the list of haplogroup specific markers had to be reviewed 
accordingly. A general list of 26 RFLP markers was developed for the preliminary 
analysis which involved screening of 64 Egyptian individuals. Based on the results 
obtained by the preliminary work, a more specific list of 18 RFLP markers was 
developed to be used for mitochondrial haplogroup assignment in the Egyptian 
population. These markers were screened for in all the remaining Egyptian individuals 
separately using thirteen different restriction enzymes in eighteen digestion reactions. 
These digestion reactions were performed in certain order to enable haplogroup 
assignment as accurate and as quick as possible. This newly developed scheme for 
RFLP analysis was proved to be reliable through comparison of the given results to 
those obtained via hypervariable region sequencing.  
 
7.6 Mitochondrial DNA haplogroup distribution in the Egyptian 
population      
 
Using the newly developed scheme of PCR-RFLP analysis of the mitochondrial genome 
together with the hypervariable region sequencing data, mtDNA was confidently 
assigned to well known mitochondrial haplogroups in all the Egyptian population 
sample (n=261). The overall genetic structure of present day Egyptians was found to be 
a mixture of different maternal lineages with varying racial backgrounds. The major 
component of the Egyptian mtDNA dataset was European and constituted around 
62.5% of the whole population. These European lineages were mainly represented by 
haplogroups T, H, U, and HV. The African origin was found in 25% leaving the 
remaining 12.5% for Asian representatives. The African lineages were mainly identified 
as haplogroups L3 and L2, and the Asian derived lineages were mainly M1 and N1b. 
The most frequently reported mitochondrial lineage was the European haplogroup T 
which occurred at a frequency of 13.8%. This frequency is significantly higher than any 
other previously reported figures in North West or East Africa and even higher than the 
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reported frequencies in many European populations where the average was around 
10.5%. This striking finding doubts the early hypothesis which considered haplogroup T 
as European in origin because such a very high frequency in the Egyptian population 
can not be easily explained by the admixture between populations. The next common 
haplogroups were L3, H, U, and M. The African haplogroup L3 was found in 12.6% of 
the Egyptian population and was mainly represented by L3f1 and L3e clades. These 
findings are highly consistent with the results obtained via high-resolution analysis of 
sub-Saharan African mitochondrial DNA lineages. Distribution of which was highly 
affected by the trans-Saharan slave trade (Harich et al. 2010). The European haplogroup 
H was found in 12.3% which is very similar to the frequency reported in Saudi Arabia 
(13%) (Achilli et al. 2004; Abu-Amero et al. 2007) but significantly lower than the 
frequencies reported in North West Africa (Plaza et al. 2003; Turchi et al. 2009). This 
remarkable differential distribution of the European haplogroups T and H in Egypt and 
North West Africa demonstrates that those two lineages found their ways to Africa 
through different routes of human migration. This finding supports the aforementioned 
doubts regarding the origin of haplogroup T. The European Haplogroup U accounted 
for 10% of the Egyptian lineages, of which only 1.5% belonged to haplogroup U6 
which is an established North African lineage. This frequency of U6 is significantly 
lower than the frequencies reported in North West Africa, 6.3 % in Tunisians and 4.7% 
in Moroccans (Plaza et al. 2003; Turchi et al. 2009). Mitochondrial macro-haplogroup 
M was mainly represented by M1 lineage which accounted for 8.4% of the Egyptian 
population. This relatively high frequency of haplogroup M1 disagree with a previous 
study which reported a low frequency of 3%  in Egypt and Israeli Druze (Rowold et al. 
2007). The Asian derived macro-haplogroup N was found in a total of 8.1% and was 
represented by haplogroups N1a, N1b, N1e, W, X, and I. Similar frequencies were 
reported in the Middle East, 9% in Palestine and 8% in Jordan (Gonzalez et al. 2008), 
whereas, most of these N derived lineages were not found in North West Africa. Thus, a 
close genetic relationship between Egypt and the Middle East was not excluded. 
Overall, the genetic structure of present day Egyptians was found to be heterogeneous 
and consisted of a mixture of over twenty different mitochondrial lineages with varying 
racial backgrounds. This mixed maternal ancestry could be the result of admixture 
between past Egyptians and the past ruling populations and/or might have been 
influenced by several waves of modern human migration facilitated by the peculiar 
geographic location of Egypt next to the Levantine Corridor. The frequency distribution 
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of mitochondrial haplogroups showed that Egypt is clearly distinguished from all the 
other African populations including North West Africa. It was concluded that the 
general sub-Saharan maternal gene flow to Egypt was minimal and present day 
Egyptians are genetically related to the Middle East. 
 
7.7 Future work on mitochondrial DNA 
 
The current study has developed an easy and economic method for the analysis of 
mitochondrial DNA without the use of highly advanced technology. This method can be 
applied in mtDNA studies involving other populations in North Africa, which is an 
important geographic area currently lacking the attention of researchers, since not much 
data was published in the last 6 months. Hence, this study helped to enrich the global 
mitochondrial DNA database, not only by adding information about the Egyptian 
population but also by providing a suitable, easy and economic method to be further 
used for the analysis of mtDNA of other North African populations.  
 
Analysis of the mitochondrial HVII region in those Egyptian individuals for whom the 
HVII sequences were not determined in the present study will increase the diversity 
estimates and reduce the number of shared mitochondrial haplotypes and thus will 
demonstrate a higher power of discrimination of the mitochondrial hypervariable 
regions. In addition, the mtDNA database is lacking sufficient information about the 
genetic structure and the haplogroup distribution in the Libyan population which will be 
the future point of interest, due to the long lasting strong relationship between the 
Egyptians and the Libyans through the geographic neighbourhood.   
 
7.8 Screening of amelogenin Y deletion in the Egyptian population  
 
Amelogenin gene is the routinely used locus for gender determination in forensic 
investigations and it is an integral part of the most common multiplexing PCR kits used 
for DNA profiling. However, the lately reported few cases of amelogenin gene deletion 
on the short arm of the Y-chromosome in certain populations (Chang et al. 2007; Yong 
et al. 2007; Kumagai et al. 2008) raised a doubt regarding the absolute validity of using 
amelogenin gene as the only marker for sex determination, particularly in those 
populations. Therefore, amelogenin gene was typed in 131 Egyptian males from 
Alexandria city using PCR amplification and gel electrophoresis and no deletion was 
reported in the studied individuals. However, a larger sample size will be required to 
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provide a better conclusion regarding this issue as the previously reported cases in other 
populations occurred at very low frequencies. 
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